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Executive Summary
1  Background
• Death is an integral part of life. All people die, and 
in high-income countries like Ireland a large and 
growing majority die from serious chronic diseases 
like cancer, heart disease, organ failure and dementia. 
People have a right to compassion, dignity and 
participation in decision-making as they approach 
the end of life.
• The end-of-life period can impose significant 
challenges and burden on individuals with terminal 
illness and their families.
• Care delivery at the end of life involves a mix of 
public, private and informal health and social care 
providers. However, contemporary health systems 
are not well equipped to meet the needs of complex 
ageing populations with many people are living and 
dying with multiple serious conditions.
• The importance of reforming health and social care 
systems, and wider societal structures, to ensure 
that dying people have access to appropriate care 
and psychological and spiritual supports is being 
increasingly recognised.
• To begin to address these aims it is important to 
have a national overview of the existing trends in 
death and dying in the Republic of Ireland.
• This report is the first output of the Palliative and 
End-of-Life Care Ireland (PELCI) project, a 
secondary data analysis project, grant funded by  
the Health Research Board.
2  Place of death
We used Central Statistics Office (CSO) data to analyse 
place of death between 2013 and 2018 across hospital, 
home, long-stay residential care facilities (LSRCFs), 
hospice and elsewhere.
• Hospitals were consistently the most common place 
of death across the six-year period, accounting for 
approximately 40% of deaths in the State. This is 
lower than most similar countries in Europe, which 
is a positive indicator since most people state a 
preference for dying at home provided appropriate 
supports are available. Nevertheless, the proportion 
could almost certainly be lower still with care 
provision that is more responsive to people’s needs 
and preferences.
• Home deaths comprised a consistent proportion 
of state deaths across the time period (23%) but 
with significant regional variations. While Dublin 
experienced 17% of its deaths at home, most 
counties had home death rates above the national 
average. Lower home deaths in Dublin may be 
due to low home care capacity and overreliance 
on hospitals, and/or high home deaths in rural 
areas may be due to improved accessibility to other 
services or high reliance on unpaid family carers.
• There were small increases in the number of deaths 
that occurred in LSRCFs. Within LSRCFs, deaths 
in nursing homes have increased while deaths in 
community hospitals have decreased.
• There was a small increase in hospice deaths, largely 
explained by the increase in the number of in-patient 
hospice beds between 2013 and 2018. Regional 
variations in hospice deaths highlight that only 8  
out of the 26 counties in the State have a hospice.
3  Cause of death
We used CSO data to examine cause of death between 
2013 and 2018. We grouped 1,780 different causes of 
death into eight main categories: cancer, diseases of the 
circulatory system, diseases of the respiratory system, mental 
and behavioural disorders, diseases of the nervous system, 
diseases of the digestive system, external causes of injury 
and poisoning, and other.
• Between 2013 and 2018, cancer replaced diseases 
of the circulatory system as the leading cause of death 
in Ireland, partly reflecting a long-term trend of 
declining heart-related mortality in Ireland. Diseases 
of the respiratory system were the third most 
common cause of death in 2018.
• Deaths caused by mental and behavioural disorders 
increased 61% as both prevalence and identification of 
dementia grew across the health care system.
• Cause of death varied widely by age and gender.  
Most deaths occurred among older people, with 
people aged 65+ accounting for 82% of all deaths 
in 2018. This varies across different cause of death 
categories, ranging from 77% for deaths caused 
by cancer to 99% for deaths caused by mental and 
behavioural diseases. Cancer mortality is higher 
among males, whereas deaths from diseases caused 
by mental and behavioural disorders are more 
prevalent among females.
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• Death and dying are a core activity of acute public 
hospitals in Ireland. We estimate that among 
all adults in an acute public hospital in Ireland 
following emergency admission on a given day,  
one in five will die within the next 12 months.
• Diffusing palliative care approaches across  
hospital staff is essential to meet this large and 
growing need. Moreover, better community services 
could potentially reduce emergency admission of 
patients with serious illness to acute hospitals in 
the first place.
• Weaknesses in data recording and infrastructure 
mean that we do not know how many hospital 
in-patients receive palliative care nationally, and we 
cannot follow their trajectories of experience and 
health care use following hospital discharge.
8  Challenges and policy 
implications
8.1  The need for reliable indicators and 
outcome measures
• Place of death: We examined place of death, which is 
commonly used as an indicator of a ‘good death’  
and as a proxy for quality of care. However, on its 
own, it is not necessarily a good indicator for either 
and the focus needs to be broadened beyond place  
of death as a sole indicator. It should instead be  
used as part of a suite of indicators of quality  
of care at end of life.
• Cause of death: As populations age, and people 
live and die with multiple serious conditions and 
limitations, the concept of a single identifiable ‘cause 
of death’ becomes increasingly flawed. Primary cause 
of death is recorded on the death certificate and is 
often a value judgement of the person reporting. 
Understanding total prevalence of conditions, and 
the co-occurrence of specific conditions, as people 
age and die is critical to planning and providing 
appropriate services.
• Dementia: The proportion of deaths attributed to 
dementia is likely to be an undercount, signalling the 
need for improvements in dementia diagnosis as well 
as better reporting of dementia on death certificates.
• SPC MDS: The SPC MDS does not tell us if there 
is an essential minimum core of professionally 
trained staff with recognised post-qualification 
specialist training in SPC services. Moreover, it does 
not include standardised outcome measures for use 
in evaluating and monitoring the quality of SPC 
services at national level.
• Not all patients who could benefit from SPC 
services will receive those services. Therefore, access 
to a broad range of data, including person-centred 
outcome measures, is needed to understand end-of-
life care of all people with life-limiting illnesses.
• With respect to in-patients in acute hospitals, the 
lack of a reliable indicator of receipt of SPC is 
an important barrier to measuring access and to 
evaluating the effectiveness and cost-effectiveness  
of SPC for in-patients in acute hospital services.
8.2  Classification and coding practices
• The introduction of 11 place of death categories 
by the CSO in 2017 is a positive development and 
allows for reasonably accurate data that will inform 
regional and national trends and impact future 
service planning.
• However, clearer definitions for the included 
categories would be beneficial, in particular 
‘community hospitals’ and ‘nursing homes’, 
to further aid interpretation.
• Each of the datasets accessed classified long-
stay residential care facilities differently, and 
incompatibility across datasets is an issue that  
needs to be addressed. 
• With respect to the SPC MDS, classification 
changes affected comparability over time.
8.3  Absence of a unique patient identifier
• The absence of a unique patient identifier in 
the Republic of Ireland presents challenges for 
secondary data analysis. For example, not being able 
to track people before or following a given hospital 
admission profoundly limits our understanding of 
how they came to be admitted and how they fared 
after discharge.
• Understanding how the trajectory of disease and 
need changes, how people use and access services 
throughout their illness, and how people die 
therefore requires linking multiple data sources  
over time at the individual level.
• The Covid-19 crisis has illustrated the limitations 
imposed on providers and patients by the lack of a 
unique identifier. Acting upon existing legislation 
to implement a unique identifier is a long-standing 
priority in the Irish health system and a pre-requisite 
if patients are to receive responsive, efficient, high-
quality health care across multiple providers and 
settings as they approach end of life.
4  Cancer as a cause of death
As cancer is the primary cause of death in the state and 
a term that covers multiple illnesses, we examined this in 
more detail. We grouped different types of cancer into 
nine categories using CSO data to provide an overview for 
different cancer deaths and how these differ by age and sex.
• Four cancer categories accounted for over three-quarters 
of cancer deaths in 2018: gastrointestinal (31% of 
cancer deaths), respiratory and thoracic (20%),  
breast and gynaecological (14%), and genitourinary 
and testicular (12%).
• Cancer type varied widely by age and gender. Of the 
9,466 deaths due to cancer, 7,245 (77%) were people 
aged 65+. This age group accounts for a minimum of 
half of deaths in each cancer category (56%-89%). 
There were important sex differences, with females 
accounting for a higher proportion of deaths in two 
categories (breast and gynaecological and cancer of 
unknown primary), and males accounting for the 
majority in all other cancer categories.
5  Dementia as a cause of death
As international evidence is showing that deaths caused by 
dementia are increasing, we examined this in more detail. 
We grouped dementia deaths into three categories using 
CSO data: vascular dementia, unspecified dementia and 
Alzheimer’s disease.
• There was a steady increase in deaths caused by dementia 
between 2013 (6% of state deaths) and 2018 (8%). 
Of the 2,466 deaths in 2018, 64% were attributed 
to unspecified dementia, 23% to Alzheimer’s disease 
and the remaining 12% to vascular dementia.
• Factors likely to be contributing to this rise include 
longer life expectancy and increasing dementia 
prevalence, improved diagnosis, and better reporting 
of dementia on death notification forms. It is highly 
likely that there is underreporting of deaths caused by 
dementia.
• Nearly all deaths caused by dementia were among older 
age groups, and the proportion of deaths in each age 
category increased as age increased.
• Women accounted for two-thirds of the deaths caused by 
dementia, highlighting the importance of promoting 
gender-sensitive approaches in end-of-life and 
palliative care services for people with dementia. The 
availability of data showing place of death for people 
with dementia would help inform where the focus 
needs to be for end-of-life and palliative care services 
for people with dementia.
6  HSE Specialist Palliative  
Care Services Minimum Data  
Set (SPC MDS)
The SPC MDS is a national survey of patient activity 
data for specialist palliative care services in the State. We 
examined data from the SPC MDS between 2013 and 
2019 across three main types of SPC: in-patient SPC, 
community SPC and day SPC.
• While there was an upward trend in the number of 
new patients admitted to an in-patient SPC unit 
and receiving community SPC for the first time, the 
number of new patients receiving day SPC decreased 
from 2018.
• Nationally the number of SPC in-patient beds per 
100,000 population increased to 4.7; however, this is 
still below the level recommended by national policy, 
and there is wide variation regionally.
• The majority of new patients receiving in-patient, 
community and day SPC had cancer as a primary 
diagnosis. However, over the seven-year period, 
the proportion of cancer diagnoses receiving these 
services has decreased, and non-cancer diagnoses 
have increased. This is in keeping with the principle 
that palliative care should be available to all, 
irrespective of diagnosis, which underpins national 
policy and the substantial work of the Irish Hospice 
Foundation (IHF) through its Palliative Care for  
All programme.
• With regard to place of death, two-thirds of new 
patients admitted to in-patient SPC units die there, 
with most of the remainder discharged home. The 
place of death for new patients receiving community 
SPC is varied.
7  Hospital In-Patient  
Experience data
We examined Hospital In-Patient Experience (HIPE) data, 
the main source of data on patient activity in acute hospital 
settings, for indications of palliative care and end-of-life 
care need between 2013 and 2017.
• People with a diagnosis of cancer, major organ  
failure or dementia make up approximately half of  
all adult emergency admissions to acute hospitals.  
It is clear that the volume of admissions with  
a serious illness far exceeds the capacity of SPC 
services in acute hospitals.
• These admissions account disproportionately for both 
length of stay and discharges ending in death. Patterns 
of length of stay and discharge locations are broadly 
consistent across hospital groups and over time.
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8.4  Data limitations and gaps
• The wide regional variations with respect to use  
of SPC services and age disparities with respect to 
place of death were highlighted. However, it was 
not possible to show whether such disparities can 
be attributed to variations in need, which would 
be required for the purposes of demonstrating 
inequities that exist.
8.5  Gaining access to data for secondary 
analysis is challenging
• It was intended at the outset of this report to use 
National Cancer Registry (NCRI) data, but access  
to the national dataset was not achieved due to 
NCRI capacity issues.
• While access to data from other sources was 
achieved, capacity issues contributed to delays in 
accessing MDS and HIPE data, and there were 
limits to the level of data that the CSO could 
produce for the research team. Getting access to or 
clarification about data was further hampered by the 
Covid-19 pandemic and in 2021 the cybersecurity 
attack on the HSE.
• There is increasing recognition of the power of data 
to inform better care, but our experience is that 
accessing population data for secondary data analysis 
is problematic. Better systems need to be put in place 
to facilitate researcher access to health and social 
care data, and capacity issues preventing access need 
to be addressed.
8.6  Data on impact of Covid-19 pandemic 
not yet available
• Data for 2020 is not yet available from any of the 
datasets examined and it remains to be seen how 
the Covid-19 pandemic has impacted trends. It is 
highly likely that when the data become available 
it will show that Covid-19 had an impact on place 
of death, SPC activity and utilisation, and hospital 
emergency admissions, as has been shown in other 
countries such as the UK3,4.
• In the UK, concerns have been raised that without 
adequate support and care in the community, dying 
at home may not have been a positive experience 
during the pandemic, and many gaps in knowledge 
were highlighted. In Ireland, even in the absence of 
data, Covid-19 provides us with an opportunity to 
generate debate on important issues relating to  
dying and death.
9  Conclusions
• Population-level monitoring of end-of-life trends 
provides descriptive information that can help 
inform public health policy regarding the  
allocation of end-of-life care resources and  
support improvement strategies.
• Our results can assist provision and planning in 
palliative and end-of-life care by providing, for 
the first time, a national picture of how people die 
in Ireland, and how services such as acute public 
hospitals and SPC care for patients.
• However, our understanding is only as good as the 
available data. We have identified a range of issues 
and challenges in trying to establish the state of 
the nation for death and dying. These include the 
reliability of indicators, the absence of outcome 
measures, classification and coding practices, 
the absence of a unique patient identifier, data 
limitations and gaps, and problems gaining  
access to data, all of which need to be addressed  
if routine data are to be used to inform palliative  
and end-of-life care policy planning, resource 
allocation and practice.
Background
Death is an integral part of life. All people die, and in 
high-income countries a large and growing majority die 
from serious chronic diseases like cancer, heart disease, 
organ failure and dementia.  In Ireland, the number of 
people living and dying with serious chronic disease 
will approximately double over the next 30 years. People 
have a right to compassion, dignity and participation in 
decision-making as they approach the end of life. This 
is important not only so that people are supported as 
well as possible in dying, but also to support family and 
friends for whom death of a loved one is itself a unique 
and important life event. Health systems designed  
a century ago to provide acute, episodic care are not  
well equipped to meet the needs of ageing populations 
where many people are living and dying with multiple 
serious conditions.
Governments increasingly recognise these facts. 
Reforming health and social care systems, and wider 
societal structures, to ensure that dying people have 
access to appropriate care, and psychological and spiritual 
supports, is a declared priority of the European Union 
and its member states. A growing number of European 
countries have focused on data as a key component of any 
strategy to measure and improve end-of-life experiences 
for citizens. Where do people die, and what do they die 
from? What health care do they use? Do they access 
palliative and hospice care? Does experience differ  
by age or disease, geographical region or social class?  
These are important questions, and answering them 
requires appropriate data.
The purpose of this report
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1. Introduction
This chapter presents an overview of deaths in Ireland by 
place of occurrence for the period 2013–2018 inclusive 
using data from the Central Statistics Office (CSO).  
This is the most up-to-date data on place of death at the 
time of writing.  
In Ireland, every death is officially recorded with the 
General Register Office (GRO) in the Department 
of Social Protection using a death registration form. 
These registration forms are the basis for CSO mortality 
statistics, which represent the definitive national dataset 
on all deaths in Ireland, including place of occurrence.
02
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In Ireland and internationally, levels of funding 
for research on death, dying and end-of-life care 
have historically been low. If we are to improve our 
planning and provision of care and supports for people 
approaching end of life in Ireland, then we must first 
establish current patterns of experience. Routinely 
collected health and social care data – that is, data 
generated by administrative and clinical processes and 
not solely for the purposes of research – is the largest 
single source of relevant information.
The aim of this report is to establish what is known 
currently about death and dying in Ireland through 
major sources of routine population-level data collection. 
By establishing what is known, we inform ourselves 
about how people currently die in Ireland, we learn ways 
to improve experiences, and we identify gaps in current 
data collection that should be addressed to strengthen 
future planning and provision.
Data sources and chapters
We accessed data from three main sources to  
evaluate the circumstances surrounding how  
people die in the State:
• Central Statistics Office (CSO) death registration  
data (taken from death certificates)
• Health Service Executive (HSE) Specialist Palliative 
Care Minimum Dataset (SPC MDS), and
• Hospital In-Patient Experience (HIPE) database  
of acute public hospital admissions.
We employ the CSO data in four chapters:
• Chapter 2 examines where people died in Ireland 
2013–2018.
• Chapter 3 examines the primary recorded cause of 
death for people in Ireland 2013–2018.
• Chapter 4 analyses in more detail deaths from cancer in 
Ireland 2013–2018. Cancer is the most common cause 
of death in Ireland according to the most recent data.
• Chapter 5 analyses in more detail deaths from 
dementia in Ireland 2013–2018. Dementia is the 
fastest-growing cause of death in Ireland according  
to the most recent data.
We use the SPC MDS data in one chapter:
• Chapter 6 analyses the number of specialist palliative 
care encounters in Ireland 2013–2019, that is, the 
number of people receiving specialist palliative care  
at home, in in-patient hospices, and in day care.
We use the HIPE data in one chapter:
• Chapter 7 analyses emergency admissions to acute 
public hospitals in Ireland 2013–2017. What 
proportion of admissions are accounted for by those 
with serious chronic illness, what proportion end in 
death, where do people go after discharge, and how  
do these factors vary by region?
Implications of findings
In Chapter 8, we summarise the main findings from our 
analysis and discuss the most important implications 
with respect to data access, classification and coding 
practices, and data gaps and limitations.
Population-level monitoring of end-of-life trends 
provides descriptive information that can help inform 
public health policy regarding the allocation of end-of-
life care resources and support improvement strategies. 
Our results can assist provision and planning in palliative 
and end-of-life care by providing, for the first time, 
a national picture of how people die in Ireland, and 
how the data we collect shapes – and restricts – our 
understanding of these experiences.
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2. Place of death in  
CSO statistics 
The CSO classifies place of death according to 11 
categories: General and Orthopaedic Hospitals, Private 
Hospitals, Community Hospitals, Maternity Hospitals, 
Paediatric Hospitals, Oncology Hospitals, Nursing Homes, 
Psychiatric Hospitals, Hospices, Domiciliary  
and Elsewhere. 
These can be grouped into five places: in a hospital, at home, 
in a long-stay residential care setting, in a hospice and in 
another place. The 11 CSO classifications include discrete 
categories for home, hospice and in another place, and the 
other eight classifications relate to hospital and long-stay 
residential care settings: 
Hospital: Of all deaths in the State, the most common 
place of occurrence is general and orthopaedic hospitals. 
The category ‘general and orthopaedic hospitals’ refers to 
all major acute settings, including for example, university 
and other public hospitals and we look at this category 
separately. A low proportion of deaths occur in other 
hospitals and this report groups together five of these 
hospital types – Private Hospitals, Maternity Hospitals, 
Paediatric Hospitals, Oncology Hospitals and  
Psychiatric Hospitals. 
Long-stay residential care setting: Among the 11 categories 
is ‘community hospitals’. There is no official definition of 
a ‘community hospital’ in Ireland, but the convention is to 
differentiate it from an acute hospital if it does not have an 
accident and emergency department. Effectively community 
hospitals are long-stay residential care facilities1. The CSO 
also uses ‘Nursing Homes’ as a place of death category. In 
Ireland nursing home definitions are broad but in general 
can be taken to mean services that cater for the needs of 
vulnerable and dependent people in residential settings2. 
For the purposes of this report, we have combined the 
categories ‘community hospitals’ and ‘nursing homes’ into 
one category, long-stay residential care facilities. 
The CSO collects data by county and we present those 
data accordingly. It is not possible to provide precise data 
by community healthcare organisation (CHO) regions as 
some counties overlap with more than one CHO. Deaths 
are presented according to the county of residence of the 
decedent, not the county of occurrence. 
Deaths in 2018 by age group and place of death are 
presented in Table 2.1 Ages 65+ account for over 75% of 
deaths in hospital, LSRCF, hospice and home. The majority 
of deaths in LSRCFs are accounted for by those aged over 
85 (61%), whereas in other categories the proportion of 
deaths across age groups is broadly similar. 
3. National overview by place 
of occurrence (2013–2018) 
Of the 31,140 deaths that occurred in Ireland in 2018, 44% 
occurred in a hospital, 23% at home (domiciliary) and 23% 
in a long-stay residential care facility (8% in a community 
hospital and 16% in a nursing home). Eight per cent died  
in a hospice, and 3% died elsewhere (Figure 2.1).
Figure 2.1 
All deaths in Ireland by place of death, 2018 (%)
Figure 2.2  
Place of death trends in Ireland, 2013–2018
Table 2.1.  
State death totals by age: total, and as a proportion (%)  





Hospital LSRCF Hospice Domiciliary Elsewhere 
N (%) N (%) N (%) N (%) N (%) N (%) 
0-4yr 40 (<1) 138 (10) <10 (<1) <10 (<1) 17 (<1) <10 (<1) 
5-14yr 14 (<1) 17 (1) <10 (<1) <10 (<1) 14 (<1) <10 (<1) 
15-24yr 53 (<1) <10 (<1) <10 (<1) <10 (<1) 54 (1) 42 (5) 
25-34yr 109 (1) <10 (<1) <10 (<1) 13 (1) 120 (2) 73 (9) 
35-44yr 232 (2) 24 (2) 19 (<1) 58 (2) 222 (3) 95 (11) 
45-54yr 549 (4) 68 (5) 54 (1) 149 (6) 456 (7) 106 (13) 
55-64yr 1181 (10) 140 (10) 185 (3) 356 (15) 861 (12) 110 (13) 
65-74yr 2533 (21) 275 (20) 594 (8) 642 (27) 1517 (22) 126 (15) 
75-84yr 3942 (32) 419 (30) 1983 (27) 731 (31) 1796 (26) 152 (18) 
85+yr 3616 (29) 299 (21) 4409 (61) 420 (18) 1954 (28) 139 (16) 











Over the six-year period 2013–2018 inclusive, there 
has been little change in the proportion of deaths that 
occurred in each of these settings (Figure 2.2). There was 
a small decrease in the proportion of deaths that occurred 
in hospitals (from 45% in 2013 to 44% in 2018). Small 
increases were recorded in the proportion of deaths that 
occurred in long-stay residential settings (from 22% to 
23%) and hospices (from 6% to 8%). Deaths occurring  
in the home remained constant in proportional terms  
(at 23% in both 2013 and 2018).
Note: in all exhibits, 
percentage totals 
















Domiciliary LSRCFs Hospice Elsewhere
12 Dying and Death in Ireland: What Do We Routinely Measure, How Can We Improve? 13Place of Death
4. Deaths by county and place 
of occurrence (2013–2018) 
4.1 Hospitals 
4.1.1 General and orthopaedic hospitals 
In 2018, 39% of all deaths in the State occurred in general 
and orthopaedic hospitals. There was a small reduction 
over the time period under review from 12,273 deaths in 
2013 (42% of all deaths) to 12,269 deaths in 2018 (39% 
of state deaths in the state (‘state deaths’). However, these 
overall figures conceal the large variation that exists between 
counties with regard to deaths in general and orthopaedic 
hospitals, as shown in Table 2.2. 
We also present the average proportions of deaths in 
general and orthopaedic hospitals in each county within 
the five-year period (Table 2.2). This is calculated using the 
average number of general and orthopaedic hospital deaths 
(2013–2018) and the average number of total deaths within 
each county (2013–2018). 
With respect to the national average, 40% of deaths occurred 
in general and orthopaedic hospitals within the time period. 
Table 2.2 shows that the death rate in 14 counties was higher 
than the national average within this setting (highlighted 
orange). Conversely, in ten counties the death rate was lower 
than the national average (highlighted blue) and in two 
counties it corresponded to the national average  
(highlighted green). 
Louth was the county where the highest proportion of all 
deaths on average occurred in hospital (51%), followed 
by Roscommon (45%), Westmeath (45%), Kildare (44%) 
and Monaghan (44%). The counties with the smallest 
percentage of hospital deaths on average as a proportion  
of all deaths were: Limerick (31%), Clare (32%),  
Donegal (33%), Leitrim (34%) and Cork (35%). 
Table 2.2  
General and orthopaedic hospital deaths by county:  















deaths in a 
G&O hospital 
2013–2018* 
State 12273 (42) 11311 (39) 12050 (40) 12309 (40) 12028 (40) 12269 (39) 12040 (40) 
Leinster
Dublin 3531 (47) 2839 (38) 3573 (45) 3341 (43) 3314 (41) 3228 (40) 3304 (42)
Carlow 164 (42) 162 (44) 141 (36) 154 (40) 136 (34) 151 (41) 151 (39)
Kildare 443 (48) 413 (44) 404 (44) 452 (46) 419 (42) 424 (42) 426 (44)
Kilkenny 273 (42) 200 (36) 235 (38) 262 (39) 238 (38) 286 (43) 249 (40)
Laois 187 (42) 176 (42) 180 (39) 181 (38) 177 (38) 196 (44) 183 (40)
Longford 110 (38) 113 (43) 109 (37) 103 (37) 118 (41) 102 (37) 109 (39)
Meath 381 (46) 369 (43) 382 (43) 392 (45) 399 (44) 394 (40) 386 (43)
Louth 391 (53) 354 (49) 396 (48) 411 (54) 428 (53) 402 (50) 397 (51)
Offaly 219 (46) 179 (39) 192 (40) 219 (44) 206 (44) 229 (47) 207 (43)
Wexford 420 (42) 417 (41) 400 (41) 433 (41) 427 (40) 477 (42) 429 (41)
Wicklow 354 (44) 332 (42) 337 (40) 341 (40) 326 (38) 364 (42) 342 (41)
Westmeath 270 (45) 301 (50) 251 (45) 279 (46) 244 (43) 223 (39) 261 (45)
Munster
Cork 1224 (35) 1176 (35) 1141 (33) 1288 (34) 1298 (35) 1319 (36) 1241 (35)
Clare 249 (31) 239 (29) 281 (33) 280 (32) 283 (36) 281 (33) 269 (32)
Kerry 452 (38) 424 (36) 443 (38) 449 (37) 434 (39) 544 (45) 458 (39)
Limerick 420 (31) 430 (31) 406 (30) 459 (32) 409 (30) 475 (33) 433 (31)
Tipperary 481 (38) 458 (38) 467 (37) 502 (37) 456 (37) 459 (36) 471 (37)
Waterford 355 (44) 361 (44) 341 (43) 354 (42) 357 (47) 342 (42) 352 (43)
Connacht
Leitrim 92 (35) 84 (34) 94 (33) 99 (34) 86 (34) 90 (32) 91 (34)
Sligo 172 (36) 180 (39) 181 (36) 195 (39) 172 (34) 179 (35) 180 (36)
Galway 653 (44) 649 (43) 656 (43) 659 (42) 621 (40) 622 (40) 643 (42)
Mayo 457 (40) 439 (41) 429 (40) 446 (41) 445 (41) 457 (41) 446 (41)
Roscommon 226 (47) 244 (47) 246 (47) 221 (43) 215 (46) 213 (40) 228 (55)
Ulster RoI
Cavan 219 (44) 210 (41) 230 (46) 226 (43) 218 (44) 213 (42) 219 (43)
Donegal 354 (32) 373 (330) 353 (31) 395 (35) 410 (34) 398 (34) 381 (33)
Monaghan 176 (43) 189 (44) 182 (44) 168 (39) 192 (45) 201 (47) 185 (44)
*  Counties highlighted in green correspond to the national average,  
counties highlighted in orange are higher than the national average  
and counties highlighted in blue are below the national average.
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4.1.2 Other hospitals
As well as deaths occurring in general and orthopaedic 
hospitals, deaths occur in a range of other hospitals 
including private hospitals, maternity hospitals, oncology 
hospitals, paediatric hospitals and psychiatric hospitals. 
In 2017, 4% of all deaths in the State occurred in other 
hospitals. Over the period under review, the proportion of 
deaths that occurred in other hospitals remained the same.
In Table 2.3 we present a national breakdown of the other 
hospital categories and their death rates across the six-year 
period. We do not report county-level rates for two reasons. 
First, low numbers of deaths in some settings for some 
counties undermine the anonymity of decedents. Second, 
these speciality hospitals are not evenly distributed across 
the country so county-level comparisons would be skewed 
by, for example, the higher prevalence of private hospitals in 
Dublin. Whereas private hospitals accounted for an average 
of 3% of deaths in the State between 2013–2018, they 
accounted for an average of 6.6% in Dublin. Nationally, 
the proportion of private hospital deaths (3%) remained 
relatively unchanged across the six-year period, despite 
the number of deaths increasing between 2013 and 2018. 
There was a notable spike nationally in 2014 (1,609 deaths) 
whereby figures more than doubled compared to 2013 
(797 deaths) and 2015 (781 deaths). To the best of our 
understanding this reflects a data measurement issue for 
the CSO (e.g. some hospices were included in the data for 
one year) and not a like-for-like comparison across years 
(e.g. private hospitals admitted double the usual number of 
people approaching end of life due to a policy or  
system factor).
The remaining ‘other hospitals’ (psychiatric, maternity, 
paediatric and oncology) each accounted for less than  
1% of national deaths in each of the years between  
2013 and 2018.
4.2 Long-stay residential care 
facilities
When the data on community hospitals and nursing homes 
are combined, just over one-fifth of deaths in Ireland occur 
in long-stay residential care facilities. Figure 2.3 shows 
that the number of deaths in long-stay residential care 
facilities rose from 6,417 in 2013 to 7,247 in 2018. This is 
an approximate increase of 13% in the absolute number of 
deaths when comparing 2013 to 2018. With respect to the 
proportion of state deaths, this corresponds to a 1% increase 
(22% to 23%).
When nursing homes and community hospitals are 
examined separately, distinct trends are observable. For 
nursing homes, the number of deaths increased from 3,976 
in 2013 to 4,894 in 2018, an increase of 23% in absolute 
number of deaths and a 3% change in proportion of state 
deaths (13% to 16%). For community hospitals, the number 
of deaths decreased from 2,441 in 2013 to 2,352 in 2018, 
a decrease of 4% in absolute number of deaths, and the 
proportion of state deaths remained at 8% in both years.
Table 2.3  





















Hospitals’ 1146 (4) 1891 (6) 1067 (4) 1185 (4) 1159 (4) 1391 (4) 1307 (4)
Psychiatric 
Hospitals 64 (<1) 48 (<1) 72 (<1) 67 (<1) 52 (<1) 79 (<1) 64 (<1)
Private  
Hospitals 797 (3) 1609 (6) 781 (3) 919 (3) 909 (3) 1039 (3) 1009 (3)
Maternity  
Hospitals 123 (<1) 102 (<1) 112 (<1) 88 (<1) 92 (<1) 100 (<1) 103 (<1)
Paediatric  
Hospitals 99 (<1) 97 (<1) 72 (<1) 70 (<1) 77 (<1) 146 (<1) 94 (<1)
Oncology  
Hospitals 63 (<1) 35 (<1) 30 (<1) 41 (<1) 29 (<1) 27 (<1) 38 (<1)
Figure 2.3  
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Table 2.4.  















deaths in a com-
munity hospital 
2013–2018* 
State 2441 (8) 2264 (8) 2476 (8) 1876 (6) 1782 (6) 2352 (8) 2199 (7)
Leinster
Dublin 377 (5) 360 (5) 393 (5) 285 (4) 278 (3) 445 (5) 356 (4)
Carlow 53 (14) 42 (11) 43 (11) 28 (7) 39 (10) 31 (8) 39 (10)
Kildare 52 (6) 58 (6) 42 (5) 39 (4) 29 (3) 29 (3) 42 (4)
Kilkenny 55 (9) 46 (8) 55 (9) 50 (8) 53 (9) 50 (7) 52 (8)
Laois 41 (9) 47 (11) 39 (8) 25 (5) 36 (8) 31 (7) 37 (8)
Longford 13 (4) 15 (6) 26 (9) <10 (1) 13 (4) 25 (9) 16 (6)
Meath 33 (4) 17 (2) 34(4) 30 (3) 15 (2) 39 (4) 28 (3)
Louth 44 (6) 35 (5) 44 (5) 28 (4) 26 (3) 46 (6) 37 (5)
Offaly 35 (7) 37 (8) 50 (10) 27 (5) 22 (5) 27 (6) 33 (7)
Wexford 102 (10) 87 (9) 77 (8) 71 (7) 73 (7) 90 (8) 83 (8)
Wicklow 40 (5) 42 (5) 53 (6) 37 (4) 32 (4) 50 (6) 42 (5)
Westmeath 64 (11) 39 (6) 46 (8) 17 (3) <10 (1) 34 (6) 35 (6)
Munster
Cork 381 (11) 349 (10) 413 (12) 279 (7) 371 (10) 414 (11) 368 (10)
Clare 118 (15) 107 (15) 105 (12) 123 (14) 56 (7) 99 (12) 101 (12)
Kerry 126 (11) 146 (12) 170 (15) 158 (13) 141 (13) 132 (11) 146 (12)
Limerick 96 (7) 96 (7) 114 (8) 63 (4) 48 (4) 99 (7) 86 (6)
Tipperary 126 (10) 114 (9) 150 (12) 115 (8) 85 (7) 115 (9) 118 (9)
Waterford 120 (15) 84 (10) 88 (11) 99 (12) 61 (8) 74 (9) 88 (11)
Connacht
Leitrim 39 (15) 48 (19) 43 (15) 29 (10) 20 (8) 28 (10) 35 (13)
Sligo 66 (14) 57 (12) 57 (11) 39 (8) 36 (7) 40 (8) 49 (10)
Galway 58 (4) 55 (4) 50 (3) 31 (2) 39 (3) 75 (5) 51 (3)
Mayo 138 (12) 118 (11) 123 (12) 93 (8) 94 (9) 94 (8) 110 (10)
Roscommon 43 (9) 36 (7) 36 (7) 24 (5) 19 (4) 45 (8) 34 (7)
Ulster RoI
Cavan 19 (4) 25 (5) 22 (4) 15 (3) 19 (4) 41 (8) 24 (5)
Donegal 174 (15) 189 (17) 196 (17) 141 (12) 155 (13) 175 (15) 172 (15)
Monaghan 28 (7) 15 (4) <10 (2) 26 (6) 14 (3) 24 (6) 19 (4)
*  Counties highlighted in green correspond to the national average,  counties highlighted in orange are higher than the national average 
and counties highlighted in blue are below the national average.
4.2.1 Community hospitals
In Table 2.4 we present the average proportions of deaths 
in community hospitals in each county within the six-
year period (Table 2.4). The state average showed that 
7% of deaths occurred in community hospitals within 
the time period. In Table 2.4, 13 counties are shown 
(highlighted orange) as experiencing a higher death rate 
than the national average within this setting. Conversely, 
11 counties (blue) experienced a lower death rate and two 
counties matched the national average (green). Over the 
six-year period, there is a marked variance between counties 
with respect to the proportion of all deaths that occur in 
community hospitals, ranging from 1% (Longford, 2016) to 
19% (Leitrim, 2014) of all deaths in the county. For some 
counties the proportion of deaths varied greatly from one 
year to the next.
In the six-year period, Donegal has the highest average 
proportion of deaths occurring in community hospitals 
(15%), followed by Leitrim (13%), Kerry (12%), Clare 
(12%) and Waterford (11%). The counties with the smallest 
percentage of deaths were: Galway (3%), Meath (3%), 
Kildare (4%), Monaghan (4%) and Dublin (5%).
4.2.2 Nursing homes
In Table 2.5 we present the average proportions of deaths 
in nursing homes in each county within the six-year 
period. In the State, on average, 15% of deaths occurred 
in nursing homes over the period 2013 to 2018. Table 2.5 
shows that 12 counties (highlighted orange) experienced 
a death rate higher than the national average within this 
setting. Conversely, ten counties (blue) experienced a death 
rate lower than and four counties corresponded with the 
national average (green). Similar to community hospitals, 
there is a marked variance between counties with respect 
to the proportion of all deaths that occur in nursing homes. 
For example, this can range from 6% to 25% of all deaths in 
the county, and for some counties the proportion of deaths 
varied greatly from one year to the next.
Limerick has the highest average proportion of deaths 
occurring in nursing homes (21%), followed by Tipperary 
(19%), Longford (19%), Wexford (19%) and Westmeath 
(17%). The counties with the smallest percentage of nursing 
home deaths on average were: Donegal (9%), Sligo (12%), 
Leitrim (13%), Carlow (13%) and Clare (14%).
Table 2.5.  















deaths in a 
nursing home 
2013–2018** 
State 3976 (13) 3860 (13) 4408 (15) 5117 (17) 5201 (17) 4895 (16) 4576 (15)
Leinster
Dublin 967 (13) 982 (13) 1114 (14) 1197 (16) 1349 (17) 1286 (16) 1149 (15)
Carlow 38 (10) 40 (11) 56 (14) 60 (16) 72 (18) 46 (12) 52 (13)
Kildare 104 (11) 135 (14) 141 (15) 142 (14) 183 (18) 168 (17) 146 (15)
Kilkenny 75 (12) 94 (17) 110 (18) 127 (19) 109 (17) 119 (18) 106 (17)
Laois 64 (14) 54 (13) 80 (17) 86 (18) 86 (18) 71 (16) 74 (16)
Longford 54 (19) 50 (19) 49 (17) 70 (25) 60 (21) 39 (14) 54 (19)
Meath 102 (12) 143 (17) 135 (15) 137 (16) 159 (18) 150 (15) 138 (16)
Louth 78 (11) 103 (14) 123 (15) 111 (15) 131 (16) 102 (13) 108 (14)
Offaly 67 (14) 48 (10) 68 (14) 83 (17) 92 (20) 66 (14) 71 (15)
Wexford 150 (15) 160 (16) 193 (20) 226 (22) 203 (19) 210 (19) 190 (19)
Wicklow 115 (14) 127 (16) 145 (17) 143 (17) 155 (18) 127 (15) 135 (16)
Westmeath 94 (16) 85 (14) 91 (16) 117 (19) 120 (21) 98 (17) 101 (17)
Munster
Cork 441 (13) 388 (12) 427 (12) 620 (17) 498 (13) 521 (14) 483 (14)
Clare 128 (16) 102 (12) 93 (11) 96 (11) 111 (14) 144 (17) 112 (14)
Kerry 183 (15) 152 (13) 151 (13) 178 (15) 178 (16) 172 (14) 169 (14)
Limerick 283 (21) 259 (18) 281 (20) 350 (24) 308 (23) 294 (20) 296 (21)
Tipperary 216 (17) 177 (15) 228 (18) 293 (22) 286 (23) 256 (20) 243 (19)
Waterford 109 (13) 114 (14) 124 (15) 161 (19) 137 (18) 151 (18) 133 (16)
Connacht
Leitrim 26 (10) 16 (6) 31 (11) 39 (13) 48 (19) 53 (19) 36 (13)
Sligo 36 (8) 37 (8) 61 (12) 75 (15) 73 (14) 69 (13) 59 (12)
Galway 233 (16) 203 (13) 230 (15) 252 (16) 313 (20) 260 (17) 249 (16)
Mayo 147 (13) 122 (11) 124 (12) 180 (16) 173 (16) 164 (15) 152 (14)
Roscommon 43 (9) 36 (7) 36 (7) 24 (5) 19 (4) 45 (8) 34 (7)
Ulster RoI
Cavan 76 (15) 73 (14) 79 (16) 80 (15) 75 (15) 74 (15) 76 (15)
Donegal 85 (8) 70 (6) 110 (10) 122 (11) 134 (11) 114 (10) 106 (9)
Monaghan 44 (11) 50 (12) 70 (17) 77 (18) 59 (14) 47 (11) 58 (14)
*  Counties highlighted in green correspond to the national average,  counties highlighted in orange are higher than the national average 
and counties highlighted in blue are below the national average.
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4.3 Hospices
Hospices are specialist units which provide palliative care. 
Individuals can attend a hospice as an in-patient or an out-
patient (day-care). There was a 16% increase in hospice bed 
capacity between 2013 (190 beds) and 2018 (221 beds).
On average, 7% of all deaths in the State occurred in 
hospices, increasing from 1,883 deaths in 2013 (6% of  
state deaths) to 2,373 deaths by 2018 (8% of state deaths) 
(Table 2.6). This is an approximate increase of a quarter 
(26%) in absolute number of hospice deaths when 
comparing 2018 to 2013.
We also present the average proportions of deaths in 
hospices in each county within the six-year period (Table 
6). The state average showed that 7% of deaths occurred in 
hospices within the time period. In Table 2.6, eight counties 
(highlighted orange) experienced a death rate higher than 
the national average within this setting. Conversely, 17 
counties (blue) experienced a death rate lower than and 
1 county corresponded with the national average (green). 
Including this differential allows us to demonstrate which 
counties are diverging from national average.
Sligo has the highest average proportion of deaths occurring 
in hospices (16%), followed by Cork (13%), Limerick 
(12%), Clare (12%) and Dublin (11%). The counties with 
the smallest average percentage of hospice deaths were 
Kilkenny, Offaly, Laois and Carlow, with deaths in hospices 
accounting in each of these counties for less than 1% of 
average county deaths (see Table 2.6). This highlights the 
requirement for individuals to travel outside their county of 
residence to receive hospice care, as 18 counties in the State 
did not have hospices during the six-year period. Some of 
the variation in hospice deaths by county may be explained 
by changing capacity over the time period, and we return to 
this in Section 5.
Table 2.6  















of deaths in 
a hospice 
2013–2018* 
State 1883 (6) 2074 (7) 2285 (8) 2388 (8) 2455 (8) 2373 (8) 2243 (7)
Leinster
Dublin 724 (10) 780 (10) 884 (11) 910 (12) 1023 (13) 997 (12) 886 (11)
Carlow <10 (1) <10 (<1) <10 (<1) <10 (1) <10 (<1) 3 (1) 2 (<1)
Kildare 62 (7) 57 (6) 67 (7) 66 (7) 81 (8) 81 (8) 69 (7)
Kilkenny <10 (1) <10 (<1) <10 (<1) <10 (<1) <10 (<1) 1 (<1) 1 (<0)
Laois <10 (<1) <10 (<1) <10 (<1) <10 (<1) <10 (<1) 5 (1) 2 (<1)
Longford <10 (<1) <10 (1) <10 (<1) <10 (1) <10 (1) 1 (<1) 2 (1)
Meath 13 (2) 16 (2) 25 (3) 59 (7) 47 (5) 46 (5) 34 (4)
Louth <10 (1) <10 (1) <10 (1) <10 (1) <10 (1) 8 (1) 6 (1)
Offaly <10 (<1) <10 (<1) <10 (<1) <10 (<1) <10 (<1) 2 (<1) 2 (<1)
Wexford <10 (1) <10 (1) <10 (<1) <10 (<1) <10 (<1) 7 (1) 5 (<1)
Wicklow 32 (4) 37 (5) 30 (4) 31 (4) 49 (6) 44 (5) 37 (4)
Westmeath <10 (<1) 12 (2) 11 (2) 14 (2) 12 (2) 24 (4) 12 (2)
Munster
Cork 394 (11) 406 (12) 526 (15) 531 (14) 487 (13) 399 (11) 457 (13)
Clare 53 (7) 128 (15) 118 (14) 117 (13) 119 (15) 64 (7) 100 (12)
Kerry 12 (1) 16 (1) 14 (1) 18 (1) 13 (1) 9 (1) 14 (1)
Limerick 139 (10) 169 (12) 168 (12) 172 (12) 176 (13) 181 (12) 168 (12)
Tipperary 41 (3) 40 (3) 43 (3) 33 (2) 35 (3) 42 (3) 39 (3)
Waterford <10 (1) <10 (1) 10 (1) <10 (1) <10 (1) 11 (1) 8 (1)
Connacht
Leitrim 30 (12) 25 (10) 19 (7) 45 (15) 30 (12) 32 (11) 30 (11)
Sligo 91 (19) 77 (17) 73 (14) 63 (12) 76 (15) 87 (17) 78 (16)
Galway 100 (7) 131 (9) 129 (8) 144 (9) 120 (8) 143 (9) 128 (8)
Mayo 22 (2) 17 (2) 16 (2) <10 (<1) 16 (1) 20 (2) 16 (1)
Roscommon 12 (2) 10 (2) <10 (2) <10 (2) <10 (1) 14 (3) 10 (2)
Ulster RoI
Cavan 19 (4) 13 (3) 10 (2) 20 (4) 21 (4) 20 (4) 17 (3)
Donegal 110 (10) 105 (9) 116 (10) 122 (11) 115 (10) 126 (11) 116 (10)
Monaghan <10 (1) <10 (2) <10 (1) <10 (1) 11 (3) 6 (1) 7 (2)
*  Counties highlighted in green correspond to the national average,  counties highlighted in orange are higher than the national average 
and counties highlighted in blue are below the national average.
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4.4 Domiciliary
Close to 7,000 people die at home each year, representing 
just under a quarter (23%) of all deaths in the State. There 
was an approximate increase of 5% in the absolute number 
when comparing 2013 to 2018, consistent with overall 
trends in the time period.
We also present the average proportions of domiciliary 
deaths in each county within the six-year period (Table 
2.7). On average, 23% of all deaths were domiciliary 
deaths within the time period. In Table 2.7, 20 counties 
(highlighted orange) experienced a death rate higher than 
the national average within this setting. Conversely, three 
counties (blue) experienced a lower death rate and three 
counties matched the national average (green). There is 
considerable variation across counties with respect to the 
proportion of deaths that occur at home, ranging from  
17% to 34% in 2018.
Longford has the highest average proportion of domiciliary 
deaths (30%), followed by Kilkenny (30%), Monaghan 
(30%), Carlow (29%) and Offaly (29%). The counties with 
the smallest average percentage of domiciliary deaths were: 
Dublin (17%), Kildare (21%), Cork (21%), Sligo (23%) and 
Clare (23%) (Table 2.8).
4.5 Elsewhere
In the CSO data, ‘elsewhere’ is defined as ‘Deaths that 
occurred in locations other than those listed’. This includes 
deaths in hotels and similar accommodation, on roads, at 
rivers and lakes, in public places, etc. On average, 3% of  
all state deaths occurred ‘elsewhere’, falling from 1,124 
deaths in 2013 (4% of state deaths) to 843 deaths in 2018 
(3%) (Table 2.8). This is a 25% decrease in absolute number  
of deaths that occurred ‘elsewhere’ when comparing  
2013 to 2018.
We also present the average proportions of deaths that 
occurred ‘elsewhere’ for each province within the six-
year period (Table 2.8). Table 2.8 shows that the average 
proportion of deaths that occurred ‘elsewhere’ was higher 
than the national average in three provinces (highlighted 
orange): Ulster ROI (4%), Munster (4%) and Connacht 
(4%). Leinster corresponded to the national average (green) 
(3%). Including this differential allows us to demonstrate 
which counties are diverging from the national average.
Table 2.7  


















State 6661 (23) 6788 (23) 6921 (23) 6849 (22) 6898 (23) 7012 (23) 6855 (23)
Leinster
Dublin 1266 (17) 1310 (17) 1343 (17) 1313 (17) 1369 (17) 1352 (17) 1326 (17)
Carlow 104 (27) 97 (26) 125 (32) 117 (31) 124 (31) 109 (30) 113 (29)
Kildare 186 (20) 195 (21) 188 (20) 211 (21) 213 (21) 221 (22) 202 (21)
Kilkenny 188 (29) 181 (32) 192 (31) 189 (28) 197 (32) 181 (27) 188 (30)
Laois 112 (25) 118 (28) 138 (30) 155 (32) 139 (30) 120 (27) 130 (29)
Longford 90 (31) 65 (25) 93 (32) 80 (29) 85 (29) 92 (34) 83 (30)
Meath 249 (30) 232 (27) 262 (29) 186 (21) 225 (25) 261 (27) 236 (26)
Louth 176 (24) 169 (23) 217 (27) 170 (22) 176 (22) 200 (25) 185 (24)
Offaly 118 (25) 164 (36) 147 (31) 132 (27) 123 (26) 140 (29) 137 (29)
Wexford 264 (27) 279 (27) 248 (25) 267 (25) 285 (27) 284 (25) 271 (26)
Wicklow 177 (22) 169 (21) 196 (23) 212 (25) 222 (26) 201 (23) 196 (24)
Westmeath 140 (23) 137 (23) 132 (24) 147 (24) 153 (27) 165 (29) 146 (25)
Munster
Cork 751 (22) 753 (22) 730 (21) 773 (21) 778 (21) 744 (20) 755 (21)
Clare 184 (23) 174 (21) 195 (23) 189 (22) 179 (22) 220 (26) 190 (23)
Kerry 288 (24) 306 (26) 311 (27) 297 (24) 269 (24) 273 (23) 291 (25)
Limerick 332 (25) 365 (26) 337 (25) 330 (23) 363 (27) 349 (24) 346 (25)
Tipperary 328 (26) 343 (28) 312 (25) 326 (24) 302 (24) 338 (27) 325 (26)
Waterford 195 (24) 213 (26) 208 (26) 185 (22) 174 (23) 203 (25) 196 (24)
Connacht
Leitrim 56 (22) 68 (27) 83 (29) 65 (20) 56 (22) 66 (23) 66 (24)
Sligo 94 (20) 91 (20) 116 (23) 114 (23) 134 (26) 126 (24) 113 (23)
Galway 347 (23) 364 (24) 364 (24) 363 (23) 339 (22) 363 (23) 357 (23)
Mayo 304 (26) 289 (27) 299 (28) 298 (27) 293 (27) 313 (28) 299 (27)
Roscommon 113 (23) 125 (24) 122 (23) 127 (25) 115 (24) 132 (25) 122 (24)
Ulster RoI
Cavan 129 (26) 143 (28) 129 (26) 160 (31) 128 (26) 132 (26) 137 (27)
Donegal 341 (30) 313 (28) 313 (27) 309 (27) 332 (28) 308 (26) 319 (28)
Monaghan 129 (31) 125 (29) 121 (29) 134 (31) 125 (29) 119 (28) 126 (30)
*  Counties highlighted in green correspond to the national average,  counties highlighted in orange are higher than the national average 
and counties highlighted in blue are below the national average.
Table 2.8  


















State 1124 (4) 1064 (4) 920 (3) 943 (3) 895 (3) 848 (3) 966 (3)
Leinster 455 (3) 406 (3) 362 (2) 366 (2) 375 (2) 345 (2) 385 (3)
Munster 394 (4) 420 (5) 345 (4) 350 (4) 316 (4) 296 (3) 354 (4)
Connacht 182 (5) 143 (4) 129 (3) 162 (4) 133 (3) 125 (3) 146 (4)
Ulster ROI 93 (5) 95 (5) 84 (4) 65 (3) 71 (3) 82 (4) 82 (4)
*  Provinces highlighted in green correspond to the national average,  counties highlighted in orange are higher than the national average 
and counties highlighted in blue are below the national average.
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5 Summary and policy 
implications
This chapter has used the CSO data on death to summarise 
data currently available on the place of death in Ireland for 
the period 2013–2018 inclusive. In this section we consider 
and interpret the key findings.
5.1 Hospital death rate is steady, 
but poorly aligned with 
population preferences
The CSO data show that hospital is the most common 
place of death in Ireland. This is the case for all age groups, 
apart from those aged 85+. Approximately 40% of deaths 
in Ireland occur in acute general and orthopaedic hospitals, 
highlighting the importance of continuing to expand and 
improve palliative care provision in hospital settings3.
The proportion of people in Ireland who die in hospital 
remains far in excess of the proportion of people who state 
a preference for dying in a hospital4. Moreover, deaths in 
hospital often offer poor-value care: acute in-patient care 
costs are high, and often the needs of dying patients would 
be met more appropriately elsewhere. Among western 
European countries, the  hospital death rate of 40% is 
lower than average but far higher than countries like the 
Netherlands (22% in 20175) and Norway (31%6). Ireland, 
like most high-income countries, must continue to reduce 
the in-hospital mortality rate in the context of population-
level preferences, costs and future needs. The goal should 
be to reduce the in-hospital mortality rate without 
compromising the level or quality of care for a person  
at the end of their life.
These national data come with two important caveats. 
First, there are people for whom the hospital setting is 
appropriate to needs and preferences. For example, in a 
survey of 356 bereaved relatives undertaken in two acute 
hospitals in Dublin with established palliative care services, 
81% reported that on balance hospital was the appropriate 
place of death and 87% rated the overall quality of end-of-
life care highly7. Second, while the majority of people state a 
preference for dying outside hospital, these preferences may 
change during disease progression, particularly if needs are 
complex and there is limited homecare and family support8. 
While more research is needed to quantify how many 
people change preferences in this way and why, it is essential 
that health services are responsive to these changing needs. 
Given that 12% of bereaved relatives thought that hospital 
was not the right place of death for their relative7, there is 
some margin for reducing hospital deaths.
The CSO data also show that, as well as deaths in general 
and orthopaedic hospitals, an additional 4% of all deaths 
in Ireland occur in ‘Other Hospitals’, a figure that has 
remained relatively stable over the period under review. 
While deaths in these ‘other hospitals’ represent a small 
proportion of all deaths, this figure is still important.  
This grouping is made up of a disparate range of hospitals 
meeting the needs of the diverse groups of people  
(e.g. paediatric, maternity, psychiatric and oncology-specific 
hospitals, and private hospitals). These data highlight  
the need for optimising end-of-life and palliative care 
services across all hospital settings. Palliative care services 
in all hospital settings need to be tailored to the needs  
of the people being cared for at end of life in specific 
hospital contexts.
5.2 Deaths in nursing home rise 
quickly as deaths in community 
hospitals fall
The proportion of all deaths that occurred in long-stay 
residential care facilities increased from 22% to 23% in the 
six-year period. Although the changes are relatively small, 
they may be an indication that when residents of long-stay 
residential care facilities are dying, an increasing number are 
being cared for in their place of residence, rather than being 
transferred to a hospital to die. Long-stay residential care 
facilities are an important place of death for older people; 
96% of all deaths in LSRCFs are of people aged 65+ and  
a greater proportion of people aged 85+ die in LSRCFs 
than in hospitals.
When the two types of long-stay residential facilities are 
examined separately, we observe clear and different trends. 
Of the places examined in this report, the fastest increase in 
number of deaths was in nursing homes and fastest decrease 
in community hospitals.
These trends raise important questions. Are nursing homes 
meeting the end-of-life care needs of residents better than 
community hospitals? Are these trends linked to a growth 
in the private and voluntary nursing home sector, and  
a reduction in the role of public sector when it comes  
to long-stay residential care? These questions warrant  
further consideration.
5.3 Hospice deaths are more 
commonplace but still a minority
The data show that there has been an increase in the 
proportion of deaths in hospices over the period under 
review, from 6% to 8%, reflecting the small increase in the 
number of in-patient hospice beds that were made available 
during this period, from a total of 190 beds in ten hospices 
across the country in 2013 to 221 beds in eleven hospices by 
the end of 2017. The data show marked regional variation 
with respect to the proportion of deaths that occur in 
hospices. Of the eight counties that experienced a death 
rate in hospices that was higher than the national average, 
seven were counties in which a hospice was located. This 
underscores the need for regional change to improve access 
to in-patient hospice care and reduce geographical inequity. 
The opening of new hospices in Mayo and Wicklow in 
2021 and the planned opening of a hospice in Waterford 
will increase hospice bed capacity nationally and at the same 
time will help improve access to hospices geographically.
5.4 Deaths at home remain steady, 
well below population preferences
The CSO data show that nearly a quarter (23%) of deaths 
occur at home, and this proportion was steady in the 
period under review. Given that around two-thirds of the 
population in Ireland state a preference for dying at home, 
the data suggest that at the population-level the preferences 
of many people are not being met.
The reasons behind the divergence between preferred place 
of death and actual place of death are complex. Evidence 
from research consistently shows that a majority of the 
population favour death in their own home if appropriate 
supports are available4,9. However, people are reluctant to 
face the end-of-life period at home if professional help 
is inaccessible or the care burden falls too heavily on 
family and close friends. Preferences also change as health 
deteriorates and needs grow.
People with complex needs and fewer family supports may 
therefore be more likely to spend their end-of-life period 
in hospital or in a long-stay residential care facility. As the 
population ages, this issue will become more pressing10.  
This highlights the need for more development of supports 
to enable more people with complex needs to stay at home 
and, where this is their preference and is appropriate, to 
die at home. To achieve this, more investment is needed 
to integrate palliative care into home care services. 
Engagement between generalist and specialist palliative 
care and other health and social care services, including 
primary care and home-based services, is also needed. It 
must be remembered that place of death is often regarded 
as a quality indicator for evaluating end-of-life care at the 
population level. However, given that the quality of an 
individual’s end-of-life care is determined by a complex 
interplay of factors, some of which are not easily modified11, 
place of death, on its own, is not necessarily a very good 
indicator of a ‘good death’. However, it could form part of a 
suite of quality of care indicators at the end of life.
5.5 Data collection practices are a 
challenge for interpretation
Place of death is currently classified by the CSO in 11 
categories: General and Orthopaedic Hospitals, Private 
Hospitals, Community Hospitals, Maternity Hospitals, 
Paediatric Hospitals, Oncology Hospitals, Nursing 
Homes, Psychiatric Hospitals, Hospices, Domiciliary and 
Elsewhere. This 11-category classification was introduced 
in 2017 and its introduction is important as the previous 
classification, with just four categories, was considered 
outdated and failed for the most part to correspond in any 
meaningful way to where people die or may be cared for at 
the end of life12. The new 11-category classification, which 
was applied retrospectively to data for the years 2013 to 
2018 by the CSO, allows for reasonably accurate data that 
will inform regional and national trends of place of death 
and impact future service planning.
However, interpreting CSO data on place of death can still 
be challenging as the CSO does not provide definitions for 
each category. In particular, a definition is not provided for 
‘community hospitals’, which is not surprising, as there is 
no official definition of a ‘community hospital’ in Ireland. 
Similarly, no definition is provided for ‘nursing homes’, 
which again is not surprising as in Ireland definitions of 
a nursing home are somewhat broad and can be open to 
interpretation. For the purposes of this report, we have 
combined the categories ‘community hospitals’ and ‘nursing 
homes’ into one category, i.e., long-stay residential care 
facilities, allowing us to report data on deaths in these 
facilities separately to hospital deaths. However, without 
clear definitions, the findings are less meaningful and open 
to interpretation.





This chapter examines the leading causes of death in Ireland 
during the years 2013–2018 using mortality data from the 
Central Statistics Office (CSO). Every death in the State 
is registered with the General Register Office (GRO). 
Following a death, an attending physician completes a 
medical certificate of the primary and contributory causes 
of death1 and this and other information are reported to the 
GRO and CSO. In this chapter, the term ‘cause of death’ is 
used to refer to the primary cause of death as recorded on 
medical certificates and reported by the GRO and CSO. 
Identifying a single ‘primary’ or ‘underlying’ cause of death 
is a challenging exercise with no ‘true’ answer. This is the 
case for many deaths, and particularly deaths among older 
people with multiple serious illnesses1. In addition, errors  
in death certificates are common2–4 and it is likely that there 
are issues with respect to data accuracy and completeness  
in this dataset.
The CSO data list 1,780 different causes of death and  
these have been grouped into eight main categories for  
the purposes of this chapter. The eight ‘cause of death’ 
categories and their corresponding ICD-10 codes5 are 
presented in Table 3.1.
Table 3.1  
Cause of death categories and corresponding ICD-10 codes
Cause of death categories Common examples ICD-10 Codes
Cancer Malignant neoplasms: breast, digestive organs, genital organs,  
bone, skin, thyroid
C00-D48
Diseases of the circulatory system Heart attack, chronic heart failure, angina, hypertension, arrhythmia I00-I99
Diseases of the respiratory system Chronic bronchitis, cystic fibrosis, chronic obstructive  
pulmonary disease (COPD)
J00-J99
Mental and behavioural disorders Vascular dementia, eating disorders, abuse of non-dependence-producing 
substances, mental and behavioural disorders due to alcohol
F00-F99
Diseases of the digestive system Inflammatory bowel disease, chronic liver disease,  
Crohn’s disease, pancreatitis
K00-K93
Diseases of the nervous system Multiple sclerosis, Alzheimer’s, meningitis, Parkinson’s,  
Huntington’s, motor neuron
G00-G99
External causes of injury and poisoning Collision, fall, accident, explosion, assault, drowning, poisoning,  
shooting, war, animal injury
V00-Y89
Other Infectious & parasitic disease; diseases of blood & blood-forming organs; 
endocrine, nutritional & metabolic disease; diseases of eye,  
skin, musculoskeletal system, genitourinary system; complications of 
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2 National overview by cause 
of death (2013–2018)
Of the 31,104 deaths that occurred in Ireland in 2018, the 
two most common causes were cancer (31%) and diseases  
of the circulatory system (29%). An additional 13% of 
deaths were caused by diseases of the respiratory system, 5% 
by diseases of the nervous system illness, 6% due to mental 
and behavioural disorders, 4% by diseases of the digestive 
system, and 4% were a result of external causes of injury 
and poisoning. In the remaining 8% of deaths, the cause 
of death was attributed to ‘other’ diseases or health 
conditions (Figure 3.1).
Figure 3.1 
All deaths in Ireland by cause of death, 2018 (%)
Over the six-year period, 2013–2018 inclusive, there has 
been little change in the proportion of deaths that occurred 
across each cause of death category (Figure 3.2).
Figure 3.2. 













 Mental & Behavioural Disorders
 External Causes of  
Injury & Poisoning
 Other
Deaths in 2018 by age group and cause of death are 
presented in Table 3.2. Ages 65+ account for approximately 
three-quarters of deaths or more in each cause of death 
category (72%–99%), apart from external cause of injury 
and poisoning. There are significant differences in the causes 
of death for different age groups. For example, external 
causes of injury and poisoning is the main cause of death in 
people aged 35–44 years, whereas the main causes of 
death for people aged 85+ are mental and behavioural 
disorders, diseases of the respiratory system and diseases 
of the circulatory system. With respect to the latter three 
cause of death categories, the majority of deaths relate 
to people aged 85+, making up 64%, 46% and 44% 
of all deaths respectively.
Table 3.2  























N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
0-4yr <10 (<1) <10 (<1) <10 (<1) <10 (<1) <10 (<1) <10 (<1) <10 (<1) 177 (7)
5-14yr 12 (<1) <10 (<1) <10 (<1) <10 (<1) <10 (<1) <10 (<1) <10 (1) 19 (1)
15-24yr 19 (<1) <10 (<1) <10 (<1) <10 (<1) <10 (<1) 16 (1) 95 (7) 12 (<1)
25-34yr 59 (1) 27 (<1) <10 (<1) <10 (<1) 11 (1) 19 (1) 164 (12) 33 (1)
35-44yr 211 (2) 90 (1) 17 (<1) <10 (<1) 41 (4) 24 (1) 215 (15) 50 (2)
45-54yr 566 (6) 310 (3) 54 (1) <10 (<1) 102 (9) 43 (3) 217 (16) 87 (4)
55-64yr 1357 (14) 647 (7) 193 (5) 18 (1) 154 (14) 88 (5) 216 (15) 160 (7)
65-74yr 2589 (27) 1397 (15) 647 (16) 114 (6) 215 (19) 282 (18) 135 (10) 308 (13)
75-84yr 2905 (31) 2634 (29) 1273 (31) 570 (29) 290 (26) 550 (34) 145 (10) 656 (27)
85+yr 1776 (19) 3967 (44) 1851 (46) 1236 (64) 287 (26) 576 (36) 201 (14) 943 (39)










































of Injury & 
Poisoning
Other
Deaths in 2018 by sex and cause of death are presented 
in Table 3.3. Males accounted for a higher proportion of 
deaths in the following categories: cancer (53.3%), diseases 
of the circulatory system (52.9%), diseases of the digestive 
system (53.9%), and external causes of injury and poisoning 
(67.8%). Conversely, females accounted for a higher 
proportion of deaths in the following categories: diseases 
of the respiratory system (52.6%), mental and behavioural 
disorders (61.4%), diseases of the nervous system (51.0%), 
and ‘other’ (52.3%).
Table 3.3  























N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Total 9500 (31) 9084 (29) 4051 (13) 1946 (6) 1105 (4) 1611 (5) 1398 (4) 2445 (8) 31140
Male 5065 (16) 4809 (15) 1920 (6) 751 (2) 596 (2) 789(3) 948 (3) 1167 (4) 16045 (52)
Female 4435 (14) 4275 (14) 2131 (7) 1195 (4) 509 (2) 822 (3) 450 (1) 1278 (4) 15095 (48)
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3 Deaths by county and cause  
of death (2013–2018)
3.1  Cancer
Cancer is an umbrella term to describe a group of illnesses 
that share common characteristics, including an over-
growth of cells to form a tumour. According to the National 
Cancer Registry Ireland (NCRI), approximately 43,000 
people are diagnosed with cancer in the Republic of Ireland 
each year. This includes both invasive and non-invasive 
tumours, as well as non-melanoma skin cancers6. In 2018, 
31% of all deaths in the State were caused by cancer. There 
was a small increase over the time period under review in 
both the number and proportion of deaths caused by cancer 
from 8,961 deaths in 2013 (30% of all deaths) to 9,500 
deaths in 2018 (31% of state deaths). These overall figures 
conceal the variation that exists between counties with 
regard to cancer deaths, as shown in Table 3.4.
Table 3.2 shows that in 2018, cancer was the leading cause 
of death in 9,500 cases, and that, when examined by age, 
the death rate increased by age group up to 75–84 years and 
declined again for aged 85+: <1% of all deaths caused by 
cancer were at 0–24 years, 9% at 25–54 years, 14% at 55–64 
years, 27% at 65–74 years, 31% at 75–84 years, and 19% at 
85+. Cancer was the leading cause of death for both males 
and females. However, as Table 3.3 shows, males account for 
a greater proportion of cancer deaths than females (males: 
16% of all deaths; female: 14% of all deaths).
We also present the average proportion of deaths due to 
cancer for each county within the six-year period (Table 
3.4). This is calculated using the average number of cancer 
deaths (2013–2018) and the average number of total deaths 
within each county (2013–2018). The state average showed 
that 31% of deaths occurred due to cancer within the time 
period. In Table 3.4, seven counties (highlighted orange) 
experienced a higher death rate than the national average 
within this setting. Conversely, 17 counties (highlighted 
blue) experienced a lower death rate than the national 
average and two counties matched the national average 
(highlighted green).
Meath was the county where the highest proportion of all 
deaths on average occurred due to cancer (33%), followed 
by Kildare (33%), Waterford (33%), Louth (32%) and 
Carlow (32%). The counties with the smallest percentage 
of cancer deaths on average as a proportion of all deaths 
were: Monaghan (28%), Roscommon (29%), Leitrim (29%), 
Kerry (28%), and Offaly (29%).
Table 3.4  


















State 8961 (30) 9218 (32) 9072 (30) 9408 (31) 9361 (31) 9500 (31) 9253 (31)
Leinster
Dublin 2409 (32) 2499 (33) 2443 (31) 2472 (32) 2495 (31) 2565 (31) 2481 (32)
Carlow 129 (33) 111 (30) 130 (33) 136 (36) 110 (28) 116 (31) 122 (32)
Kildare 319 (35) 283 (30) 299 (33) 343 (35) 329 (33) 323 (32) 316 (33)
Kilkenny 206 (32) 170 (30) 183 (29) 174 (26) 214 (34) 190 (28) 190 (30)
Laois 114 (26) 133 (31) 141 (30) 155 (32) 137 (29) 131 (30) 135 (30)
Longford 78 (27) 86 (32) 93 (32) 69 (25) 77 (26) 91 (33) 82 (29)
Meath 255 (31) 285 (33) 294 (33) 298 (34) 308 (34) 330 (34) 295 (33)
Louth 251 (34) 236 (33) 247 (30) 255 (34) 252 (31) 246 (31) 248 (32)
Offaly 125 (26) 144 (31) 151 (31) 142 (29) 153 (33) 124 (26) 140 (29)
Wexford 295 (30) 345 (34) 298 (30) 322 (31) 351 (33) 318 (28) 322 (31)
Wicklow 260 (33) 266 (34) 236 (28) 290 (34) 275 (32) 277 (32) 268 (32)
Westmeath 161 (27) 176 (29) 179 (32) 176 (29) 182 (32) 178 (31) 175 (30)
Munster
Cork 1050 (30) 1000 (30) 1044 (30) 1096 (29) 1135 (31) 1091 (30) 1069 (30)
Clare 225 (28) 254 (31) 253 (29) 259 (30) 229 (29) 264 (31) 247 (30)
Kerry 341 (29) 341 (29) 331 (28) 350 (29) 316 (28) 360 (30) 340 (29)
Limerick 376 (28) 429 (31) 378 (27) 419 (29) 420 (31) 456 (31) 413 (29)
Tipperary 384 (30) 389 (32) 361 (29) 398 (29) 372 (30) 403 (32) 285 (30)
Waterford 288 (35) 309 (38) 258 (32) 250 (30) 246 (32) 228 (28) 263 (33)
Connacht
Leitrim 82 (32) 73 (29) 83 (29) 91 (31) 70 (28) 67 (24) 78 (29)
Sligo 159 (33) 136 (29) 161 (32) 146 (29) 155 (30) 155 (30) 152 (31)
Galway 424 (28) 485 (32) 465 (31) 483 (31) 441 (29) 481 (31) 463 (30)
Mayo 308 (27) 320 (30) 320 (30) 302 (28) 326 (30) 336 (30) 319 (29)
Roscommon 136 (28) 157 (31) 153 (29) 139 (27) 133 (28) 148 (28) 144 (29)
Ulster RoI
Cavan 141 (28) 142 (28) 144 (29) 169 (32) 159 (32) 141 (28) 149 (30)
Donegal 331 (29) 331 (30) 325 (28) 359 (32) 346 (29) 356 (30) 341 (30)
Monaghan 114 (28) 118 (28) 102 (25) 115 (27) 130 (31) 125 (29) 117 (28)
*  Counties highlighted in green correspond to the national average,  counties highlighted in orange are higher than the national average 
and counties highlighted in blue are below the national average.
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3.2 Diseases of the circulatory system
Diseases of the circulatory system, which refers to diseases 
of the heart and circulation, is the second leading cause of 
death in the State after cancer. The most common examples 
include coronary heart disease, heart failure, cerebral brain 
conditions (e.g. stroke) and other blood vessel diseases7. 
In 2018, 29% of all deaths in the State were recorded as 
circulatory-related. Although figures fluctuated, there was a 
decrease between 2013 (9,473 deaths, 32% of state deaths) 
and 2018 (9,084 deaths, 29% of state deaths). The absolute 
number of deaths due to circulatory illness decreased by 4% 
between 2013 and 2018 (See Table 5).
Table 3.2 shows that 9,084 deaths were caused by diseases 
of the circulatory system in 2018, and that these deaths 
were age-related: <1% of deaths were at 0–24 years, 4% at 
25–54 years, 7% at 55–64 years, 15% at 65–74 years, 29% 
at 75–84 years, and 44% at 85+. Diseases of the circulatory 
system are the second leading cause of death for both males 
and females. Table 3.3 shows that of the 31,140 deaths in 
2018, male circulatory system deaths accounted for 15% and 
female circulatory system deaths accounted for 14%.
We also present the average proportion of deaths caused by 
diseases of circulatory system for each county within the 
six-year period (Table 3.5). On average, 30% of all deaths 
were caused by diseases of the circulatory system within 
the time period. In Table 3.5, 18 counties (highlighted 
orange) experienced a higher death rate than the national 
average within this setting. Conversely, five counties (blue) 
experienced a lower death rate and three counties matched 
the national average (green). Including this differential 
allows us to demonstrate which counties are diverging from 
national average.
Leitrim has the highest average proportion of deaths 
occurring caused by diseases of the circulatory system 
(35%), followed by Mayo (33%), Kerry (33%), Monaghan 
(32%) and Roscommon (32%). The counties with the 
smallest average percentage of circulatory deaths were 
Louth (27%), Wicklow (28%), Meath (28%), Dublin (28%) 
and Kildare (29%) (Table 3.5).
Table 3.5  



















State 9473 (32) 8852 (30) 9371 (31) 9237 (30) 8889 (29) 9084 (29) 9151 (30)
Leinster
Dublin 2196 (29) 2122 (28) 2351 (30) 2123 (28) 2273 (28) 2271 (28) 2223 (28)
Carlow 118 (30) 112 (30) 127 (32) 101 (27) 131 (33) 124 (34) 119 (31)
Kildare 263 (28) 301 (32) 269 (29) 282 (29) 298 (30) 286 (28) 283 (29)
Kilkenny 213 (33) 172 (31) 206 (33) 210 (32) 182 (29) 202 (30) 198 (31)
Laois 170 (38) 128 (30) 146 (31) 142 (30) 131 (28) 112 (25) 138 (30)
Longford 107 (37) 68 (26) 87 (30) 93 (34) 85 (29) 78 (28) 86 (31)
Meath 274 (33) 244 (28) 269 (30) 247 (28) 232 (26) 247 (25) 252 (28)
Louth 207 (28) 190 (26) 253 (31) 202 (27) 204 (25) 205 (25) 210 (27)
Offaly 168 (35) 149 (32) 148 (31) 143 (29) 138 (29) 140 (29) 148 (31)
Wexford 327 (33) 295 (29) 306 (31) 350 (33) 327 (31) 376 (33) 330 (32)
Wicklow 234 (29) 225 (28) 226 (27) 255 (30) 222 (26) 231 (26) 232 (28)
Westmeath 216 (36) 210 (35) 161 (29) 186 (31) 175 (31) 165 (29) 186 (32)
Munster
Cork 1109 (32) 1072 (32) 1115 (32) 1187 (32) 1127 (30) 1122 (31) 1122 (31)
Clare 283 (36) 272 (33) 289 (34) 271 (31) 229 (29) 244 (28) 265 (32)
Kerry 405 (34) 400 (34) 369 (31) 382 (31) 365 (32) 382 (32) 384 (33)
Limerick 472 (35) 447 (32) 458 (33) 449(31) 373 (27) 400 (27) 433 (31)
Tipperary 419 (33) 370 (30) 427 (34) 447 (33) 381 (31) 376 (30) 403 (32)
Waterford 268 (33) 239 (29) 248 (31) 249 (30) 211 (28) 240 (29) 243 (30)
Connacht
Leitrim 96 (37) 86 (34) 90 (32) 95 (32) 91 (36) 115 (41) 96 (35)
Sligo 166 (35) 148 (32) 171 (34) 174 (34) 157 (31) 142 (28) 160 (32)
Galway 482 (32) 444 (29) 473 (31) 463 (30) 468 (31) 459 (29) 465 (30)
Mayo 405 (35) 325 (31) 356 (34) 356 (32) 345 (32) 349 (32) 365 (33)
Roscommon 186 (38) 165 (32) 172 (33) 157 (31) 133 (28) 166 (31) 163 (32)
Ulster RoI
Cavan 167 (34) 168 (33) 162 (32) 159 (30) 140 (29) 143 (28) 157 (31)
Donegal 381 (34) 363 (32) 364 (32) 359 (32) 338 (28) 380 (32) 364 (32)
Monaghan 141 (34) 137 (32) 128 (31) 155 (36) 133 (31) 129 (30) 137 (32)
*  Counties highlighted in green correspond to the national average,  counties highlighted in orange are higher than the national average 
and counties highlighted in blue are below the national average.
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3.3 Diseases of the  
respiratory system
Diseases of the respiratory system cover both common and 
rare conditions that affect the lungs and other parts of the 
respiratory system. Chronic obstructive pulmonary disease 
(COPD) is one of the most common respiratory illnesses in 
the State in terms of prevalence and mortality8. Deaths due 
to infectious diseases such as pneumonia are also included 
in this cause of death category. In 2018, 13% of all deaths 
in the State were recorded as being caused by diseases of 
the respiratory system. There was an increase between 2013 
(3,504 deaths, 12% of state deaths) and 2018 (4,051 deaths, 
13% of state deaths). The absolute number of deaths caused 
by diseases of the respiratory system increased by 16% 
between 2013 and 2018 (See Table 3.6).
Table 3.2 shows that 4,051 deaths were caused by  
diseases of the respiratory system in 2018 and that these 
deaths are age-related: <1% of deaths were at 0–24 years, 
1% at 25–54 years, 5% at 55–64 years, 16% at 65–74 years, 
31% at 75–84 years, and 46% at 85+. Table 3.3 shows that 
of the 31,140 deaths in 2018, male respiratory system 
deaths accounted for 6% and female respiratory system 
deaths accounted for 7%.
We also present the average proportion of deaths caused by 
diseases of the respiratory system for each county within 
the six-year period (Table 3.6). On average, 13% of deaths 
were caused by diseases of the respiratory system within 
the time period. In Table 3.6, eight counties (highlighted 
orange) experienced a higher death rate than the national 
average within this setting. Conversely, 13 counties (blue) 
experienced a lower death rate and five counties matched 
the national average (green).
Longford has the highest average proportion of respiratory 
deaths (17%), followed by Kilkenny (14%), Roscommon 
(14%), Limerick (14%) and Meath (14%). The counties with 
the smallest average percentage of respiratory deaths were 
Cork (11%), Waterford (12%), Cavan (12%), Carlow (12%) 
and Leitrim (12%) (Table 3.6).
Table 3.6  



















State 3504 (12) 3492 (12) 3865 (13) 3935 (13) 4059 (13) 4051 (13) 3818 (13)
Leinster
Dublin 891 (12) 857 (11) 977 (12) 975 (13) 1068 (13) 1060 (13) 971 (12)
Carlow 47 (12) 44 (12) 49 (12) 45 (12) 55 (14) 38 (10) 46 (12)
Kildare 113 (12) 106 (11) 123 (13) 117 (12) 131 (13) 135 (13) 121 (13)
Kilkenny 88 (14) 69 (12) 85 (14) 120 (18) 84 (13) 97 (14) 91 (14)
Laois 53 (12) 54 (13) 56 (12) 60 (13) 63 (13) 70 (16) 59 (13)
Longford 43 (15) 47 (18) 49 (17) 50 (18) 56 (19) 44 (16) 48 (17)
Meath 115 (14) 114 (13) 122 (14) 119 (14) 125 (14) 153 (16) 125 (14)
Louth 88 (12) 91 (13) 102 (12) 120 (16) 130 (16) 98 (12) 105 (14)
Offaly 74 (16) 60 (13) 59 (12) 67 (14) 57 (12) 69 (14) 64 (13)
Wexford 105 (11) 127 (12) 123 (12) 131 (12) 137 (13) 151 (13) 129 (12)
Wicklow 90 (11) 95 (12) 127 (15) 93 (11) 102 (12) 111 (13) 103 (12)
Westmeath 81 (13) 76 (13) 75 (13) 81 (13) 71 (13) 83 (14) 78 (13)
Munster
Cork 374 (11) 357 (11) 403 (12) 415 (11) 457 (12) 412 (11) 403 (11)
Clare 93 (12) 106 (13) 100 (12) 137 (16) 124 (16) 136 (16) 116 (14)
Kerry 137 (12) 130 (11) 152 (13) 160 (13) 160 (14) 150 (12) 148 (13)
Limerick 166 (12) 182 (13) 224 (16) 220 (15) 188 (14) 198 (14) 196 (14)
Tipperary 159 (12) 143 (12) 145 (11) 169 (12) 163 (13) 160 (13) 157 (12)
Waterford 64 (8) 90 (11) 88 (11) 102 (12) 105 (14) 112 (14) 94 (12)
Connacht
Leitrim 25 (10) 30 (12) 38 (13) 36 (12) 32 (13) 38 (14) 33 (12)
Sligo 46 (10) 64 (14) 66 (13) 68 (13) 65 (13) 61 (12) 62 (12)
Galway 189 (13) 185 (12) 213 (14) 173 (11) 178 (12) 205 (13) 191 (12)
Mayo 173 (15) 141 (13) 135 (13) 168 (15) 148 (14) 143 (13) 151 (14)
Roscommon 63 (13) 61 (12) 78 (15) 82 (16) 76 (16) 72 (14) 72 (14)
Ulster RoI
Cavan 60 (12) 51 (10) 69 (14) 57 (11) 56 (11) 66 (13) 60 (12)
Donegal 120 (11) 150 (13) 150 (13) 130 (11) 168 (14) 140 (12) 143 (12)
Monaghan 47 (11) 62 (14) 57 (14) 40 (9) 60 (14) 49 (12) 53 (12)
*  Counties highlighted in green correspond to the national average,  counties highlighted in orange are higher than the national average 
and counties highlighted in blue are below the national average.
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3.4 Mental and behavioural disorders
Mental and behavioural disorders refer to clinical 
conditions characterised by disturbances in thinking, mood 
or behaviour associated with personal distress or impaired 
functioning. The majority of deaths in this category are 
due to dementia, but other examples include mental 
disorders due to known physiological conditions, and 
mental and behavioural disorders due to alcohol use or 
other psychoactive substance use5. In 2018, 6% of all deaths 
in the State were recorded as being caused by mental or 
behavioural disorders. There was a steady increase between 
2013 (1,207 deaths, 4% of state deaths) and 2018 (1,946 
deaths, 6% of state deaths). Of the 1,946 deaths in 2018, 
dementia was the cause of death in the vast majority 
(96.6%) of cases. The absolute number of deaths due to 
mental and behavioural disorders increased by 61% between 
2013 and 2018 (See Table 3.7).
Table 3.2 shows that 1,946 deaths in 2018 were caused by 
mental and behavioural disorders, and when examined by 
age, it is striking that almost two-thirds of these deaths 
were aged 85+: <1% of deaths were at 0–54 years, 1% at 
55–64 years, 6% at 65–74 years, 29% at 75–84 years, and 
64% at 85+. As Table 3.3 shows, of the 31,140 deaths in 
2018, deaths caused by mental and behavioural disorders 
were much more prevalent among females than males.
We also present the average proportion of deaths caused by 
mental and behavioural disorders for each county within 
the six-year period (Table 3.7). On average, 5% of deaths 
were caused by mental and behavioural disorders within 
the time period. In Table 3.7, three counties (highlighted 
orange) experienced a higher death rate than the national 
average within this setting. Conversely, 14 counties (blue) 
experienced a lower death rate and nine counties matched 
the national average (green).
Dublin has the highest average proportion of mental and 
behavioural disorder deaths (7%), followed by Wicklow 
(7%), Cork (6%), Laois (5%) and Kilkenny (5%). The 
counties with the smallest average percentage of mental 
and behavioural disorder deaths were Longford (2%), 
Westmeath (3%), Monaghan (4%), Wexford (4%) and Sligo 
(4%) (Table 3.7).
Table 3.7  
Mental and behavioural disorder deaths by county: total, and as a proportion (%)  




















State 1207 (4) 1352 (5) 1557 (5) 1679 (5) 1759 (6) 1946 (6) 1583 (5)
Leinster
Dublin 408 (5) 486 (6) 607 (8) 537 (7) 638 (8) 693 (8) 562 (7)
Carlow 14 (4) 23 (6) 11 (3) 23 (6) 18 (5) 18 (5) 18 (5)
Kildare 24 (3) 33 (4) 35 (4) 40 (4) 41 (4) 45 (4) 36 (4)
Kilkenny 22 (3) 35 (6) 38 (6) 34 (5) 26 (4) 37 (6) 32 (5)
Laois 19 (4) 20 (5) 23 (5) 23 (5) 35 (7) 30 (7) 25 (5)
Longford 7 (2) 7 (3) 9 (3) 9 (3) 6 (2) 4 (1) 7 (2)
Meath 17 (2) 31 (4) 29 (3) 38 (4) 40 (4) 50 (5) 34 (4)
Louth 28 (4) 32 (4) 38 (5) 28 (4) 32 (4) 48 (6) 34 (4)
Offaly 13 (3) 12 (3) 17 (4) 25 (5) 35 (7) 37 (8) 23 (5)
Wexford 26 (3) 31 (3) 40 (4) 32 (3) 40 (4) 58 (5) 38 (4)
Wicklow 45 (6) 51 (6) 52 (6) 52 (6) 73 (8) 64 (7) 56 (7)
Westmeath 15 (2) 20 (3) 15 (3) 23 (4) 21 (4) 26 (5) 20 (3)
Munster
Cork 163 (5) 179 (5) 184 (5) 234 (6) 203 (5) 230 (6) 199 (6)
Clare 29 (4) 28 (3) 48 (6) 44 (5) 40 (5) 40 (5) 38 (5)
Kerry 51 (4) 48 (4) 46 (4) 58 (5) 53 (5) 51 (4) 51 (4)
Limerick 48 (4) 44 (3) 50 (4) 61 (4) 86 (6) 83 (6) 62 (4)
Tipperary 45 (4) 39 (3) 58 (5) 58 (4) 53 (4) 72 (6) 54 (4)
Waterford 35 (4) 32 (4) 42 (5) 56 (7) 29 (4) 41 (5) 39 (5)
Connacht
Leitrim 9 (3) 10 (4) 13 (5) 16 (5) 17 (7) 9 (3) 12 (5)
Sligo 11 (2) 16 (3) 8 (2) 20 (4) 23 (5) 34 (7) 19 (4)
Galway 53 (4) 38 (3) 46 (3) 75 (5) 80 (5) 69 (4) 60 (4)
Mayo 38 (3) 42 (4) 38 (4) 56 (5) 44 (4) 58 (5) 46 (4)
Roscommon 7 (1) 18 (4) 21 (4) 32 (6) 21 (4) 36 (7) 23 (4)
Ulster RoI
Cavan 25 (5) 19 (4) 29 (6) 24 (5) 21 (4) 30 (6) 25 (5)
Donegal 45 (4) 46 (4) 47 (4) 56 (5) 72 (6) 65 (6) 55 (5)
Monaghan 10 (2) 12 (3) 13 (3) 25 (6) 12 (3) 18 (4) 15 (4)
*  Counties highlighted in green correspond to the national average,  counties highlighted in orange are higher than the national average 
and counties highlighted in blue are below the national average.
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3.5 Diseases of the digestive system
The digestive system comprises the gastrointestinal tract, 
pancreas, liver and gallbladder. This system is responsible 
for the breakdown of food that helps to fuel our bodies 
and promote cell repair. Common diseases of the digestive 
system include irritable bowel syndrome and Crohn’s 
disease, gastric ulcers, ventral hernias, liver disease, acute 
pancreatitis and vascular disorders of the intestine5. While 
the deaths caused by diseases of the digestive system as a 
proportion of all deaths has remained fairly constant over 
the six-year period, the absolute number of such deaths has 
increased marginally in recent years from 1,069 deaths (4% 
of state deaths) in 2013 to 1,105 deaths (4% in state deaths) 
in 2018 (see Table 3.8). This represents an increase of less 
than 3% in the absolute number of deaths due to diseases  
of the digestive system between 2013 and 2018.
Table 3.2 shows that 1,105 deaths in 2018 were caused by 
diseases of the digestive system, and that, when examined 
by age, more than 50% of these deaths were aged 65+:  
<1% of these deaths were at 0–14 years, 14% at 25–54 years, 
14% at 55–64 years, 19% at 65–74 years, 26% at 75–84 
years, and 26% at 85+. Table 3.3 shows that of the 31,140 
deaths in 2018, the proportion of deaths among males  
and females caused by diseases of digestive system deaths 
were the same at 2%.
We also present the average proportion of deaths caused by 
diseases of the digestive system for each county within the 
six-year period (Table 3.8). On average, 13% of deaths were 
caused by diseases of the digestive system within the time 
period. In Table 3.8, seven counties (highlighted orange) 
experienced a higher death rate than the national average 
within this setting. Conversely, no counties experienced 
a lower death rate (blue) and 19 counties matched the 
national average (green). Including this differential allows 
us to demonstrate which counties are diverging from 
national average.
Dublin has the highest average proportion of deaths caused 
by diseases of the digestive system (4%), followed by Kerry 
(4%), Louth (4%), Wicklow (4%) and Cork (4%). The 
counties with the smallest average percentage of digestive 
system deaths were Laois (3%), Sligo (3%), Meath (3%) and 
Monaghan (3%) (see Table 3.8).
Table 3.8  















deaths due to 
digestive illness
2013–2018* 
State 1069 (4) 1040 (4) 966 (3) 1055 (3) 1064 (3) 1105 (4) 1050 (3)
Leinster
Dublin 308 (4) 309 (4) 295 (4) 312 (4) 324 (4) 332 (4) 313 (4)
Carlow 11 (3) 12 (3) 7 (2) 11 (3) 10 (3) 15 (4) 11 (3)
Kildare 29 (3) 36 (4) 32 (3) 35 (4) 26 (3) 26 (3) 31 (3)
Kilkenny 22 (3) 20 (4) 20 (3) 13 (2) 19 (3) 21 (3) 19 (3)
Laois 9 (2) 13 (3) 12 (3) 8 (2) 16 (3) 14 (3) 12 (3)
Longford 5 (2) 9 (3) 6 (2) 6 (2) 14 (5) 15 (5) 9 (3)
Meath 33 (4) 23 (3) 23 (3) 22 (3) 25 (3) 22 (2) 25 (3)
Louth 33 (4) 33 (5) 30 (4) 20 (3) 32 (4) 29 (4) 30 (4)
Offaly 14 (3) 21 (5) 13 (3) 20 (4) 14 (3) 20 (4) 17 (4)
Wexford 36 (4) 28 (3) 34 (3) 34 (3) 30 (3) 30 (3) 32 (3)
Wicklow 24 (3) 24 (3) 30 (4) 26 (3) 50 (6) 36 (4) 32 (4)
Westmeath 25 (4) 12 (2) 20 (4) 21 (3) 16 (3) 21 (4) 19 (3)
Munster
Cork 128 (4) 127 (4) 114 (3) 127 (3) 143 (4) 144 (4) 131 (4)
Clare 26 (3) 27 (3) 15 (2) 36 (4) 25 (3) 34 (4) 27 (3)
Kerry 45 (4) 45 (4) 44 (4) 55 (5) 40 (4) 41 (3) 45 (4)
Limerick 46 (3) 49 (3) 45 (3) 46 (3) 28 (2) 45 (3) 43 (3)
Tipperary 38 (3) 36 (3) 33 (3) 33 (2) 42 (3) 33 (3) 36 (3)
Waterford 29 (4) 30 (4) 28 (3) 17 (2) 18 (2) 31 (4) 26 (3)
Connacht
Leitrim 12 (5) 9 (4) 6 (2) 13 (4) 5 (2) 7 (2) 9 (3)
Sligo 14 (3) 10 (2) 13 (3) 15 (3) 12 (2) 16 (3) 13 (3)
Galway 57 (4) 47 (3) 53 (3) 66 (4) 54 (4) 58 (4) 56 (4)
Mayo 40 (3) 40 (4) 31 (3) 33 (3) 34 (3) 41 (4) 37 (3)
Roscommon 15 (3) 20 (4) 10 (2) 18 (4) 15 (3) 15 (3) 16 (3)
Ulster RoI
Cavan 10 (2) 17 (3) 10 (2) 25 (5) 19 (4) 18 (4) 17 (3)
Donegal 42 (4) 34 (3) 32 (3) 31 (3) 37 (3) 35 (3) 35 (3)
Monaghan 18 (4) 9 (2) 10 (2) 12 (3) 16 (4) 6 (1) 12 (3)
*  Counties highlighted in green correspond to the national average,  counties highlighted in orange are higher than the national average 
and counties highlighted in blue are below the national average.
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3.6 Diseases of the nervous system
Diseases of the nervous system include those that are 
invisible but still impact on quality of life, and those that 
are marked by severe and progressive physical or cognitive 
decline. Common diseases include Huntington’s disease, 
multiple sclerosis, Parkinson’s disease, Alzheimer’s disease 
and epilepsy. According to the Neurological Alliance of 
Ireland (2020), it is estimated that over 800,000 people 
in the Republic of Ireland are living with a disease of the 
nervous system9. In 2018, 5% of all deaths in the State were 
caused by diseases of the nervous system. Over the period 
under review, the number of deaths increased from 1,378 
deaths (5% of state deaths) in 2013 to 1,611 deaths (5% 
of state deaths) in 2018. This represents an increase of less 
than 17% in the absolute number of nervous system deaths 
between 2013 and 2018 (Table 3.9).
Table 3.2 shows that, when the 1,611 deaths in 2018 caused 
by diseases of the nervous system are examined by age, the 
majority (70%) were aged 75+: 2% of deaths were at 0–24 
years, 5% at 25–54 years, 5% at 55–64 years, 18% at 65–74 
years, 34% at 75–84 years, and 36% at 85+. Table 3.3 shows 
that, of the 31,140 deaths in 2018, the proportion of deaths 
among males and females caused by diseases of the nervous 
system deaths were the same at 3%.
We also present the average proportion of deaths due to 
diseases of the nervous system for each county within the 
six-year period (Table 3.9). On average, 5% of deaths were 
caused by diseases of the nervous system within the time 
period. In Table 3.9, five counties (highlighted orange) 
experienced a higher death rate than the national average 
within this setting. Conversely, seven counties (blue) 
experienced a lower death rate and 14 counties matched 
the national average (green). Including this differential 
allows us to demonstrate which counties are diverging from 
national average.
Louth has the highest average proportion of deaths 
occurring due to nervous system illness (6%), followed by 
Galway (6%), Donegal (6%), Laois (6%) and Monaghan 
(6%). The counties with the smallest average percentage 
of nervous system deaths were Carlow (4%), Clare (4%), 
Longford (4%), Roscommon (4%) and Offaly (4%) (see 
Table 3.9).
Table 3.9  















deaths due to 
nervous system
2013–2018* 
State 1378 (5) 1420 (5) 1555 (5) 1603 (5) 1564 (5) 1611 (5) 1522 (5)
Leinster
Dublin 383 (5) 388 (5) 417 (5) 438 (6) 402 (5) 415 (5) 407 (5)
Carlow 10 (3) 11 (3) 17 (4) 12 (3) 17 (4) 15 (4) 14 (4)
Kildare 44 (5) 42 (5) 28 (3) 34 (3) 52 (5) 52 (5) 42 (4)
Kilkenny 20 (3) 27 (5) 21 (3) 38 (6) 29 (5) 30 (4) 28 (4)
Laois 18 (4) 26 (6) 29 (6) 24 (5) 33 (7) 23 (5) 26 (6)
Longford 9 (3) 9 (3) 12 (4) 10 (4) 14 (5) 8 (3) 10 (4)
Meath 39 (5) 43 (5) 37 (4) 36 (4) 49 (5) 58 (6) 44 (5)
Louth 29 (5) 40 (6) 52 (6) 45 (6) 48 (6) 50 (6) 46 (6)
Offaly 17 (4) 22 (5) 26 (5) 21 (4) 18 (4) 15 (3) 20 (4)
Wexford 45 (5) 51 (5) 38 (4) 54 (5) 46 (4) 54 (5) 48 (5)
Wicklow 44 (6) 30 (4) 59 (7) 36 (4) 27 (3) 42 (5) 40 (5)
Westmeath 31 (5) 27 (4) 32 (6) 31 (5) 28 (5) 32 (6) 30 (5)
Munster
Cork 197 (6) 186 (6) 185 (5) 208 (6) 193 (5) 197 (5) 194 (5)
Clare 22 (3) 38 (5) 35 (4) 33 (4) 36 (5) 20 (2) 31 (4)
Kerry 44 (4) 64 (5) 80 (7) 73 (6) 64 (6) 56 (5) 64 (5)
Limerick 54 (4) 66 (5) 64 (5) 80 (6) 69 (5) 77 (5) 68 (5)
Tipperary 51 (4) 51 (4) 71 (6) 58 (4) 60 (5) 59 (5) 58 (5)
Waterford 33 (4) 25 (3) 43 (5) 43 (5) 38 (5) 48 (6) 38 (5)
Connacht
Leitrim 6 (2) 11 (4) 16 (6) 17 (6) 12 (5) 12 (4) 12 (5)
Sligo 19 (4) 22 (5) 20 (4) 30 (6) 24 (5) 43 (8) 26 (5)
Galway 81 (5) 76 (5) 73 (5) 92 (6) 99 (6) 107 (7) 88 (6)
Mayo 48 (4) 48 (5) 64 (6) 55 (5) 62 (6) 51 (5) 55 (5)
Roscommon 21 (4) 21 (4) 27 (5) 17 (3) 22 (5) 17 (3) 21 (4)
Ulster RoI
Cavan 26 (5) 29 (6) 22 (4) 20 (4) 21 (4) 24 (5) 24 (5)
Donegal 56 (5) 43 (4) 68 (6) 72 (6) 78 (7) 77 (7) 66 (6)
Monaghan 21 (5) 24 (6) 19 (5) 26 (6) 23 (5) 29 (7) 24 (6)
*  Counties highlighted in green correspond to the national average,  counties highlighted in orange are higher than the national average 
and counties highlighted in blue are below the national average.
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3.7  External causes of injury  
and poisoning
External causes of injury and poisoning codes are used for 
classifying environmental events and circumstances that 
cause injury, poisoning and other adverse effects resulting 
in death5. Common examples include road traffic accidents; 
falls; drowning; choking; burns; and poisoning by, adverse 
effect of, and overdosing  of drugs, medicaments and 
biological substances. In 2018, 4% of all deaths in the  
State were caused by external causes of injury and 
poisoning. Over the period under review, the number of 
deaths decreased from 1,491 deaths (5% of state deaths) 
in 2013 to 1,398 deaths (4% of state deaths) in 2018. This 
represents a decrease of 6% in the absolute number of 
external causes of injury and poisoning deaths between 
2013 and 2018 (Table 3.10).
Table 3.2 shows that there were 1,398 deaths caused by 
external injury and poisoning in 2018 and that, when 
examined by age, most of these deaths are aged 25–54 years. 
Overall, 8% of deaths were at 0–24 years, 43% at 25–54 
years, 15% at 55–64 years, 10% at 65–74 years, 10% at 
75–84 years, and 14% at 85+. The number of deaths caused 
by external injury and poisoning for males was more than 
twice the number for females in 2018.
We also present the average proportion of deaths caused 
by external causes of injury and poisoning for each county 
within the six-year period (Table 3.10). On average, 5% 
of deaths were caused by external causes of injury and 
poisoning within the time period. In Table 10, five counties 
(highlighted orange) experienced a higher death rate 
than the national average within this setting. Conversely, 
9 counties (blue) experienced a lower death rate and 12 
counties matched the national average (green). Including 
this differential allows us to demonstrate which counties are 
diverging from the national average.
Cavan has the highest average proportion of deaths 
occurring due to external causes of injury and poisoning 
(6%), followed by Monaghan (6%), Kildare (6%), Galway 
(6%) and Louth (6%). The counties with the smallest 
average percentage of external causes of injury and 
poisoning deaths were Dublin (4%), Sligo (4%), Wicklow 
(4%), Donegal (4%) and Laois (4%) (see Table 3.10).
Table 3.10  
External causes of injury and poisoning deaths by county: total, and as a proportion (%)  















deaths due to 
external causes 
of injury & 
poisoning
2013–2018* 
State 1491 (5) 1530 (5) 1316 (4) 1323 (4) 1299 (4) 1398 (4) 1393 (5)
Leinster
Dublin 385 (5) 356 (5) 247 (3) 270 (4) 251 (3) 257 (3) 294 (4)
Carlow 28 (7) 19 (5) 23 (6) 16 (4) 19 (5) 11 (3) 19 (5)
Kildare 59 (6) 52 (6) 53 (6) 57 (6) 44 (4) 70 (7) 56 (6)
Kilkenny 23 (4) 27 (5) 29 (5) 30 (5) 23 (4) 32 (5) 27 (4)
Laois 16 (4) 13 (3) 22 (5) 18 (4) 17 (4) 24 (5) 18 (4)
Longford 19 (7) 15 (6) 12 (4) 12 (4) 14 (5) 12 (4) 14 (5)
Meath 56 (6) 47 (5) 53 (6) 40 (5) 53 (6) 47 (5) 48 (5)
Louth 48 (6) 44 (6) 35 (4) 29 (4) 44 (5) 55 (7) 43 (6)
Offaly 22 (5) 20 (4) 23 (5) 26 (5) 19 (4) 26 (5) 23 (5)
Wexford 44 (4) 56 (5) 47 (5) 39 (4) 35 (3) 54 (5) 46 (4)
Wicklow 26 (3) 42 (5) 35 (4) 20 (2) 39 (4) 35 (4) 33 (4)
Westmeath 31 (5) 28 (5) 17 (3) 31 (5) 22 (4) 30 (5) 27 (5)
Munster
Cork 185 (5) 208 (6) 194 (6) 212 (6) 175 (5) 174 (5) 191 (5)
Clare 47 (6) 34 (4) 47 (5) 37 (4) 48 (6) 51 (6) 44 (5)
Kerry 55 (5) 62 (5) 52 (4) 56 (5) 32 (3) 61 (5) 53 (5)
Limerick 68 (5) 81 (6) 52 (4) 62 (4) 69 (5) 79 (5) 69 (5)
Tipperary 66 (5) 64 (5) 65 (5) 58 (4) 55 (4) 57 (4) 61 (5)
Waterford 30 (4) 32 (4) 37 (5) 39 (5) 44 (6) 50 (6) 39 (5)
Connacht
Leitrim 14 (5) 8 (3) 11 (4) 11 (4) 11 (4) 10 (4) 11 (4)
Sligo 21 (4) 25 (5) 11 (2) 14 (3) 24 (5) 19 (4) 19 (4)
Galway 83 (6) 96 (6) 89 (6) 83 (5) 89 (6) 72 (5) 85 (6)
Mayo 49 (4) 57 (5) 46 (4) 43 (4) 42 (4) 45 (4) 47 (4)
Roscommon 25 (5) 28 (5) 20 (4) 24 (5) 23 (5) 30 (6) 25 (5)
Ulster RoI
Cavan 31 (6) 36 (7) 21 (4) 34 (7) 30 (6) 35 (7) 31 (6)
Donegal 45 (4) 55 (5) 52 (5) 39 (3) 54 (5) 30 (3) 46 (4)
Monaghan 25 (6) 25 (6) 23 (6) 23 (5) 23 (5) 32 (8) 25 (6)
*  Counties highlighted in green correspond to the national average,  counties highlighted in orange are higher than the national average 
and counties highlighted in blue are below the national average.
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3.8  Deaths caused by ‘other’ diseases
‘Other’ refers to all deaths caused by other diseases that are 
not encompassed in the seven cause of death categories 
previously presented, i.e. cancer, diseases of the circulatory 
system, diseases of the respiratory system, mental and 
behavioural disorders, external causes of injury and poisoning, 
diseases of the digestive system and diseases of the nervous 
system. See Table 3.11 for a list of the diseases and health 
conditions included in the ‘other’ cause of death category.
Table3.11  
‘Other’ illness types and corresponding ICD-10 code
'Other' illnesses ICD-10 Codes
Infectious and parasitic diseases A00-B99
Diseases of the blood and blood-forming organs, immunological disorders D50-D89
Endocrine, nutritional and metabolic diseases E00-E90
Diseases of the eye and adnexa H00-H59
Diseases of the ear and mastoid process H60-H95
Diseases of the skin and subcutaneous tissue L00-L99
Diseases of the musculoskeletal system/connective tissue M00-M99
Diseases of the genitourinary system N00-N99
Complications of pregnancy, childbirth and puerperium O00-O99
Certain conditions originating in the perinatal period P00-P96
Congenital malformations and chromosomal abnormalities Q00-Q99
Symptoms, signs, abnormal findings, ill-defined causes R00-R99
In 2018, 8% of all deaths in the State were caused by ‘other’ 
diseases and health conditions, and this remained constant 
between 2013 and 2018. However, over this period, the 
number of deaths increased marginally from 2,421 deaths 
in 2013 to 2,445 deaths in 2018. This represents an increase 
of 1% in the absolute number of deaths caused by ‘other’ 
diseases and health conditions between 2013 and 2018. 
We also present the average proportion of deaths caused by 
‘other’ diseases for each province over the six-year period 
(Table 3.12).
Table 3.2 shows that when the 2,445 deaths caused by 
‘other’ disease or health conditions in 2018 are examined 
by age, 9% of these deaths were at 0–24 years, 7% at 25–54 
years, 7% at 55–64 years, 13% at 65–74 years, 27% at 75–84 
years, and 39% at 85+. Table 3.3 shows that, of the 31,140 
deaths in 2018, the proportion of male and female deaths 
caused by ‘other’ diseases and health conditions was the 
same at 4%.
Table 3.12  













State 2421 (8) 2348 (8) 2425 (8) 2427 (8) 2423 (8) 2445 (8)
Leinster 1184 (4) 1124 (4) 1206 (4) 1222 (4) 1187 (4) 1188 (4)
Munster 750 (3) 689 (2) 696 (2) 741 (2) 746 (2) 763 (2)
Connacht 313 (1) 347 (1) 309 (1) 305 (1) 316 (1) 314 (1)
Ulster ROI 174 (1) 188 (1) 214 (1) 159 (1) 174 (1) 180 (1)
3.9 Place of death for different  
causes of death
The most recently available data on place of death for 
different causes of death are from 2017. The data are 
available for six different cause of death categories: cancer, 
diseases of the circulatory system, diseases of the respiratory 
system, diseases of the digestive system, diseases of the 
nervous system, and ‘other’, and five places of death: 
hospital, LSRCF, hospice, home, other. These data are 
presented in Table 3.13.
For cancer, hospital was the most common place of death 
(38%) although this was lower than the national incidence 
rate (43%). Home deaths from cancer were in line with 
national trends for this place of occurrence (24%).  
LSRCF deaths from cancer were relatively low – 13%  
of cancer deaths versus 23% for all conditions. Hospice 
deaths accounted for 22% of deaths from cancer, a much 
higher proportion than for any other condition. Indeed, 
deaths from cancer accounted for 85% of deaths in this 
setting nationally.
For diseases of the circulatory system, places of death were 
broadly in line with national figures. Hospital was the most 
common place of death (43%). LSRCF (25%) and home 
(28%) deaths were slightly more common than the national 
average, offset by relatively few deaths in hospice.
For diseases of the respiratory system, a majority of deaths 
occurred in hospital (55%). This was offset by lower rates of 
death at home (15%) and in hospice (2%), while LSRCF 
deaths (26%) were slightly above the national average.
Diseases of the nervous system was the only cause of death 
for which hospital (30%) was not the most common place. 
LSRCFs accounted for 45% of deaths for this cause, double 
the national average, while deaths at home (17%) and in 
hospice (5%) were less common.
For diseases of the digestive system, death in hospital was 
notably high (73%). All other places of occurrence were 
markedly lower than the national average.
Table 3.13  
Place of death for each cause of death category, and as a proportion (%)  
















Hospital 3578 (38) 3797 (43) 2251 (55) 467 (30) 776 (73) 2318 (42) 13187 (43)
LSRCF 1215 (13) 2246 (25) 1065 (26) 711 (45) 96 (9) 1650 (30) 6983 (23)
Hospice 2096 (22) 100 (1) 92 (2) 84 (5) 16 (2) 67 (1) 2455 (8)
Domiciliary 2281 (24) 2498 (28) 609 (15) 273 (17) 157 (15) 1080 (20) 6898 (23)
Elsewhere 191 (2) 248 (3) 42 (1) 29 (2) 19 (2) 366 (7) 895 (3)
Total 9361 8889 4059 1564 1064 5481 30418
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4 Summary and policy 
implications
This chapter has used the CSO data on death to summarise 
data available at the time of writing on the leading causes  
of death in the State for the period 2013–2018 inclusive.  
In this section we consider and interpret the key findings.
4.1 Ireland’s leading causes  
of death
The CSO data show that cancer was the leading cause of 
death in Ireland in 2018, accounting for 31% of all deaths 
in that year, closely followed by diseases of the circulatory 
system (29%). This is in contrast to 2013, when diseases of 
the circulatory system accounted for the highest proportion 
of all deaths (32%). Over the six-year period 2013–2018, 
there has been a small increase in deaths caused by cancer, 
and a slight decrease in deaths caused by diseases of the 
circulatory system. This partly reflects a long-term trend of 
declining heart-related mortality in Ireland10.
Diseases of the respiratory system were the third most 
common cause of death in 2018 (13%) and there was a 
small increase in these deaths over the six-year period. 
Deaths caused by mental and behavioural disorders, diseases 
of the nervous system and diseases of the digestive system 
accounted for smaller proportions of all deaths in 2018, at 
6%, 5% and 4% respectively.
In the period 2013–2018 there has been a 61% increase in 
the number of people recorded as dying from mental and 
behavioural disorders. A more in-depth analysis of deaths 
due to dementia is provided separately in Chapter 5, where 
we will discuss factors that could be driving this increase 
including population ageing, better understanding of 
dementia, improvements in dementia diagnosis and better 
reporting of dementia on death certificates.
4.2 Cause of death categories  
and age
Most deaths in Ireland occur among older people, with 
aged 65+ accounting for 82% of all deaths in 2018. 
Approximately three-quarters (77%) of the 9,500 deaths 
caused by cancer were in individuals aged 65+. As cancer 
was leading cause of death in Ireland in 2018, a more in-
depth analysis of this category by cancer type is undertaken 
in Chapter 4. Deaths due to diseases of the circulatory 
system and respiratory system also occurred predominantly 
in individuals aged 65+ (88% of deaths caused by diseases of 
the circulatory system and 93% of deaths caused by diseases 
of the respiratory system). Whereas the cancer category 
showed a decrease in the number of deaths of individuals 
aged 85+ (19% of cancer deaths) compared to individuals 
aged 65–84, diseases of the circulatory and respiratory 
system experienced a steady increase in number of  
deaths as age increased (44% of circulatory and 46% of  
respiratory deaths).
Mental and behavioural disorders (6% of state deaths), 
diseases of the nervous system (5%), diseases of the 
digestive system (4%), external causes of injury and 
poisoning (4%), and ‘other’ diseases (8%) made up the 
remaining 27% of state deaths. The distribution of deaths 
across age categories within these cause of death categories 
was more varied compared to diseases of the circulatory 
and respiratory systems. The majority of deaths caused 
by mental and behavioural disorders are attributable 
to dementia, and almost all of these deaths occurred in 
individuals aged 65+ (99%).
Diseases of the digestive system and diseases of the 
nervous system are two cause of death categories with a 
similar distribution of deaths across age groups. Ages 0–54 
accounted for 15% of disease of the digestive system deaths 
and 6% of disease of the nervous system deaths. Ages 55–64 
accounted for 14% and ages 65+ made up the remaining 
two-thirds (71%) of diseases of the digestive system deaths. 
Similarly, ages 55–64 accounted for 5% and ages 65+ made 
up the remaining 88% of diseases of the nervous system 
deaths. Diverging from these cause of death categories, 
‘external causes of injury and poisoning’ and ‘other’ diseases 
have a broader scope of included illnesses within their 
classifications, and therefore have a broader age distribution 
when examining death.
4.3 Cause of death categories 
disaggregated by sex
Males experienced a higher proportion of deaths in two 
out of the three leading causes of deaths in Ireland in 2018: 
cancer and diseases of the circulatory system. This supports 
previous research demonstrating that sex, in particular 
being male, plays an important role in cancer incidence, 
progression and mortality11,12. Males experienced three 
times the deaths from ‘external injury and poisoning’ (3%) 
compared to females (1%). Females experienced a higher 
proportion of deaths in the third leading cause of death in 
the State: diseases of the respiratory system. Interestingly, 
females experienced nearly double (4%) the proportion 
of mental and behavioural disorder deaths compared to 
males (2%). This reflects evidence of a higher incidence and 
prevalence of dementia among females than men, especially 
in the oldest age groups13,14. Three categories experienced 
an equal proportion of deaths between males and females: 
diseases of the digestive system, diseases of the nervous 
system, and ‘other’ diseases.
4.4 Cause of death and  
place of death
Place of death varies greatly for different cause of death 
categories. This highlights that where a person dies is likely 
to be influenced by the type of disease and end-of-life 
trajectory15. This is consistent with evidence from other 
countries16,17. For example, prognosis is more accurate in 
cancer than other major terminal diseases, so people with 
cancer and their families, and those providing care, are 
better able to arrange hospice or home care at the right 
time and to reduce hospital visits near end of life where 
appropriate. In major organ failure, a person’s death is 
not typically foreseeable long in advance and occurs after 
a longer period of physical debilitation, and unplanned 
hospital visits are more common. In dementia, people often 
live with the disease for many years and are in the oldest age 
groups when they die. The wide variation in place of death 
by cause has implications for palliative care in all settings.





This chapter focuses on deaths caused by cancer in Ireland 
during the years 2013–2018 using mortality data from the 
Central Statistics Office (CSO) dataset. Within the CSO 
dataset, cancer deaths are categorised according to ICD-
10 (International Classification of Disease 10th Revision)1 
codes C00-D48 indicating malignant neoplasms. 
These ICD-10 codes can be broken down into 18 
categories. For this report, we enlisted guidance from a 
palliative medicine consultant to further condense these 
categories for discussion purposes, resulting in nine 
established cancer categories (Table 4.1). 
Table 4.1  
Cancer types and corresponding ICD-10 codes
Cancer Category ICD-10 Codes
Head and neck Malignant neoplasms of lip, oral cavity and pharynx (C00-C14)
In situ neoplasms (D00)
Gastrointestinal Malignant neoplasms of digestive organs (C15-C26, D01)
In situ neoplasms (D01)
Respiratory and thoracic Malignant neoplasms of respiratory and intrathoracic organs (C30-C39)
In situ neoplasms (D02)
Skin and musculoskeletal Malignant neoplasms of bone and articular cartilage (C40-C41)
Melanoma and other malignant neoplasms of skin (C43-C44)
Malignant neoplasms of mesothelial and soft tissue (C45-C49)
In situ neoplasms (D03-D04)
Breast and gynaecological Malignant neoplasm of breast (C50-C50)
Malignant neoplasms of female genital organs (C51-C58)
In situ neoplasms (D05-D06)
Genitourinary cancers and testicular Malignant neoplasms of male genital organs (C60-C63)
Malignant neoplasms of urinary tract (C64-C68)
Neurological Malignant neoplasms of eye, brain and other parts of central nervous system (C69-C72)
Malignant neoplasms of thyroid and other endocrine glands (C73-C75)
Cancer of unknown primary sites Malignant neoplasms of ill-defined, secondary and unspecified sites (C76-C80)
Malignant neoplasms of independent (primary) multiple sites (C97-C97)
In situ neoplasms (D07 & D09)
Haematological Malignant neoplasms, stated or presumed to be primary, of lymphoid,  
haematopoietic and related tissue (C81-C96)
Neoplasms of uncertain behaviour, polycythaemia vera  
and myelodysplastic syndromes (D37-D48)
The category ‘in situ neoplasms (D00-D09)’ was split and 
re-assigned to the category that corresponded to the site 
specified. The category ‘benign neoplasms, except benign 
neuroendocrine tumours (D10-D36)’ was excluded on the 
consultant’s recommendation, as benign neoplasms are 
generally not considered to be cancer and normally would 
not account for the death. Cancer is considered separate 
from these. Cancer is a leading cause of death in the State, 
and this breakdown allows for an overview of death rates 
for different types of cancer and how these differ by age and 
sex. The remaining 17 ICD-10 categories are split between 
our predefined nine cancer categories as shown in Table 4.1. 









 Head and Neck (C00–C14; D00)
 Gastrointestinal (C15–C26; D01)
 Respiratory and theoracic 
(C30–C39; D02)
 Skin and musculoskeletal 
(C40–C49; D03–D04)
 Breast and gynaecological 
(C50–C58; D05–D06)
 Haematological (C81–C96; D37–D48)
 Genitourinary cancers and testicular 
(C60-C68)
 Neurological (C69–C75)
 Cancer of unknown primary 
(C76–C80; C97–C97; D07; D09)
2  National overview of cancer deaths (2013–2018)
Of the 31,140 deaths that occurred in the State in 2018, 
approximately one-third were caused by cancer (30%).  
Of these 9,466 deaths, 30% were caused by gastrointestinal 
cancer and 20% by respiratory and thoracic cancer. The 
remaining 50% of deaths were spread across the remaining 
seven categories (each accounting for less than 15%).
Figure 4.1 
All cancer deaths in Ireland by cancer type, 2018 (%)
Over the six-year period, 2013–2018 inclusive, there has 
been little change in the proportion of deaths caused 
by each of the cancer type categories. There were small 
increases in the proportion of cancer deaths in the following 
categories: skin and musculoskeletal cancer, and breast 
and gynaecological cancer. There were small decreases 
in the proportion of cancer deaths across two categories 
(respiratory and thoracic cancer, and cancer of unknown 
primary sites). The remaining five categories accounted for 
the same percentage of deaths in both 2013 and 2018.
Analyses of these data for the period 2013–2018 showed 
negligible change across groups (data not shown).
Deaths in 2018 by age group and cancer type are presented 
in Table 4.2. Of the 9,466 deaths due to cancer, 7,245 
(77%) are people aged 65+. This age group accounts for a 
minimum of half of deaths in each cancer type category 
(56%–89%).
Table 4.2  






















Head and neck 
(C00-14) <10 (<1) <10 (<1) <10 (<1) <10 (1) <10 (3) 14 (7) 48 (24) 75 (38) 31 (16) 22 (11) 197
Gastrointestinal 




<10 (<1) <10 (<1) <10 (<1) <10 (<1) 26 (1) 79 (4) 333 (17) 655 (34) 588 (31) 233 (12) 1918
Skin and  
musculoskeletal 
(C40-C49)
<10 (<1) <10 (1) <10 (1) 15 (3) 12 (3) 28 (6) 36 (8) 103 (24) 128 (29) 102 (23) 435
Breast and  
gynaecological 
(C50-C58)
<10 (<1) <10 (<1) <10 (<1) 16 (1) 67 (5) 173 (13) 232 (17) 319 (24) 320 (24) 212 (16) 1339
Genitourinary  
cancers and  
testicular 
(C60-C68)
<10 (<1) <10 (<1) <10 (<1) <10 (<1) 11 (1) 32 (3) 75 (7) 233 (21) 399 (37) 335 (31) 1086
Neurological 
(C69-C75) <10 (1) <10 (1) <10 (1) <10 (2) 23 (7) 25 (8) 74 (23) 94 (29) 61 (19) 25 (8) 320
Cancer of  unknown 
primary (C76-C80, 
C97-C97)




<10 (<1) <10 (<1) <10 (1) <10 (<1) 11 (1) 35 (4) 94 (10) 213 (22) 371 (38) 240 (25) 977
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3 Deaths by cancer type, 2013–2018
3.1 Deaths at state level
In 2018, 30% of all deaths in the State occurred due to 
cancer (C00-D09, D37-D48). There was a small increase 
over the time period under review in the number of cancer 
deaths from 8,938 in 2013 (30% of state deaths) to 9,466 
in 2018 (30% of state deaths). While the absolute number 
of deaths due to cancer increased by 6% when 2018 is 
compared to 2013, cancer deaths as a proportion of all 
deaths remained the same at 30% (see Table 4.3). However, 
these overall figures conceal the large variation that exists 
between different cancer types, as shown in Table 4.3.
We also present the average proportion of deaths due to 
each cancer type nationally within the six-year period 
(Table 3). This is calculated using the average number of 
deaths for each cancer type (2013–2018) as a proportion 
of the average number of total deaths within the State 
(2013–2018). ‘Gastrointestinal (C15-C26, D01)’ accounted 
for the highest average proportion of deaths occurring 
due to cancer (9%), followed by ‘respiratory and thoracic 
(C30-C39, D02)’ (6%) and ‘breast and gynaecological 
(C50-C58, D05-D06)’ (4%). The cancer types causing the 
smallest average percentage of cancer deaths were: ‘head 
and neck (C00-14, D00)’ (1%), ‘cancer of unknown primary 
(C76-C80, C97-C97, D07, D09)’ (1%), and ‘neurological 
(C69-C75)’ (1%) (Table 4.3).
Table 4.3  


















(C00-D09, D37-D48) 8938 (30) 9180 (31) 9017 (30) 9363 (31) 9337 (31) 9466 (30) 9217 (31)
Head and neck 
(C00-14, D00) 163 (2) 168 (2) 187 (2) 188 (2) 190 (2) 197 (2) 182 (1)
Gastrointestinal 
(C15-C26, D01) 2710 (30) 2793 (30) 2793 (31) 2856 (30) 2845 (30) 2879 (30) 2813 (9)
Respiratory and thoracic 
(C30-C39, D02) 1896 (21) 2023 (22) 1903 (21) 1985 (21) 1999 (21) 1918 (20) 1954 (6)
Skin and musculoskeletal 
(C40-C49, D03-D04) 386 (4) 357 (4) 340 (4) 416 (4) 386 (4) 435 (5) 387 (1)
Breast and gynaecological 
(C50-C58, D05-D06) 1195 (13) 1272 (14) 1211 (13) 1300 (14) 1287 (14) 1339 (14) 1267 (4)
Haematological 
(C81-C96, D37-D48) 934 (10) 879 (10) 868 (10) 923 (10) 947 (10) 977 (10) 921 (3)
Genitourinary cancers and testicular 
(C60-C68) 994 (11) 1051 (11) 1023 (11) 989 (11) 1029 (11) 1086 (11) 1029 (3)
Neurological 
(C69-C75) 298 (3) 348 (4) 382 (4) 390 (4) 327 (4) 320 (3) 344 (1)
Cancer of unknown primary 
(C76-C80, C97-C97, D07, D09) 362 (4) 289 (3) 310 (3) 316 (3) 327 (4) 315 (3) 320 (1)
3.2 Deaths at state level – males
In 2018, 16% of all deaths in the State occurred due to 
cancer in males (C00-D09, D37-D48). There was a small 
increase over the time period under review in the number 
of these deaths from 4,732 in 2013 (16% of all deaths) to 
5,036 in 2018 (16% of state deaths). The absolute number 
of deaths due to cancer in males increased by 6% when 
2018 is compared to 2013, although as a proportion of all 
state deaths, the percentage remained the same (see Table 
4.4). Mirroring the figures for the whole population, these 
overall figures conceal the large variation that exists between 
different cancer types in males, as shown in Table 4.4.
We also present the average proportion of deaths due to 
each cancer type in males nationally within the six-year 
period (Table 4.4). This is calculated using the average 
number of deaths for each cancer type in males (2013–
2018) and the average number of total deaths within the 
State (2013–2018). ‘Gastrointestinal (C15-C26, D01)’ 
accounted for the highest average proportion of deaths 
occurring due to cancer (5%), followed by ‘respiratory and 
thoracic (C30-C39, D02)’ (4%), and ‘genitourinary cancers 
and testicular (C60-C68)’ (3%). The cancer types with the 
smallest average percentage of cancer deaths were: ‘breast 
and gynaecological (C50-C58, D05-D06)’ (<1%), ‘head 
and neck (C00-14, D00)’ (<1%), and ‘cancer of unknown 
primary (C76-C80, C97-C97, D07, D09)’ (1%) (Table 4.4).
Table 4.  


















(C00-D09, D37-D48) 4732 (16) 4815 (16) 4814 (16) 4920 (16) 4966 (16) 5053 (16) 4883 (16)
Head and neck 
(C00-14, D00) 117 (2) 116 (2) 141 (3) 125 (3) 138 (3) 147 (3) 131 (<1)
Gastrointestinal 
(C15-C26, D01) 1554 (33) 1620 (34) 1659 (34) 1650 (34) 1677 (34) 1689 (33) 1642 (5)
Respiratory and thoracic 
(C30-C39, D02) 1132 (24) 1138 (24) 1103 (23) 1106 (22) 1103 (22) 1105 (22) 1115 (4)
Skin and musculoskeletal 
(C40-C49, D03-D04) 229 (5) 205 (4) 209 (4) 252 (5) 244 (5) 279 (6) 236 (1)
Breast and gynaecological 
(C50-C58, D05-D06) 9 (<1) 5 (<1) 2 (<1) 8 (<1) 5 (<1) 8 (<1) 6 (<1)
Haematological 
(C81-C96, D37-D48) 507 (11) 521 (11) 476 (10) 556 (11) 543 (11) 564 (11) 528 (2)
Genitourinary cancers and testicular 
(C60-C68) 836 (18) 869 (18) 863 (18) 841 (17) 896 (18) 915 (18) 870 (3)
Neurological 
(C69-C75) 168 (4) 197 (4) 211 (4) 235 (5) 198 (4) 190 (4) 200 (1)
Cancer of unknown primary 
(C76-C80, C97-C97, D07, D09) 180 (4) 144 (3) 150 (3) 147 (3) 162 (3) 156 (3) 157 (1)
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3.3 Deaths at state level – females
In 2018, 14% of all deaths in the State occurred due to 
cancer in females (C00-D09, D37-D48). There was a small 
increase over the time period under review in the number 
of these deaths from 4,206 in 2013 (14% of state deaths) to 
4,413 in 2018 (14% of state deaths). The absolute number 
of deaths due to cancer in females increased by 5% when 
2018 is compared to 2013 (see Table 4.5). Like males, these 
overall figures conceal the large variation that exists between 
different cancer types in females, as shown in Table 4.5.
We also present the average proportion of deaths due to 
each cancer type in females nationally within the six-year 
period (Table 4.5). This is calculated using the average 
number of deaths for each cancer type in females (2013–
2018) and the average number of total deaths within the 
State (2013–2018). ‘Breast and gynaecological (C50-C58, 
D05-D06)’ (4%), followed by ‘gastrointestinal (C15-C26, 
D01)’ (4%), and ‘respiratory and thoracic (C30-C39, D02)’ 
(3%) accounted for the highest average proportion of deaths 
due to cancer in females. The cancer types with the smallest 
average percentage of cancer deaths were: ‘head and neck 
(C00-14, D00)’ (<1%), ‘neurological (C69-C75)’ (<1%), and 
‘skin and musculoskeletal (C40-C49)’ (<1) (Table 4.5).
Table 4.5  


















(C00-D09, D37-D48) 4206 (14) 4365 (15) 4203 (14) 4443 (14) 4371 (14) 4413 (14) 4334 (14)
Head and neck 
(C00-14, D00) 46 (1) 52 (1) 46 (1) 63 (1) 52 (1) 50 (1) 52 (<1)
Gastrointestinal 
(C15-C26, D01) 1156 (27) 1173 (27) 1134 (27) 1206 (27) 1168 (27) 1190 (27) 1171 (4)
Respiratory and thoracic 
(C30-C39, D02) 764 (18) 885 (20) 800 (19) 879 (20) 896 (20) 813 (18) 840 (3)
Skin and musculoskeletal 
(C40-C49, D03-D04) 157 (4) 152 (3) 131 (3) 164 (4) 142 (3) 156 (4) 150 (<1)
Breast and gynaecological 
(C50-C58, D05-D06) 1186 (28) 1267 (29) 1209 (29) 1292 (29) 1282 (29) 1331 (30) 1261 (4)
Haematological 
(C81-C96, D37-D48) 427 (10) 358 (8) 392 (9) 367 (8) 404 (9) 413 (9) 394 (1)
Genitourinary cancers and testicular 
(C60-C68) 158 (4) 182 (4) 160 (4) 148 (3) 133 (3) 171 (4) 159 (1)
Neurological 
(C69-C75) 130(3) 151 (3) 171 (4) 155 (3) 129 (3) 130 (3) 144 (<1)
Cancer of unknown primary 
(C76-C80, C97-C97, D07, D09) 182 (4) 145 (3) 160 (4) 169 (4) 165 (4) 159 (4) 163 (1)
3.4 Trends across male and  
female populations
3.4.1 Similarities
When comparing 2013 and 2018, there were increases for 
both males and females in the number of deaths across the 
following categories: ‘head and neck (C00-C14, D00)’, 
‘gastrointestinal (C15-C26, D01)’, ‘genitourinary cancers 
and testicular (C60-C68)’, and ‘neurological (C69-C75)’ 
(Table 4.6).
Table 4.6  
Male and female cancer deaths by cancer type: increases in both categories between 2013 and 2018
2013 2014 2015 2016 2017 2018
Head and neck 
(C00-14, D00)
Male 117 116 141 125 138 147
Female 46 51 46 63 52 50
Gastrointestinal 
(C15-C26, D01)
Male 1554 1620 1659 1650 1677 1689
Female 1156 1173 1134 1206 1168 1190
Genitourinary cancers and 
testicular (C60-C68)
Male 836 869 863 841 896 915
Female 158 182 160 148 133 171
Neurological 
(C69-C75)
Male 168 197 211 235 198 190
Female 130 151 171 155 129 130
Similarly, both males and females showed decreases across 
the following category: ‘cancer of unknown primary 
(C76-C80, C97-C97, D07, D09)’ (Table 4.7).
Table 4.7  
Male and female cancer deaths by cancer type: decreases in both categories between 2013 and 2018
2013 2014 2015 2016 2017 2018
Cancer of unknown primary   
(C76-C80, C97-C97)
Male 180 144 150 147 162 156
Female 182 145 160 169 165 159
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3.4.2 Differences
When comparing 2013 and 2018, there were some 
differences between males and females. It was found that 
where males showed increases in the following categories, 
females showed decreases: ‘skin and musculoskeletal 
(C40-C49, D03-D04)’ and ‘haematological (C81-C96, 
D37-D48)’ (Table 4.8).
Table 4.8  
Male and female cancer deaths by cancer type: increases in male category and decreases in female 
category between 2013 and 2018
2013 2014 2015 2016 2017 2018
Skin and musculoskeletal  
(C40-C49, D03-D04)
Male 229 205 209 252 244 279
Female 157 152 131 164 142 156
Haematological 
(C81-C96, D37-D48)
Male 507 521 476 556 543 564
Female 427 358 392 367 404 413
Contrasting this, where females exhibited increases 
in the following categories, males exhibited decreases: 
‘respiratory and thoracic (C30-C39, D02)’ and ‘breast and 
gynaecological (C50-C58, D05-D06)’ (Table 4.9).
Table 4.9  
Male and female cancer deaths by cancer type: increases in female category and decreases in male 
category between 2013 and 2018
2013 2014 2015 2016 2017 2018
Respiratory and thoracic   
(C30-C39, D02)
Male 1132 1138 1103 1106 1103 1105
Female 764 885 800 879 896 813
Breast and gynaecological  
(C50-C58, D05-D06)
Male 9 5 2 8 5 8
Female 1186 1267 1209 1292 1282 1331
4 Summary and policy 
implications
This chapter has used the CSO data on death to summarise 
data currently available on deaths caused by cancer in the 
State for the period 2013–2018 inclusive. In this section  
we consider and interpret the key findings.
4.1 Cancer as a leading cause of  
death and the importance of  
type of cancer
The CSO data show that the number of deaths caused by 
cancer has increased over the six-year period, although, 
as a proportion of all deaths, it has remained the same. 
There were four leading cancer categories causing death in 
2018: gastrointestinal (31% of cancer deaths), respiratory 
and thoracic (20%), breast and gynaecological (14%), and 
genitourinary and testicular (12%). Individuals aged 65+ 
accounted for a minimum of two-thirds of deaths in each 
of these four cancer categories (64%–89%). The remaining 
five cancer categories accounted for the remaining 23% 
of cancer deaths in 2018: head and neck (2% of cancer 
deaths), skin and musculoskeletal (5%), neurological (3%), 
haematological (10%) and cancer of unknown  
primary (3%).
4.2 Cancer disaggregated by sex
Out of the 9,466 deaths caused by cancer reported in 2018, 
males accounted for a greater percentage of deaths (53% of 
cancer deaths) compared to females (47%). This is broadly 
in line with the national average for 2018, when males 
accounted for 52% of deaths. Males accounted for a higher 
proportion of deaths in each of the following categories: 
head and neck, gastrointestinal, respiratory and thoracic, 
skin and musculoskeletal, haematological, genitourinary and 
testicular, and neurological. Conversely, females accounted 
for a higher proportion of deaths in two categories: breast 
and genealogical, and cancer of unknown primary.
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05
Dementia as 
a cause of death
1 Introduction
This chapter focuses on deaths caused by dementia in 
Ireland during the years 2013-2018 using mortality data 
from the Central Statistics Office (CSO) dataset.  
Dementia is not a specific disease but an umbrella term 
for the impaired ability to remember, think, or make 
decisions that is sufficiently severe to interfere with a 
person’s ability to do everyday activities. The most common 
type of dementia is Alzheimer’s disease, followed by 
Vascular Dementia. Other common types of dementias are 
Lewy body dementia, frontotemporal degeneration, and 
mixed dementias. It is estimated that there are between 
approximately 39,000 and 55,000 people with dementia  
in Ireland1. Dementia has been identified as a public  
health priority2.
In recent years, dementia increasingly features in discussions 
surrounding the leading causes of death in the State and 
the wider world. In Ireland, until 2016, the CSO Vital 
Statistics Report3 did not specifically mention dementia as 
a leading cause of death, but focused on deaths attributed 
predominantly to three ICD-104 categories: neoplasms 
(cancer); diseases of the circulatory system; and diseases 
of the respiratory system. In 2016, these three categories 
accounted for almost three-quarters (73.6%) of all State 
deaths. Since 2017, the Vital Statistics Annual Reports5 
have included a short section reporting on dementia as a 
cause of death. Although neoplasms, circulatory illness and 
respiratory illness continue to account for three-quarters 
(73.3%) of all State deaths, there has been a steady increase 
in the proportion of deaths caused by dementia over recent 
years (6% of deaths in 2013 and 8% in 2018). 
Dementia death figures can become concealed under 
ICD-10 code categories, as is evident within ‘Mental 
and Behavioural Disorder’ (F00-F99) deaths, a category 
that includes Vascular Dementia (F01) and Unspecified 
Dementia (F03). The steady increase in mental and 
behavioural disorder deaths between 2013 (1,207 deaths; 
4% of State deaths) and 2018 (1,946 deaths; 6% of State 
deaths) is largely attributed to dementia. Of the 1,946
deaths in 2018, dementia was the cause of death in the vast 
majority (96.6%) of cases. The absolute number of deaths 
due to mental and behavioural disorders increased by 61% 
when 2018 is compared to 2013, demonstrating a growing 
increase in deaths caused by dementia over the six-year 
period. In the UK, deaths due to dementia and Alzheimer’s 
disease ranked as the leading cause of death in 20186. In 
Australia, dementia was the second leading cause of deaths 
after heart disease in 2018, and the leading cause of death 
for women7. These trends have meant that more attention 
has become focused on dementia as a cause of death. 
In this chapter, we used the same ICD-10 (International 
Classification of Disease 10th Revision) codes for dementia 
type that were employed in a previous study utilising CSO 
data to examine population health and palliative care 
planning8. Dementia deaths are categorized according 
to three ICD-10 codes: F01 (Vascular Dementia), F03 
(unspecified dementia), and G30 (Alzheimer’s disease) 
(Table 5.1). These ICD-10 codes for dementia fall under 
two different cause of death categories discussed in Chapter 
3 on leading causes of death. Deaths caused by Vascular 
Dementia (F01) and unspecified dementia (F03) are 
classified under ‘mental & behavioural disorders’ (F00-F99), 
whereas deaths caused by Alzheimer’s disease (G30) are 
classified under deaths caused by diseases of the nervous 
system (G00-G99). Unspecified dementia is usually 
classified where the dementia sub-type is unknown, where 
symptoms include those that are found in more than one 
type of dementia, making it hard to distinguish between 
different dementia sub-types, or where different types of 
dementia coexist, e.g., mixed dementia. In this chapter, 
we examine dementia as cause of death in comparison to 
other cause of death categories, i.e. ‘Cancer’, ‘Diseases of 
the circulatory system’, ‘Diseases of the respiratory system’, 
‘Diseases of the digestive system’, ‘External causes of injury 
and poisoning’, and ‘Other’ categories. For the purposes of 
this chapter, the categories ‘Diseases of the nervous system’ 
and ‘Mental & behavioural disorder’ exclude deaths due  
to dementia.
Table 5.1  
Dementia types and corresponding ICD-10 codes
Dementia Category ICD-10 Codes
Vascular Dementia F01 — Classified under ‘Mental & behavioural disorder’ category
Unspecified Dementia F03 — Classified under ‘Mental & behavioural disorder’ category
Alzheimer’s Disease G30 — Classified under ‘diseases of the nervous system’ category
Total Dementia FO1; FO3; G30 
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1.1 National Overview of dementia 
deaths (2013-2018)
Of the 31,140 deaths that occurred in Ireland in 2018, 
2,446 (8%) of deaths were caused by dementia. Of these 
deaths, 64% were attributed to unspecified dementia, 23% 
to Alzheimer’s disease and the remaining 12% attributed  
to Vascular Dementia (12%) (Figure 5.1) 
Over the six-year period 2013-2018 inclusive, there  
was an increase in the proportion of deaths attributed  
to unspecified dementia (from 3% in 2013 to 5% in 2018), 
while deaths attributed to Alzheimer’s disease and  
Vascular Dementia remained constant in proportional 
terms. Total deaths attributed to dementia increased from 
6% of all State deaths in 2013 to 8% in 2018 (Figure 5.2). 
Deaths in 2018 by age group and dementia sub-type 
are presented in Table 5.2. Of the 2,473 deaths due to 
dementia, nearly all are people aged 65+ (99%-100%). 
A minority (1%) of deaths attributable to unspecified 
dementia and Alzheimer’s disease are among individuals 
aged 55-64. Individuals aged 85+ account for nearly  
two-thirds of deaths attributed to dementia (58%-66%). 
Figure 5.1 
All dementia deaths in Ireland by dementia type, 
2018 (%)
Table 5.2  
Dementia death totals by age: total, and as a proportion (%)  







0yr-4 <10 (<1) <10 (<1) <10 (<1)
5yr-14 <10 (<1) <10 (<1) <10 (<1)
15yr-24 <10 (<1) <10 (<1) <10 (<1)
25yr-34 <10 (<1) <10 (<1) <10 (<1)
35yr-44 <10 (<1) <10 (<1) <10 (<1)
45yr-54 <10 (<1) <10 (<1) <10 (<1)
55yr-64 <10 (<1) 10 (1) <10 (1)
65yr-74 22 (7) 74 (5) 56 (10)
75yr-84 100 (33) 452 (29) 180 (32)
84yr + 179 (59) 1040 (66) 328 (58)
All Age 302 1577 567
2 Deaths by dementia type, 2013-2018
2.1 Deaths at State level 
In 2018, 8% of all deaths in the State were attributed to 
dementia (F01; F03; and G30). There was an increase over 
the time period under review from 1,742 deaths in 2013 
(6% of all deaths) to 2,446 deaths in 2018 (8% of State 
deaths). The absolute number of deaths due to dementia 
increased by 40% when 2018 is compared to 2013 (See 
Table 5.3). However, the overall figure conceals the large 
variation that exists between different dementia types, as 
shown in Table 5.3.
We present the average proportions of deaths due to each 
dementia sub-type nationally within the six-year period 
(Table 5.3). This is calculated using the average number of 
deaths for each dementia type (2013-2018) as a proportion 
of the average number of total deaths within the State 
(2013-2018). Of the three sub-types, the highest average 
proportion of deaths were attributed to ‘unspecified 
dementia (F03)’ (4%) and the lowest to ‘Vascular Dementia 
(F01)’ (1%) (Table 5.3).
Table 5.3  


















Total Dementia 1742 (6) 1905 (7) 2127 (7) 2279 (7) 2291 (8) 2446 (8) 2132 (7)
Vascular Dementia 231 (13) 246 (13) 252 (12) 266 (12) 266 (12) 302 (12) 261 (1)
Unspecified Dementia 946 (54) 1066 (56) 1249 (59) 1358 (60) 1439 (63) 1577 (64) 1273 (4)
Alzheimer’s Disease 565 (32) 593 (31) 626 (29) 655 (29) 586 (26) 567 (23) 599 (2)
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The vast majority of deaths categorised as mental and 
behavioural disorders are caused by dementia. In 2013, 
there were 1,207 deaths (4% of State deaths) in this 
category, falling to 30 deaths (<1%) when deaths due to 
dementia were excluded.  Similarly, in 2018, 1,946 (6% 
of State deaths) deaths in this category fell to 67 deaths 
(<1%) when dementia was excluded. The large proportion 
of deaths caused by diseases of the nervous system are also 
due to dementia. In 2013, there were 1,378 deaths (5% of 
State deaths) in this category and this fell to 813 deaths 
(3%) when dementia was excluded.  In 2018, the number 
of deaths in this category decreased from 1,611 (5% of 
State deaths) to 1,044 deaths (3%) when dementia was 
excluded. See Figure 5.3 for all deaths from 2018 in the 
State, including dementia as a cause of death, which shows 
that dementia is the fourth leading cause of death after 
cancer, diseases of the circulatory system and diseases of the 
respiratory system.
Figure 5.3  
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2.2 Deaths at State level - males
In 2018, 902 male deaths (3% of all deaths) in the State 
were attributed to dementia (C00-D48). This was an 
increase over the time period under review from 549 deaths 
in 2013 (2% of all deaths). The absolute number of male 
deaths due to dementia increased by 64% when 2018 is 
compared to 2013 (See Table 5.4). Mirroring the figures for 
the whole population, most of these deaths were attributed 
to unspecified dementia, as shown in Table 5.4.
Table 5.4 















of all deaths 
2013-2018
Total Dementia 549 (2) 639 (2) 705 (2) 796 (3) 774 (3) 902 (3) 728 (2)
Vascular Dementia 91 (17) 102 (16) 107 (15) 115 (14) 107 (14) 140 (16) 110 (15)
Unspecified Dementia 281 (51) 351 (55) 414 (59) 465 (58) 460 (59) 571 (63) 424 (58)
Alzheimer’s Disease 177 (32) 186 (29) 184 (26) 216 (27) 207 (27) 191 (21) 194 (27)
2.3 Deaths at State level - females
In 2018, 1,544 female deaths (5% of all deaths) in the State 
were attributed to dementia (F01; F03; G30).  This was 
an increase over the time period under review from 1,194 
deaths in 2013 (4% of all deaths). The absolute number of 
female deaths due to dementia increased by 29% when  
2018 is compared to 2013 (See Table 5.5). Mirroring  
the figures for the whole population and for males, most 
female deaths were attributed to unspecified dementia,  
as shown in Table 5.5.
Table 5.5 
Female dementia deaths by dementia type: total, and as a proportion (%)  















of all deaths 
2013-2018
Total Dementia 1193 (4) 1266 (4) 1422 (5) 1483 (5) 1517 (5) 1544 (5) 1401 (5)
Vascular Dementia 140 (12) 144 (11) 145 (10) 151 (10) 159 (10) 162 (10) 150 (11)
Unspecified Dementia 665 (56) 715 (56) 835 (59) 893 (60) 979 (65) 1006 (65) 849 (60)
Alzheimer’s Disease 388 (33) 407 (32) 442 (31) 439 (30) 379 (25) 376 (24) 405 (29)
3. Summary and policy implications 
This chapter has used the CSO data on death to summarise 
data currently available on deaths caused by dementia in 
Ireland for the period 2013-2018 inclusive. In this section 
we consider and interpret the key findings.
3.1 Dementia is in the top four  
leading causes of death,  
but likely to be undercounted 
The CSO data show that deaths caused by dementia have 
increased steadily over the six-year period 2013 to 2018 
(F01; F03; and G30), and in 2018 accounted for 8% of all 
deaths in Ireland. In the 2017 and 2018 Vital Statistics 
Reports5, the inclusion by the CSO of dementia in their 
cause of death discussions appears to be a signal of the 
increasing importance of dementia as a  cause of death. 
Based on the data presented in this chapter, dementia 
figures in the top four main causes of death for 2018 in 
Ireland, following cancer (31%), diseases of the circulatory 
system (29%) and diseases of the respiratory system (13%). 
The proportion of all death attributable to dementia is 
higher than deaths caused by diseases of the nervous system 
(excluding dementia) (3%) and diseases of the digestive 
system (4%).
A number of factors are likely to be contributing to the 
rise in the proportion of deaths attributed to dementia. 
These include people living longer and surviving other 
illnesses, improvements in dementia diagnosis and increased 
reporting of dementia on death certificates as a result of 
better understanding of dementia9. However, at 8%, the 
proportion of deaths attributed to dementia is likely to 
be an undercount and unlikely to be a ‘true’ reflection of 
deaths caused by dementia. It is known that dementia is 
often omitted from death certificates, and more likely to be 
recorded if death occurs when dementia is severe or takes 
place in a long-stay residential care facility10. In the UK, 
where doctors are encouraged to report dementia on death 
certificates, the recording of dementia on death certificates 
has increased significantly. In 2019, the Office of National 
Statistics reported that 12.5% of all deaths registered in 
England and Wales were caused by dementia11.  
However, under-reporting of dementia on death certificates 
continues to be a major problem in the UK10.The extent 
of undercounting or under-identification of dementia as 
the main cause of death on death certificates in Ireland 
is unknown. However, if the UK death rate of 12.5% was 
applied to total deaths in Ireland in 2018, the number of 
deaths caused by dementia would be 3,893, substantially 
higher than 2,446 reported above. 
While this chapter has focused on deaths where dementia 
has been the main cause of death, there will be many more 
deaths of people with dementia, which is important to note 
as dementia interacts with other conditions to predispose to 
early death10. A study of dementia mentioned anywhere on 
death certificates would give a more accurate picture of the 
contribution of dementia to death, both as a primary and 
contributory cause. 
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3.2 An overwhelming majority of 
deaths attributed to dementia 
are in older age groups
Although younger people are affected by dementia, the vast 
majority of people living with dementia are aged 65+. The 
CSO shows that the number of deaths due to dementia in 
people aged under 65 years was very small, and included 
close to an equal number of males and females. Accordingly, 
nearly all deaths caused by dementia were in the older 
age categories (age 65+). For each dementia sub-type, the 
proportion of deaths increased as age increased, reflecting 
that increasing age is the single strongest risk factor for 
dementia. Most deaths were in the 85+ age category, and 
this was true for the three dementia sub-types and for males 
and females. 
3.3 Gender differences in deaths 
caused by dementia
In Ireland, as in other countries, the majority of people 
living with dementia are women. An explanation often 
cited for this gender difference is that females tend to live 
longer12 and the risk for developing dementia increases with 
age. Almost two-thirds of people with dementia in Ireland 
are women 13,14. This is reflected in the CSO data reviewed 
in this chapter, which shows that in 2018 women accounted 
for 63% of deaths caused by dementia. This is consistent 
with mortality data globally showing that 65% of deaths 
from dementia are women15.With respect to different 
dementia sub-types, the difference was less pronounced 
for Vascular Dementia; females accounted for 54% of 
deaths due to Vascular Dementia.  The differences between 
men and women remind us that dementia is a gendered 
issue and highlight the importance of paying attention 
to the gender dimension and promoting gender-sensitive 
approaches in end of life and palliative care services for 
people with dementia. 
3.4 For deaths caused by dementia, 
data on place of death is lacking 
In Chapter 2 we presented data on place of death for six 
main cause of death categories. Unfortunately, data on 
place of death is not available to us for deaths caused by 
dementia. International studies show that place of death 
for people with dementia differs substantially between 
countries, mainly due to organisational differences in 
end-of-life care provision16. However, most people with 
dementia die in residential long-stay facilities and to a lesser 
extent in hospital. Having evidence about where people 
with dementia die is important for knowing where the 
focus needs to be for end-of-life and palliative care services 
for people with dementia. 
3.5 ICD-10 codes for deaths 
attributable to dementia 
For the purposes of this chapter, we included three 
dementia ICD-10 codes (e.g. F01 (Vascular Dementia); 
F03 (Unspecified dementia); G30 (Alzheimer’s disease)) 
based on previous research examining mortality prediction 
of diseases indicating palliative care need8,17. However, 
unlike other previous research, we excluded the ICD-10 
code R54 (Senility). Studies estimating how many people 
are in need of palliative care17,18, tend to use a category 
developed by Rosenwax et al. (2005) which includes the 
code for senility (R54) alongside dementia ICD-10 codes19. 
While the term senility was used for many years to refer 
to people with cognitive decline or memory loss, and used 
(incorrectly) to refer to dementia, senility is not synonymous 
with dementia. Senility implies that characteristics of 
dementia are typical of advancing age, which is not true. For 
the purposes of this chapter, we are guided by the ICD-10 
codes (F01, F03, and G30) used by the Office of National 
Statistics in the UK for reporting on deaths caused by 
dementia11.
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1 Introduction
This chapter presents an overview of specialist palliative 
care (SPC) services in Ireland for the period 2013–2019 
inclusive using data from the Health Service Executive’s 
(HSE) Minimum Data Set for Specialist Palliative Care 
(MDS SPC). It aims to expand and update the previously 
published report: National Summary of Patient Activity 
Data for Adult Specialist Palliative Care Services in the 
Republic of Ireland, 2012–20151.
Data are presented by community healthcare organisation 
(CHO) regions 1–9 (Table 6.1) and by setting: in-patient, 
community and day care. In-patient SPC refers to care 
received by those admitted to SPC services as an in-patient 
in a hospice or in an acute hospital that provides specialist 
palliative care beds. At the end of 2017, there were 11 
hospices providing In-patient SPC services and one acute 
hospital with two dedicated SPC beds. Community SPC 
is provided to people in their normal place of residence by 
members of an SPC team, and is also known as ‘homecare’. 
Finally, Day SPC is defined as a short-term (day) admission 
to a service that provides care and support to patients  
with a serious illness. ‘Day hospice care’ allows a patient  
to continue living at home while having access to  
SPC facilities.
Table 6.1  
CHO regions for specialist palliative care
CHO Region
1 Cavan, Monaghan, Donegal, Sligo, Leitrim
2 Galway, Mayo, Roscommon
3 Clare, Limerick, North Tipperary
4 Kerry, Cork (North Lee, South Lee, North, West)
5 Carlow, Kilkenny, South Tipperary, Waterford, Wexford
6 Dublin South East, Dun Laoghaire, Wicklow
7 Dublin (South, South West, West), Kildare, West Wicklow
8 Laois, Offaly, Longford, Westmeath, Louth, Meath
9 Dublin (North, North Central, North West)
2 New patients in receipt of in-patient services
As shown in Table 6.2, Community SPC has the highest 
volume of new patients annually, followed by In-patient 
SPC and Day SPC. An increase in the number of new 
patients in receipt of both In-patient SPC (from 2,283 to 
3,225) and SPC in the community (from 8,822 to 10,301) 
occurred between 2013 and 2019 (Table 6.2), representing 
a 33% and 17% increase respectively. While In-patient and 
Community SPC showed a steady upward trend over the 
seven-year period, there was a different pattern for day care, 
reflecting varying patterns of change in Day SPC services 
at local level. Between 2013 and 2016, the number of new 
patients in receipt of Day SPC fluctuated around 950 but 
dropped to well below 900 in 2018 and 2019.
Table 6.2  
Number of new patients* in receipt of In-patient SPC, Community SPC and Day SPC, 2013–2019
New Patients 2013 2014 2015 2016 2017 2018 2019
In-patient SPC 2283 2433 2,628 3019 2963 3230 3225
Community SPC 8822 8889 8968 9660 9344 9977 10301
Day SPC 946 945 934 961 966 821 862
*‘New patients’ are people who have been admitted to an In-patient SPC unit or received SPC community or day care for the first time ever.  
The totals for the individual services cannot be added as many patients access more than one service.
3 Summary of In-patient SPC data
3.1 In-patient SPC: Ratio 
and number of beds
In 2019, there were 223 In-patient SPC beds available 
nationally, equating to 4.7 beds per 100,000 people. The 
number of beds is up from 156 in 2013, representing an 
increase of 1.3 beds per 100,000 people nationally (Table 
6.3). While nationally there is an upward trend, SPC in-
patient bed availability varies widely across CHO areas and 
trends vary remarkedly from one CHO area to another. 
The number of beds available per 100,000 people in CHO 
1 remained unchanged at 4.1, which was slightly above 
the national average in 2103 but slightly below in 2019. 
Increases were seen in CHOs 2, 3, 4 and 9, most notably 
in CHO 4, which in 2019 had the highest number of SPC 
in-patient beds per 100,000 population. Rising population 
figures and static bed numbers have meant that in CHO 
6 and CHO 7 the number of beds per 100,000 population 
was lower in 2019 than 2013. There were no In-patient 
SPC beds in CHO 8 in 2013 and this has remained 
unchanged. There was a large increase in the number of 
beds per 100,000 population in CHO 9 from 3.3 in 2013 
to 7.4 in 2014, but this fell to 6.9 in 2017 and remained 
unchanged in 2018 and 2019.
Table 6.3  
Ratio and number of SPC in-patient beds per 100,000 population, 2013–2019*
IPU Beds / 
100K Pop 
2013 
Beds / 100,000 
(Number of beds)
2014 
Beds / 100,000 
(Number of beds)
2015 
Beds / 100,000 
(Number of beds)
2016 
Beds / 100,000 
(Number of beds)
2017 
Beds / 100,000 
(Number of beds)
208 
Beds / 100,000 
(Number of beds)
2019 















CHO1 4.1 4.1 4.1 4.1 4.1 4.1 4.1
CHO2 2.7 2.7 2.7 4.0 4.0 4.0 4.0
CHO3 7.4 7.4 7.4 7.9 7.8 7.8 7.8
CHO4 3.6 6.0 6.0 6.6 8.5 8.5 8.5
CHO5** N/A N/A N/A N/A N/A N/A N/A
CHO6 3.3 3.3 3.3 3.3 3.1 3.1 3.1
CHO7 6.4 6.4 6.4 6.5 5.8 5.8 5.8
CHO8*** 0.0 0.0 0.0 0.0 0.0 0.0 0.0
CHO9 3.3 7.4 7.4 7.4 6.9 6.9 6.9
*  Bed total by year-end.
**   CHO 5: No hospice and only two specialist palliative care beds located in University Hospital Waterford;  
for this reason figures are not included.
***  CHO 8: No SPC in-patient service.
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3.2 In-patient SPC:  
New patients by age
There was a 41% increase in the number of patients 
accessing the in-patient service nationally between 2013 
and 2019 (Table 6.4). The use of In-patient SPC varies 
dramatically by age. Patients within the 65+ age group 
account for the highest proportion of new patients, and 
this has increased by 6% from just over two-thirds (68%) in 
2013 to almost three-quarters (74%) in 2019. In contrast, 
patients within the 18- to 64-year-old age group decreased 
by 6% and in 2019 accounted for just over one-quarter 
(26%) of new patients as compared to almost one-third 
(32%) in 2013. Consistently, 0–17 year olds accounted for 
less than 1% of new patients.
Table 6.4  
New patients in receipt of In-patient SPC by age, 2013-2019 
New Patients IPU Ages Profile 2013 2014 2015 2016 2017 2018 2019
National 2,283 2,433 2,628 3019 2963 3230 3225
0–17 <1% <1% <1% <1% <1% <1% <1%
18–64 32% 31% 31% 29% 31% 27% 26%
65+ 68% 69% 69% 71% 69% 73% 74%
3.3 In-patient SPC: New patients 
per 10,000 population
In 2013, the number of new patients per 10,000 population 
admitted to an SPC unit nationally was 4.98 (Table 6.5). 
This rose to 6.36 in 2019, representing a 22% (1.38) 
increase. This is likely to reflect the overall increase in the 
number of hospice beds across the country from a total of 
190 beds in 10 hospices in 2013 to 221 beds in 11 hospices 
by the end of 2017.
When comparing 2013 and 2019, six CHO regions showed 
an increase in new patients receiving specialist in-patient 
care per 10,000 population (CHO 2, CHO 3, CHO 4, 
CHO 6, CHO 7 and CHO 9), with the biggest increases 
in CHO 4 and CHO 9. There was a decrease in one CHO 
region (CHO 1).
Table 6.5 
New patients in receipt of specialist palliative in-patient care, per 10,000 population by CHO, 2013–2019
IPU New Patients 
/ 10K Pop 2013 2014 2015 2016 2017 208 2019
National 4.98 5.30 5.75 5.93 5.81 6.41 6.36
CHO1 8.80 7.50 6.53 7.33 6.75 6.75 4.73
CHO2 4.10 5.46 4.54 5.34 4.55 4.94 4.94
CHO3 9.03 10.26 10.60 9.95 9.64 11.38 11.12
CHO4 6.53 6.96 9.04 8.95 7.63 11.48 11.60
CHO5* N/a N/a N/a N/a N/a N/a N/a 
CHO6 5.01 5.34 5.27 5.40 6.03 5.72 7.12
CHO7 6.77 7.22 7.14 6.71 7.25 7.14 7.35
CHO8** 0.00 0.00 0.00 0.00 0.00 0.00 0.00
CHO9 4.71 4.60 7.67 9.03 9.46 9.27 9.49
*  CHO 5 has no hospice and only two specialist palliative care in-patient beds, located in  
University Hospital Waterford; for this reason figures are not included.
**  No In-patient SPC service in CHO 8; however, some patients access services in other CHOs.
3.4  In-patient SPC: New patients  
by primary diagnosis
As Chapter 3 has shown, cancer is one of the leading causes 
of death within Ireland, and while there has been a small 
increase in the absolute number of deaths due to cancer, 
cancer deaths as a proportion of all deaths has remained 
much the same2,3.
The MDS SPC data show that nationally, the vast majority 
of new patients admitted to SPC in-patient units are 
patients with a primary diagnosis of cancer. There has 
been a small but steady decrease in the proportion of new 
patients with cancer as a primary diagnosis being admitted 
to In-patient SPC units, representing a drop of 5 percentage 
points when comparing 2013 to 2019 (conversely non-
cancer increased by 5 percentage points) (Table 3.6). The 
national trend is mirrored at regional level; all CHO regions 
with SPC services showed a decrease in new patients having 
cancer as their primary diagnosis between 2013 and 2019.
Table 6.6 
SPC in-patient units, new patients by primary diagnosis and CHO, 2013–2019
New Patients 
















National 89% 11% 88% 12% 86% 14% 86% 14% 86% 14% 86% 14% 84% 16%
CHO1 87% 13% 86% 14% 82% 18% 79% 21% 80% 20% 75% 25% 71% 29%
CHO2 85% 15% 83% 17% 88% 12% 85% 15% 85% 15% 86% 14% 84% 16%
CHO3 90% 10% 89% 11% 87% 13% 88% 12% 88% 12% 84% 16% 85% 15%
CHO4 91% 9% 89% 11% 87% 13% 88% 12% 92% 8% 94% 6% 86% 14%
CHO5* 96% 4% 97% 3% 85% 15% 94% 6% 87% 13% 76% 24% 75% 25%
CHO6 84% 16% 86% 14% 77% 23% 83% 17% 82% 18% 82% 18% 79% 21%
CHO7 87% 13% 91% 9% 90% 10% 89% 11% 88% 12% 87% 13% 86% 14%
CHO8** N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
CHO9 92% 8% 86% 14% 87% 13% 87% 13% 83% 17% 86% 14% 86% 14%
* CHO 5 had only two specialist beds, located in University Hospital Waterford.
** No in-patient service in CHO 8.
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3.5 In-patient SPC: Normal place of 
residence of new patients prior to 
admission
In 2013, slightly more than half (51%) of new patients were 
living in their own or their carer’s home prior to admission 
to an In-patient SPC unit, and slightly less than a half
(46%) were admitted from an acute hospital (Table 6.7). 
This trend has reversed over time, and in 2019 slightly less 
than a half (47%) of new patients were admitted from their 
own or their carer’s home and slightly more than a half of 
new patients were admitted from an acute hospital (52%). 
The remaining new patients (<1%) were admitted from a 
range of other locations, which were categorised differently 
before and after 2019.
Table 6.7 
Location (normal place of residence) of new patients prior to admission  
to Specialist Palliative Care In-patient Units, 2013–2019
2013 2014 2015 2016 2017 208 2019
Total new patients 2,283 2,433 2,637 2,821 2,768 3,063 3029
Patient’s home/Carer’s home 51% 51% 51% 52% 49% 46% 47%
Acute hospital 46% 47% 47% 47% 50% 52% 52%
Intermediate/Support bed* 1% 1% 1% 0% 0% <1%
Non-acute bed* <1% <1% <1% 0% 0% <1%
Other* 2% <1% <1% 1% 1% N/a
Residential care (nursing home community 
nursing unit district hospital)† <1%
Designated non-specialist intermediate care 
bed in community setting† <1%
*  Categories that existed before 2019.
†  Categories that were updated from 2019.
3.6 In-patient SPC: Number of  
discharges/transfers and deaths
The data indicates that in the years 2013 to 2019, 
approximately two-thirds of patients admitted to an  
In-patient SPC unit died there and one-third were 
discharged or transferred. Compared to 2013, the 
proportion of patients who died in an In-patient SPC 
unit in 2019 (69%) increased by 5% and the proportion 
of patients who were discharged or transferred (31%) 
decreased by 5%.
Table 6.8 















Total number of patients 2909 3086 3387 3541 3436 3782 3708
Discharged/transferred 1045 (36) 1075 (35) 1156 (34) 1199(34) 1044 (30) 1180 (31) 1131 (31)
Deaths 1864 (64) 2011 (65) 2231 (66) 2342 (66) 2392 (70) 2602 (69) 2577 (69)
3.7  In-patient SPC: Normal place 
of residence of patients after 
discharge
In 2013, while nearly two-thirds (64%) of patients died 
in an In-patient SPC unit, close to one-third (31%) 
were discharged to their own home (Table 6.9). The 
proportion of patients who died in an In-patient SPC unit 
(69%) increased in 2019, compared to a decrease in the 
proportion of patients discharged to their own home (28%), 
representing a 5% increase and a 3% decrease respectively. 
The proportion of patients discharged/transferred to other 
settings was very small. These locations were categorised 
differently before and after 2019. In 2019, residential care 
(nursing home, community nursing unit district hospital) 
accounted for <1% of discharges/transfers from In-patient 
SPC units.
Table 6.9 















Total patients 2909 3086 3387 3541 3436 3782 3708
Died in In-patient SPC 1864 (64) 2011 (65) 2231 (66) 2342 (66) 2392 (70) 2602 (69) 2577 (69)
Patient’s permanent home 904 (31) 943 (30) 1046 (31) 1069 (30) 910 (26) 1052 (28) 1025 (28)
Carer’s home 2 (<1) 7 (<1) 5 (<1) 7 (<1) 11 (<1) 0 (<1) 0 (<1)
Acute hospital 39 (1) 51 (2) 51 (2) 69 (2) 53 (2) 60 (2) 68 (2)
Intermediate care bed in 
community setting (including 
designated bed in nursing 
home)
28 (1) 20 (1) 17 (1) 10 (<1) 34 (1) 54 (1) 31 (1)
Non-acute hospital* 15 (<1) 11 (<1) 9 (<1) 10 (<1) 8 (<1) 13 (<1)
Private nursing home* 32 (1) 21 (1) 26 (1) 34 (1) 28 (1) 1 (<1)
Other 25 (1) 22 (1) 2 (<1) 0 (<1) 0 (<1) 0 (<1) 0 (<1)
Residential care (nursing 
home, community nursing 
unit, district hospital)†
7 (<1)
*  Categories that existed before 2019.
†  Categories that were updated from 2019.
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3.8  In-patient SPC: Bed days – 
availability and occupancy
Table 6.10 shows that the number of In-patient SPC bed 
days available was 56,058 in 2013 and that this rose to 
78,991 in 2019, an increase of 40%. It shows that in each 
year more than three-quarters of available In-patient SPC 
unit beds were occupied. However, the percentage of bed 
days used (occupancy) fell from 86.6% in 2013, to 80.5%  
in 2019, a decrease of 6.1%.
Table 6.10. 















Bed days available 56058 61395 69450 74388 74874 79868 78991
Bed days available  
(bed days used) 56058 61395 69450 74388 74874 79868 78991
% occupancy 86.6% 84.8% 80.4% 82.6% 78.5% 79.5% 80.5%
3.9 In-patient SPC: Length of stay
Between 2013 and 2017, there was no notable change in the 
length of stay for patients in any length-of-stay category. 
In 2019, an equal proportion of patients stayed for a week 
or less (44%) and for 8–28 days (44%). The length-of-stay 
categories altered from 2018. Data show that in 2019, 14% 
of patients stayed for one to three months and a very small 
proportion (<1%) stayed more than three months.
Table 6.11 















1–7 days 1240 (43) 1257 (41) 1417 (42) 1412 (40) 1361 (40) 1670 (43) 1624 (44)
8–28 days 1293 (44) 1367 (45) 1487 (44) 1556 (44) 1549 (45) 1673 (43) 1567 (44)
29–84 days*/1–3 months† 325 (11) 373 (12) 432 (13) 492 (14) 458 (13) 551 (14) 505 (14)
84+ days*/3+ months† 54 (2) 53 (2) 57 (2) 86 (2) 74 (2) 19 (<1) 17 (<1)
* Categories that existed before 2018.
† Categories that were updated from 2018.
4  Summary of Community SPC data
4.1 Community SPC:  
New patients by age
Similar to In-patient SPC, the majority of new patients in 
receipt of SPC in the community (homecare) are people in 
the 65+ age group. For 2018 and 2019, the age categories 
were expanded and show that patients in the 65–84 age 
group make up the majority of new patients in receipt 
of SPC in the community. Patients in the 51–64-years 
age group also account for a sizeable proportion of new 
patients, around one-fifth, followed by people in the 85+ 
age group. People in younger age groups account for smaller 
proportions of new patients. In 2019, 7% were aged 18–50 
years. In 2019, <1% of patients in receipt of SPC in the 
community were aged 0–17 years, a decrease from 1% in  
the years 2013 to 2015.
Table 6.12 
New patients in receipt of Community SPC by age, 2013-2019 
2013 2014 2015 2016 2017 2018 2019
0 – 17 years 1% 1% 1% <1% <1% <1% <1%
18–64 years* 22% 23% 21% 29% 31% 27% 26%
18–50 years† 6% 7%
51–64 years† 21% 19%
65 years or over* 77% 76% 78% 71% 69% 73% 74%
65–84 years† 60% 57%
85 years and over† 13% 17%
Total 8822 8889 8967 2825 2769 3033 3029
*  Categories that existed before 2018.
†  Categories that were updated from 2018.
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4.2 Community SPC: Zero-to  
seven-day wait times by CHO
In 2014 the 0–7 day admission access target for all services 
was set at 95%. In 2019, this target was not reached in any 
CHO area, although CHO 1 came close at 94%. Over the 
seven years from 2013–2019, CHO 5 stands out as the area 
to most frequently reach the target (four out of seven years). 
CHO 1 reached the target twice, CHOs 2, 3, 8 and 9 once, 
and the target was never achieved in CHOs 4, 6 and 7.
Table 6.13 
0–7 day wait times for Community SPC by CHO, 2013–2019
2013 2014 2015 2016 2017 208 2019
National 87% 88% 89% 92% 92% 87% 86%
CHO1 91% 92% 92% 95% 96% 93% 94%
CHO2 90% 92% 91% 92% 95% 90% 90%
CHO3 100% 79% 96% 93% 93% 77% 85%
CHO4 78% 94% 91% 89% 86% 77% 72%
CHO5 95% 94% 98% 97% 96% 92% 86%
CHO6 78% 83% 77% 90% 83% 89% 88%
CHO7 78% 78% 77% 83% 86% 82% 86%
CHO8 91% 92% 91% 93% 95% 88% 88%
CHO9 76% 76% 79% 94% 94% 93% 91%
4.3 Community SPC: Rate of new 
patients per 10,000 population  
by CHO
In 2013, 19.2 new patients per 10,000 population received 
SPC in the community nationally (Table 6.5). This 
increased to 21.6 in 2019. However, there is wide variation 
across CHO areas, ranging in 2019 from 14.0 new patients 
per 10,000 population in CHO 7 to 28.8 in CHO 2. In six 
CHO areas, the rate was higher than the national average 
of 21.6. When 2013 and 2019 are compared, eight CHO 
regions showed an increase in new patients receiving SPC 
in the community per 10,000 population (CHOs 1, 2, 3, 4, 
5, 6, 7, 9), although the rate of increase varied substantially 
between these regions. CHO 8 was the only region to 
experience a decrease over the seven-year period.
Table 6.14 
New patients in receipt of Community SPC per 10,000 population by CHO, 2013–2019
2013 2014 2015 2016 2017 208 2019
National 19.2 19.4 19.6 20.3 20.2 21.0 21.6
CHO1 20.4 20.6 21.7 23.1 23.3 23.6 25.5
CHO2 21.8 22.0 24.1 24.6 26.5 26.5 28.9
CHO3 23.3 23.4 21.9 21.7 18.8 23.1 23.9
CHO4 21.2 22.7 21.8 24.7 22.2 21.7 22.7
CHO5 21.3 19.7 20.7 22.8 22.2 25.3 24.7
CHO6 16.9 19.5 21.9 21.6 22.0 20.7 23.5
CHO7 11.8 11.9 12.6 12.9 13.0 14.2 14.0
CHO8 25.3 24.0 21.2 20.6 21.6 21.8 20.4
CHO9 13.7 13.8 14.5 14.8 16.4 16.5 17.4
4.4 Community SPC: New patients by 
primary diagnosis and CHO area
Overall, between 2013 and 2019, the proportion of new 
patients with cancer as a primary diagnosis receiving 
SPC in the community decreased by 9 percentage points 
from 74% to 65% (conversely non-cancer increased by 9 
percentage points) (Table 6.15). This pattern was observed 
across the nine CHO regions, all of which showed a 
decrease in the proportion of new patients with cancer as 
their primary diagnosis between 2013 and 2019. However, 
there are differences between different CHO regions in the 
proportion of new patients living with cancer. For example, 
the lowest proportion in 2019 of new patients with a non-
cancer primary diagnosis was in CHO 5 (26%) and the 
highest proportion was in CHO 2 and CHO 6 (both 42%).
Table 6.15 
Community SPC New Patients by Primary Diagnosis and CHO, 2013–2019
















National 74% 26% 72% 28% 71% 29% 70% 30% 68% 32% 70% 30% 65% 35%
CHO1 70% 30% 67% 33% 67% 33% 66% 34% 65% 35% 64% 36% 62% 38%
CHO2 70% 30% 67% 33% 65% 35% 62% 38% 58% 42% 64% 36% 58% 42%
CHO3 71% 29% 71% 29% 68% 32% 69% 31% 72% 28% 73% 27% 66% 34%
CHO4 74% 26% 71% 29% 70% 30% 69% 31% 73% 27% 68% 32% 67% 33%
CHO5 89% 11% 85% 15% 83% 17% 79% 21% 75% 25% 83% 17% 74% 26%
CHO6 70% 30% 65% 35% 64% 36% 65% 35% 61% 39% 67% 33% 58% 42%
CHO7 81% 19% 78% 22% 75% 25% 76% 24% 75% 25% 69% 31% 70% 30%
CHO8 64% 36% 66% 34% 67% 33% 66% 34% 66% 34% 71% 29% 63% 37%
CHO9 83% 17% 84% 16% 76% 24% 74% 26% 70% 30% 69% 31% 68% 32%
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4.5 Community SPC: Patient deaths 
by place of death
In 2013, over two-fifths (42%) of patients receiving 
Community SPC died at home, compared with 14%  
who died in an In-patient SPC unit (Table 6.16). 
For 2018 and 2019, place of death categories changed 
somewhat, making it a little difficult to make comparisons 
with earlier years. Nevertheless, in 2019, patient’s home/
carer’s home continued to account for the majority (40%) 
of deaths, although the proportion who died in an In-
patient SPC unit rose to 18%. There was a decrease in the 
proportion of Community SPC patients who died in acute 
hospitals, from 20% in 2013 to 15% by 2019. Conversely, 
the proportion of patients who died in private nursing 
homes increased from 14% in 2013 to 18% in 2019. 
Residential care (community nursing unit district hospital) 
accounted for 9% of deaths in 2019.
Table 6.16. 















Total Community  
SPC patient deaths 7,382 7,676 7,828 8362 7999 8268 8889
Patient’s home* 42% 42% 41% 41% 41%
Specialist palliative care  
in-patient unit 14% 15% 17% 17% 17% 19% 18%
Acute hospital 20% 19% 16% 16% 15% 16% 15%
Intermediate care beds in com-
munity setting* 6% 6% 5% 5% 5%
Non-acute hospital bed* 4% 5% 5% 5% 5%
Private nursing home 14% 13% 14% 14% 15% 20% 18%
Other* 1% 1% 2% 2% 3%
Patient's home/carer’s home† 39% 40%
Residential care (community 
nursing unit, district hospital)† 7% 9%
*  Categories that existed before 2018.
†  Categories that were updated from 2018.
5 Summary of Day SPC data
5.1 Day SPC: New patients by age
The overall number of new patients in receipt of Day 
SPC was 946 in 2013 and 862 in 2019, representing a 9% 
decrease in the number of patients between these years 
(Table 6.17). Whereas people aged 18–64 years accounted 
for approximately one-third of patients in receipt of Day 
SPC in 2013, in 2019 they accounted for one-quarter 
of patients. There was a corresponding increase in the 
proportion of patients aged 65 years and over from two-
thirds in 2013 to three-quarters in 2019. A small proportion 
of patients are aged 0–17 years. For 2018 and 2019, the 
age categories were expanded showing that the majority 
of patients were aged 65–84 years in both 2018 and 2019, 
followed by people aged 51–64 years.
Table 6.17 
New patients in receipt of Day SPC by age, 2013–2019
2013 2014 2015 2016 2017 2018 2019
0 – 17 years N/A N/A N/A <1% <1% <1% <1%
18–64 years* 34% 33% 29% 30% 29% 25% 25%
18–50 years† 7% 5%
51–64 years† 18% 20%
65 years or over* 66% 67% 71% 70% 68% 68% 75%
65–84 years† 55% 62%
85 years and over† 13% 13%
Total 946 945 934 961 966 821 862
*  Categories that existed before 2018.
†  Categories that were updated from 2018.
5.2 Day SPC: New patients by 
primary diagnosis
Patients with a primary diagnosis of cancer accounted for 
the majority of new Day SPC patients between 2013 and  
2019. However, the proportion of patients with a primary 
diagnosis of cancer decreased from 87% in 2013 to 77% 
in 2019, and there was a corresponding increase in the 
proportion of new patients with a non-cancer diagnosis.
Table 6.18 
Day SPC – new patients by primary diagnosis, 2013–2019
2013 2014 2015 2016 2017 2018 2019
Total 946 945 928 961 966 821 862
Cancer 87% 83% 83% 83% 82% 82% 77%
Non-cancer 13% 17% 17% 17% 18% 18% 23%
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6  Discussion
6.1 New patients 
receiving SPC
The number of new patients receiving SPC varies by SPC 
type. Changes over time also vary by SPC type. Of the three 
types of SPC services, the greatest number of new patients 
are accessing Community SPC followed by In-patient SPC 
and Day SPC (Table 6.17). In 2019, there were 10,301 new 
patients accessing Community SPC, which is an increase 
of 17% when compared with 2013. There were 3,029 new 
patients accessing In-patient SPC in 2019, representing a 
bigger increase of 33% when compared with 2013. There 
were 862 patients in receipt of Day SPC in 2019, up from 
the previous year, but a decrease from over 900 new patients 
in the years 2013 to 2018. In 2019, individuals aged 65+ 
years accounted for at approximately three-quarters of the 
total number of new patients in receipt of SPC across each 
setting (in-patient, Table 6.4; community, Table 6.12; and 
day care, Table 6.17).
6.2 Access to SPC services –  
in-patient and community
There was an overall upward trend in the number of SPC 
in-patient beds available per 100,000 population over the 
period under review, rising at national level to 4.7 beds per 
100,000 population in 2019. However, this still falls far 
short of the recommendation made in 2001 by the National 
Advisory Committee on Palliative Care (NACPC) that 
‘there should be at least 8 to 10 SPC beds available per 
100,000 population to meet the increasing needs for 
specialist palliative care services in Ireland’4. Moreover, 
there was wide variation across CHO areas, with only 
CHO 4 reaching the recommended eight to ten SPC beds 
per 100,000 population. Despite a recommendation by the 
NACPC in 2001 that ‘there should be at least one SPC unit 
in each health board area’, there were no In-patient SPC 
beds available in CHO 5 or CHO 8 in 2019 (Table 6.3)4.
Nationally, there was also an increase in the number of new 
patients per 10,000 population admitted to an In-patient 
SPC unit from 4.98 in 2013 to 6.36 in 2019, a 22% (1.38) 
increase. Regionally, increases occurred in six of the nine 
CHO regions over the seven-year period (Table 6.5).
Between 2013 and 2019, there was an increase in the 
number of In-patient SPC unit bed days available (40% 
increase). On average, approximately three-quarters of 
available In-patient SPC unit beds were occupied, but 
occupancy fell by 6% between 2013 and 2019 (Table 6.10). 
There was no notable change in length of stay for patients 
between 2013 and 2017. In 2019, 44% of patients stayed for 
less than a week, 44% for 8–28 days, 14% for 1–3 months 
and <1% for 3+ months (Table 6.11).
The number of new patients per 10,000 population 
accessing Community SPC increased from 19.2 in 2013 to 
21.6 in 2019, an increase of 13% (2.4). While access varied 
widely across CHO areas, access increased in eight CHO 
regions over the seven-year period, but decreased in CHO 8 
(Table 6.14).
6.3  Access to SPC services – 
primary diagnoses
Data were available on the primary diagnosis type  
(cancer vs non-cancer diagnoses) of new patients in the 
three types of SPC service – In-Patient, Community and 
Day SPC. It shows that in 2019 the vast majority of new 
patients admitted to SPC in-patient units at national (84%) 
and CHO level (71% to 86%) were patients with cancer  
and that there has been a small but steady decrease since 
2013 at both national (89%) and CHO level (84% to 96%)  
(Table 6.6).
While the majority of patients receiving Community  
SPC at both national (65%) and CHO level (58% to 74%) 
in 2019 had cancer as a primary diagnosis, the proportion is 
lower than for SPC in-patient units. Similar to In-patient 
SPC units, the proportion of patients receiving Community 
SPC with a primary diagnosis of cancer has fallen since 
2013 at both national (74%) and CHO level (64% to 89%) 
(Table 6.15). Likewise, in 2019 the majority (77%) of  
new patients accessing Day SPC in 2019 had cancer  
as a primary diagnosis, a reduction from 87% in 2013 
(Table 6.18).
The data indicate that patients with life-limiting illness 
other than cancer are making up a greater proportion of 
new patients using SPC services. This is in keeping with 
the principle underpinning the NACPC that palliative 
care should be available to all, irrespective of diagnosis4. 
Nationally, in 2019, they make up 16% of new patients 
using In-patient SPC units, 35% of Community SPC 
patients and 23% of Day SPC patients. The desired level 
of activity for these patients within SPC services is 25%5. 
Therefore, within Community SPC the desired level 
of activity for these patients was not only achieved but 
exceeded and this level is also close to being achieved in 
Day SPC.
6.4  Normal place of residence of 
patients on admission and 
discharge
Data available on place of residence before admission to an 
In-patient SPC unit shows that in 2019 slightly more than 
a half of new patients were admitted from an acute hospital 
(52%) and slightly less than half (47%) from their own/
carer’s home, a reversal of trends in 2013 (Table 6.7).
Around two-thirds (66%) of patients admitted to an In-
patient SPC unit in 2019 died there, but around a quarter 
(28%) were discharged to their own home, a smaller 
proportion than in 2013. Discharges or transfers to other 
settings are very low (Table 6.9).
Data on place of death for new patients availing of 
Community SPC data show that in 2019 around two-fifths 
die at home (similar to 2013), around one-fifth die in an 
In-patient SPC unit (up from 2013), one-fifth in an acute 
hospital (down from 2013), and one-fifth in private nursing 
homes (up from 2013) (Table 6.16).





This chapter presents an overview of emergency admissions 
to acute public hospitals in Ireland for the period 2013–
2017 inclusive, using data from the Hospital Inpatient 
Experience (HIPE) database.
In Ireland throughout this period there were 34 acute public 
hospitals with an emergency department. Every admission 
is recorded in HIPE, which is operated by the Health 
Service Executive and Healthcare Pricing Office. Recorded 
categories of data are:
• Dates of Admission and Discharge
• Admission Type: booked or emergency
• Sex
• Marital / Civil Status
• Area of Residence by county
• Medical Card status
• Diagnoses: Principal and up to 29 additional 
secondary diagnoses, recorded using International 
Statistical Classification of Diseases and Related 
Health Problems (ICD) codes
• Procedures: Principal and up to 19 additional 
secondary procedures, recorded using ICD codes
• Discharge Destination
Due to the lack of a unique patient identifier, there 
is no way to quantify how many individuals are reflected 
 in the data.
In this chapter we present HIPE data with a particular 
focus on emergency admissions indicating palliative and 
end-of-life care needs.
2 National overview
2.1 All admissions, by discharge 
status and serious illness
HIPE specifies 15 discharge destinations. We group these 
into six categories to ease interpretation.
Table 7.1  
HIPE discharge destinations
HIPE discharge  
destination
Grouped in  
this chapter
Died no post mortem
Death
Died with post mortem
Home Home
Hospice Hospice
Hospital/acute hospital –  
emergency
Other hospital
Hospital/acute hospital – 
non-emergency
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In Table 7.2 we present emergency admissions of adults to 
acute hospitals in Ireland in 2017, resulting in overnight 
stay, by discharge status. There were 273,244 such 
admissions recorded. The majority of patients went home 
upon discharge (79%). Next most common destinations 
were LSRCF (11%) followed by transfer to another acute 
hospital (4%). Most relevant for this report are those who 
died in acute hospitals (4%) and those discharged to a 
hospice (<0.5%).
Table 7.2 separates out the 143,383 emergency admissions 
where the patient had a recorded diagnosis of serious life-
limiting illness. We identify these diagnoses in the same 
way as in Chapter 3 ICD codes for cancer, major organ 
failure or dementia. Compared to all emergency admissions, 
these admissions are more likely to end in death (6%), 
discharge to LSRCF (15%) or discharge to hospice (0.7%), 
and less likely to result in discharge home or to other place.
Admissions with a serious illness were 52% of all 
admissions. These admissions accounted overwhelmingly  
for deaths (94%) and hospice discharges (94%) as well  
as for the majority of discharges to other hospitals (71%)  
and LSRCFs (57%).
Table 7.2 
Emergency admissions of adults to acute hospitals 
















Died in hospital 9,697 (4%) 9,134 (6%) 94%
Home 215,582 (79%) 102,313 (71%) 47%
Hospice 1,074 (<0.5%) 1,006 (0.7%) 94%
LSRCF 31,386 (11%) 21,517 (15%) 57%
Other hospital 10,758 (4%) 7,612 (5%) 71%
Other place 4,747 (2%) 1,801 (1%) 38%
Total 273,244 143,383 52%
2.2 Length of stay, by discharge 
status and serious illness
In Table 7.3 we present mean and median length of stay in 
days, by discharge status and serious illness. Mean length 
of stay for all 273,244 admissions was 8.7 days and median 
length of stay was four days. This indicates that a small 
number of patients had unusually high length of stay. It 
is a near-universal characteristic of health care data that a 
minority of people account for a majority of use, and this 
is the case for all admissions and admission with a serious 
illness as well as for all discharge destinations in Table 7.3.
With respect to discharge status, admissions ending in 
discharge to hospice (average stay 20.5 days), discharge 
to LSRCF (18.8 days) and death (17.8 days) account for 
the majority of hospital days. A similar pattern is observed 
when looking only at those admissions with a serious 
illness, and average length of stay (LOS) is longer overall 
(11.6 days) and for each discharge destination.
Table 7.3 
Mean and median length of stay in days,  




With a serious 
illness (N=143,383)
Mean LOS (Median)
Died in hospital 17.8 (10) 18.0 (10)
Home 6.8 (4) 9.1 (6)
Hospice 20.5 (14) 21.0 (14)
LSRCF 18.8 (10) 21.4 (11)
Other hospital 9.0 (5) 9.6 (5)
Other place 8.4 (3) 13.1 (5)
Total 8.7 (4) 11.6 (6)
3 Hospital groups
HIPE data restrictions preclude reporting at the individual 
hospital level. Each hospital is part of one regional group:
• Ireland East Hospital Group
• Dublin Midlands Hospital Group
• RCSI Hospital Group
• South/Southwest Hospital Group
• UL Hospitals
• Saolta Hospital Group
In this section we report admission numbers, discharge 
status and LOS by hospital group. We restrict the sample 
to the 143,383 admissions with diagnosis of serious illness, 
since these account for the large majority of episodes that 
end in discharge to hospice, discharge to LSRCF and 
patient death.
3.1  Admissions, by discharge status 
and hospital group
Total number of admissions with a serious illness,  
by discharge status and hospital group, are presented  
in Table 7.4.
Five of the six hospital groups each account for 16%–20% 
of total admissions. The exception is UL Hospitals, which 
account for 8% of episodes.
There is high consistency of discharge destination across 
groups. Home is the majority destination in all cases 
(69%–72%) and LSRCF is the second most common 
(15%–16%). Between 5% and 8% of admissions end in the 
patient’s death in hospital. Approximately 1% of patients 
are discharged to hospice.
Table 7.4. 



















with a serious 
illness
Died in hospital 2,069 (7%) 1,592 (7%) 1,563 (7%) 1,926 (8%) 524 (5%) 1,460 (5%) 9,134 (6%)
Home 19,622 (69%) 21,527 (72%) 16,262 (72%) 17,943 (70%) 7,772 (70%) 19,187 (72%) 102,313 (71%)
Hospice 128 (<0.5%) 195 (1%) 174 (1%) 205 (1%) 81 (1%) 223 (1%) 1,006 (0.7%)
LSRCF 4,675 (16%) 3,355 (16%) 3,615 (16%) 4,146 (16%) 1,737 (16%) 3,989 (15%) 21,517 (15%)
Other hospital 1,484 (5%) 1,553 (4%) 942 (4%) 1,066 (4%) 896 (8%) 1,671 (6%) 7,612 (5%)
Other place 569 (2%) 419 (1%) 182 (1%) 273 (1%) 107 (1%) 251 (1%) 1,801 (1%)
All Age 28,547 28,641 22,738 25,559 11,117 26,781 143,383
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3.2 Length of stay, by discharge 
status and hospital group
Length of stay for admissions with a serious illness, by 
discharge status and hospital group, are presented in Table 7.5.
UL Hospitals had the lowest average LOS (mean=9.8 
days) and Ireland East Hospital Group the highest (12.7 
days). Both groups had a median stay of six days, and all 
groups had a median stay of six or seven days, suggesting 
that higher means are driven by a relatively small number 
of longer-stay admissions. Longer stays in the Ireland 
East Hospital Group, which includes two large university 
hospitals and cancer centres, may reflect visits for specialist 
care from all parts of the country.
Table 7.5 
Length of stay for admissions with a serious illness, by discharge status and hospital group, 2017 
Mean LOS  
(Median)
All admissions 

















Died in hospital 18.0 (10) 20.1 (10) 21.0 (12) 18.2 (10) 16.0 (10) 14.3 (8) 15.6 (9)
Home 9.1 (6) 9.1 (5) 9.6 (6) 9.5 (6) 8.8 (6) 8.3 (6) 8.5 (5)
Hospice 21.0 (14) 27.5 (18.5) 27.8 (20) 26.9 (19) 14.1 (10) 12.3 (9) 16.3 (12)
LSRCF 21.4 (11) 23.7 (12) 27.4 (13) 22.2 (11) 20.3 (11) 15.6 (11) 16.5 (10)
Other hospital 9.6 (5) 9.6 (5) 8.4 (3) 11.8 (8) 8.6 (4) 9.0 (5) 10.2 (6)
Other place 13.1 (5) 22.3 (6) 10.3 (5) 8.1 (4) 8.1 (4) 7.0 (4) 8.8 (4)
All Age 11.6 (6) 12.7 (6) 12.4 (6) 12.3 (7) 11.3 (6) 9.8 (6) 10.3 (6)
3.3 Length of stay, over time
Mean length of stay (days) for admissions by hospital group 
between 2009 and 2017 are presented in Figure 7.1.
At the start of this period, in 2009, there were notable 
differences in mean length of stay between hospital groups:
from 15.1 days (Dublin Midlands) to 9.2 (UL). Some 
convergence over time, with a drop in mean LOS among 
high-LOS hospital groups and an increase in LOS among 
low-LOS hospital groups, meant that this difference was smaller 
in 2017: from 12.7 days (Ireland East) to 9.8 days (UL).
Figure 7.1 





















4 End-of-life care as a core 
activity in acute hospitals
Summary data on admission numbers, length of stay 
and discharge status emphasise that death and dying 
are a central issue for all acute hospital services. If we 
combine the data provided in Tables 7.2 and 7.3 then we 
can calculate the total number of bed days in Irish public 
hospitals in 2017 – and the proportion accounted for by 
each discharge status. These data are presented for patients 
with a serious illness in Figure 7.2. The 6% of patients 
who die during admission account for 10% of days. Those 
discharged to long-stay residential care facilities (28%) and 
hospice (1%) also account for significant numbers of days.
Figure 7.2 
Total bed days in 2017, by discharge status,  
among admissions with a serious illness
Another useful perspective is to consider expected survival 
of hospital in-patients beyond their admission. A large 
majority of people with serious illness in Irish hospitals are 
discharged alive, but within this group exists a significant 
number who would benefit from palliative and end-of-life 
care. In their landmark paper, Clark et al. tracked 10,743 in-
patients in 25 Scottish teaching and general hospitals on 31 
March 2010 for one year1. They found that 3,098 (28.8%) 
patients died during the year following, and concluded, 
‘Large numbers of hospital in-patients have entered the 
last year of their lives. Such data could assist in advocacy 
for these patients and should influence end-of-life care 
strategies in hospital.’
A replication study is not possible in Ireland because the 
lack of a unique identifier prevents us following patients for 
the year following admission. Nevertheless, we can compare 
the data reported by Clark et al. with the data available via 
HIPE and make some inferences about the role of death 
and dying in Irish hospitals.
In Table 7.6 we replicate the data from Clark et al., 
alongside data on people in HIPE as Irish in-patients 
admitted as an emergency on 29 March 2017. We chose 
this date as (1) the most recent year in our data, (2) the date 
in 2017 that was as close as possible to Clark et al.’s census 
date of 31 March 2010 while still being the same day of the 
week (Wednesday). We adopted this strategy to minimise 
temporal effects in comparison: hospital admissions vary by 
day of the week and time of year.
The age distribution of patients in the two studies was 
extremely similar: 28% aged under 60 in Scotland compared 
to 27% in Ireland, 8% versus 7% aged 60–64, 10% in both 
places aged 65–69, 11% versus 12% aged 70–74, 14% versus 
13% aged 75–79, 13% versus 14% aged 80–84, and 16% 
versus 17% aged over 85.
An important difference immediately observable is the 
hospital mortality rate: of the Scottish cohort, 1001 (9%) 
died during the index admission. For the Irish cohort, 
the equivalent figure is 460 (6%). This is consistent with 
evidence cited elsewhere in this report that the Irish health 
care system is unusually reliant on hospital in-patient 
admissions, and so has shorter length of stay and lower 
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A direct comparison of age distributions and mortality rates 
is not possible because HIPE provides only death data for 
the admission under study, while Clark et al. do not provide 
mortality rates by age and location but instead by age and 
survival at 30 days. The 30-day mortality rate in Scotland 
was also 9%, suggesting a good level of comparability with 
index admission mortality rate even if the two are not 
identical. An indirect comparison of HIPE mortality rates 
for the admission against Scottish mortality rates after 30 
days suggests that Irish hospital mortality rates are lower 
across the age distribution: 11% of admissions for over 85 
year olds end in death, whereas in Scotland 15% of patients 
over 85 years died within a month, and proportions are lower 
in Ireland than Scotland for every other age bracket also.
Table 7.6 
Mortality among hospital in-patients in Scotland and Ireland
Scottish hospitals, 31/3/2010 Irish hospitals, 29/3/2017
Age At Census
Died during  
admission
Died 1 month Died 12 mths At Census
Died during ad-
mission
<60 3008 28% . . 110 4% 394 13% 1962 27% 55 3%
60–64 845 8% . . 60 7% 191 23% 517 7% 20 4%
65–69 1021 10% . . 87 9% 299 29% 758 10% 42 6%
70–74 1185 11% . . 105 9% 355 30% 895 12% 54 6%
75–79 1487 14% . . 148 10% 491 33% 954 13% 66 7%
80–84 1430 13% . . 180 13% 562 39% 997 14% 80 8%
85+ 1767 16% . . 261 15% 806 46% 1279 17% 143 11%
All 10743 1001 9% 951 9% 3098 29% 7362 460 6%
. = data not provided. Data for ‘Scottish Hospitals’ are replicated without change from Clark et al. (2014) under licence from Creative Commons BY 3.0.
Hospital in-patients in Scotland have approximately 1.5 
times the odds of dying compared to in-patients in Ireland 
(a 9% mortality rate versus 6%). If this differential is 
consistent across a 12-month period then approximately 
20% of adult in-patients in Irish public hospitals on a given 
day will die within the year. While not as high as trends in 
Scotland, this is still a large number of adults approaching 
end of life who would benefit from acute hospital care that 
is tailored to their needs.
5 Use of Z51.5
Palliative care engagement is not routinely recorded in 
HIPE data. In the ICD-10 handbook, the ICD-10 code 
Z51.5 denotes ‘encounter for palliative care’. However, 
there is no requirement for a palliative care team to have 
been involved in in-patient care in order for an in-patient 
to receive this code. Often it is added to a patient record 
when the attending clinical team (e.g. oncology, cardiology) 
deems that the emphasis of care has shifted from mainly 
curative to mainly supportive. Ultimately, patients who do 
not receive specialist palliative care may nevertheless have a 
Z code recorded; those who do receive specialist palliative 
care may not. Consequently, this Z code is not deemed a 
reliable indicator of specialist palliative care involvement. 
Studies in the US have shown that, on the one hand, the 
Z code has a high true negative rate , that is, it is rare for 
someone to have Z51.5 recorded in their file without having 
received specialist palliative care – for example, because 
their attending physician does not involve the palliative 
care team but shifts the emphasis to supportive rather than 
curative care in their own approach to the patient. On 
the other hand, these studies have shown that the Z code 
does not have a particularly strong true positive rate  for 
identifying palliative care involvement3, since a third of 
people who do receive palliative care do not have Z51.5 
recorded in their file, mainly because there is no systematic 
requirement for any clinical team to do so.
Despite its limitations, Z51.5 has some uses for 
understanding patterns of practice for seriously ill people 
in acute hospitals. First, while it is not perfectly aligned 
with specialist palliative care receipt it is nevertheless 
strongly correlated. Therefore, if we observe changing 
patterns of use of Z51.5 over time we can reasonably infer 
changing patterns of palliative care use. Second, where 
use of the Z51.5 code is not indicating specialist palliative 
care involvement it is nevertheless indicative of changing 
mindset among non-palliative clinicians; for example, 
increased use of the Z51.5 code for people not receiving 
palliative care would suggest that other specialisms are 
themselves more frequently changing emphasis from 
curative to supportive intent in their care of seriously  
ill patients.
5.1 Diagnoses of people  
receiving Z51.5 code
Table 7.7 includes data on the primary diagnoses (i.e. 
reason for hospital episode) of the 16,755 episodes (either 
in-patient or day case) which had a coding for Z51.5 in 
2017. To correspond with ‘Chapter 3: Cause of Death’, we 
have grouped the primary diagnoses into seven overarching 
conditions. The majority of hospital episodes had a primary 
diagnosis of cancer (29.9%), a disease of the respiratory 
system (20%) or a disease of the circulatory system (8.7%). 
Diseases of the digestive and nervous systems, and mental 
and behavioural disorders, accounted for a combined total 
of 8.4% of hospital episodes. The remaining 33.5% of 
hospital cases were due to ‘other’ conditions.
Table 7.7 









Disease of the circulatory system 1448 8.7
Disease of the respiratory system 3350 20.0
Disease of the digestive system 1066 6.4
Disease of the nervous system 234 1.4
Mental & behavioural disorders 87 0.6
Other 5566 33.5
Total 16755 100
* The true negative rate (also known as specificity) is the probability that an actual negative (in this case: did not receive SPC) will test negative (in this 
case: did not receive a Z51.5 code in their file).
† The true positive rate (also called specificity) is the probability that an actual positive (received SPC) will test positive (receive a Z51.5 code).
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5.2 Use of Z51.5 code over time
The number of Z51.5 episodes per 10,000 in-patient 
episodes by hospital group between 2013 and 2017 is 
presented in Figure 7.2.
Between 2013 and 2017, each hospital group experienced 
an increase in the number of Z51.5 episodes per 10,000 in-
patient episodes. The RCSI Hospital Group experienced the 
greatest increase over the five-year period (67% increase) 
and UL Hospitals experienced the smallest increase (24%). 
In 2017, the Dublin Midlands Hospital Group accounted 
for the highest number of Z51.5 episodes per 10,000 in-
patient episodes (279 episodes) and the South/Southwest 
Hospital Groups accounted for the lowest (240 episodes).
Figure 7.3 
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6 Discussion
Emergency in-patient hospital admissions are an important 
aspect of health care use for people living and dying with 
serious illness. This group inevitably faces a relatively high 
number of episodes requiring emergency care4. At the same 
time, most people prefer to keep hospital stays as short 
as possible provided they can access suitable supports at 
home5. Furthermore, hospital in-patient stays account for 
over half of health care costs in the last year of life6. Ireland’s 
hospital system has much lower spare capacity than many 
similar EU countries7. Therefore it is essential that hospital 
stays for people with serious illness are responsive to needs 
from the point of emergency admission, including early 
involvement of palliative care where appropriate, while 
maintaining the length of admission at no longer than 
necessary to maximise patient experience and minimise 
inefficient expenditures.
The data in this chapter show that approximately half 
of adult emergency admissions to acute hospitals in 
Ireland occur for people with a diagnosis of cancer, major 
organ failure or dementia. These admissions account 
disproportionately for both length of stay and discharges 
ending in death. Patterns of length of stay and discharge 
locations have been broadly consistent across hospital 
groups and over time.
It is therefore clear that care for dying patients is a core 
function of acute public hospitals, though this fact is not 
always clearly acknowledged. People dying with a serious 
illness accounted for 10% of all bed days in 2017 and 
additional large numbers were accounted for by those 
discharged to hospice and long-term residential care. 
Combining data from HIPE with a prior study in Scotland, 
we estimate that on a given day 20% of people in Irish 
public hospitals following an emergency admission will die 
within 12 months.
Research efforts by policymakers and academics to tackle 
the Irish system’s high reliance on hospital care face data 
challenges. First, the lack of a unique patient identifier 
means that investigators cannot track people before or 
following a given admission, which profoundly limits our 
understanding of how they came to be admitted and how 
they fared after discharge. Indeed, in this chapter we cannot 
quantify how many individuals were admitted to Irish 
hospitals – only the total number of admissions. Second, 
the lack of a reliable indicator of specialist palliative care 
receipt is an important barrier to measuring access, and 
to evaluating the effectiveness and cost-effectiveness of 
services. Third, the volume of admissions with a serious 
illness far exceeds the capacity of specialist palliative care in 
acute hospitals. Diffusing palliative care approaches across 
hospital staff is essential to meet this large and growing 
need, and data collection is essential to monitor and 
evaluate those approaches.
It is also important to consider dynamics outside the 
hospital silo. A recent study in Dublin found that better 
community services are associated with a reduction 
in length of hospital stay8. Reducing length of stay 
can improve experiences for patients and costs for the 
system, but better still might be eliminating an admission 
altogether. Up to a quarter of emergency admissions 
in Ireland are potentially avoidable9, and international 
evidence suggests that Ireland has unusually high reliance 
on in-patient stay7.
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Discussion 
1  Summary of main results
1.1  Place of death
In Chapter 2 we grouped CSO data on place of death into 
five main categories: hospital, home, long-stay residential 
care facility (LSRCF), hospice and elsewhere. For each of 
these categories we examined trends over time, regional 
variations and age-related variations.
Data showed that hospitals are the most common place 
of death in Ireland and hospital death rates remained 
steady over the period under review. Hospitals are the most 
common place of death for all age groups apart from people 
aged 85+ years. A greater proportion of people aged 85+ die 
in LSRCFs than in hospitals. Accordingly, LSRCFs are a 
significant place of death for older people. This is important 
given the ageing of the population and highlights the need 
for end-of-life and palliative care services to respond to 
changing demographics. While the proportion of deaths in 
LSRCFs has increased only slightly over the six-year period 
under review, different trends were observed when nursing 
homes and community hospitals were examined separately. 
Deaths in nursing homes have increased while deaths in 
community hospitals have decreased. The reasons for these 
diverging trends warrant further investigation.
There was a small increase in the number of in-patient 
hospice beds between 2013 and 2018, and this is likely to  
be responsible for the increase in the proportion of deaths 
in hospices from 6% to 8%. The proportion of deaths that 
take place at home has remained steady at 23%. Given that 
the expressed preference of most people is for a home death 
and the least preferred place of death is hospital, there is  
a marked mismatch between preferred and actual place  
of death. While the reasons for this are multiple, and place 
of death is determined by a complex interplay of factors, 
more attention needs to be focused on enabling people  
who wish to die at home to do so, where this is possible  
and appropriate.
With respect to regional variations in place of death, the 
most marked variation was for hospices. Not all regions 
have a hospice, so while people do move across regional 
borders for a hospice admission, this inevitably impacts 
patterns of care: access to a hospice relies heavily on 
whether you live near to one. This highlights the need for 
greater access to in-patient hospice care across the country 
to reduce the geographical inequity that currently exists. 
It is expected that the recent or planned opening of new 
hospices will go some way to addressing this inequity. 
While home death rates have remained stable at 23% since 
2013, there is marked regional variation across the country. 
Whereas in Dublin 17% of deaths occurred at home, most 
counties had home death rates above the national average 
of 23%, reaching a high of 30% or more in Carlow and 
Longford. The CSO data do not allow us to quantify how 
many such deaths occur in places consistent with preference. 
For example, low home deaths in Dublin may be due to 
low home care capacity and overreliance on hospitals, and/
or high home deaths in rural areas may be due to improved 
accessibility of other services or high reliance on unpaid 
family carers. Further investigation is needed to understand 
how regional variation reflects preferences and the extent to 
which it reflects unmet need.
1.2 Cause of death
In Chapter 3, we grouped 1,780 different causes of death 
into eight main categories, and used these data to examine 
trends over time, regional variations in leading causes of 
death, and age and sex differences.
The CSO data show that between 2013 and 2018 cancer 
replaced diseases of the circulatory system as the leading 
cause of death in Ireland. This change partly reflects a 
long-term trend of declining heart-related mortality in 
Ireland. Diseases of the respiratory system were the third 
most common cause of death in 2018. While deaths caused 
by mental and behavioural disorders was lower, accounting 
for 6% of all deaths, these deaths increased substantially, by 
61%, between 2013 and 2018.
Most deaths in Ireland occur among older people, with 
people aged 65+ accounting for 82% of all deaths in 2018. 
However, this varies across different cause of disease 
categories, ranging from 77% for deaths caused by cancer 
to 99% for deaths caused by mental and behavioural 
diseases, the latter being largely attributed to dementia. This 
highlights the importance that diseases such as dementia 
are gaining as a cause of death for older people. The data 
also show that leading causes of death vary among different 
sexes. Cancer mortality is higher among males, whereas 
deaths from diseases caused by mental and behavioural 
disorders are more prevalent among females. These findings 
highlight the importance of organising specialist palliative 
care services to be responsive to individuals’ needs, such as 
age, sex, circumstances and preferences for end-of-life care.
Cause of death was also examined with respect to place of 
death and data show that place of death varies greatly for 
different cause of death categories, highlighting that where 
a person dies is likely to be influenced by the type of disease 
and the disease trajectory.
The aim of this report was to present and appraise 
routine data collection on death and dying in the 
Republic of Ireland. The report drew on three main 
sources: CSO data generated from death certificates, 
the HSE’s specialist palliative care service’s Specialist 
Palliative Care Minimum Data Set (SPC MDS), and 
the Hospital In-Patient Experience (HIPE) database on 
admissions to public hospitals.
We used the CSO data on mortality covering the years 
2013 to 2018 inclusive in two main ways: (1) to examine 
place of death, and (2) to examine leading causes of 
death in Ireland. For the latter, we first examined the 
main cause of death categories and then examined cancer 
and dementia separately as leading causes of death. 
The SPC MDS provides summary data on activity and 
utilisation of SPC services for the period 2013–2019 
inclusive. We used HIPE data to present an overview 
of emergency admissions to acute public hospitals in 
Ireland for the period 2013–2017 inclusive, with a focus 
on those with serious life-limiting illnesses such as 
cancer, advanced organ disease and dementia.
This chapter presents the main findings from our analysis 
and discusses the most important implications with 
respect to data access, classification and coding practices, 
and data gaps and limitations.
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1.2.1  Cancer as a cause of death
In Chapter 4, we grouped different types of cancer into 
nine categories to enable us to provide an overview of death 
rates for different types of cancer and how these differ by 
age and sex. Data show that there were four leading cancer 
categories among the 9,466 deaths caused by cancer in 
2018: gastrointestinal (31% of cancer deaths), respiratory 
and thoracic (20%), breast and gynaecological (14%), and 
genitourinary and testicular cancers (12%). People aged 65+ 
accounted for at least two-thirds of deaths in each of these 
four cancer categories. There were important sex differences, 
with females accounting for a higher proportion of deaths 
in two categories (breast and gynaecological and cancer of 
unknown primary), and males accounting the majority in all 
other cancer categories.
1.2.2  Dementia as a cause of death
In Chapter 5, we analysed deaths caused by dementia. There 
has been a steady increase in deaths caused by dementia 
over the period 2013–2018 and of the 31,140 deaths that 
occurred in Ireland in 2018, 2,446 (8%) were caused by 
dementia. Of these, 64% were attributed to unspecified 
dementia, 23% to Alzheimer’s disease and 12% to vascular 
dementia. Factors likely contributing to this rise include 
longer life expectancy and increasing dementia prevalence, 
improved dementia diagnosis, and better reporting of 
dementia on death notification forms. It is highly likely that 
there is an underreporting of deaths caused by dementia 
for a variety of reasons, but the extent of underreporting 
is unknown. Nearly all deaths caused by dementia were 
among older age groups, and increased as age increased, 
which is not surprising given that increasing age is the 
biggest risk factor for dementia. Women accounted for 
two-thirds of the deaths caused by dementia. This reminds 
us that dementia is a gendered issue and highlights the 
importance of paying attention to the gender dimension 
and promoting gender-sensitive approaches in end-of-life 
and palliative care services for people with dementia. 
1.3  Activity for Specialist Palliative 
Care services
Chapter 6 summarised data on activity for and utilisation 
of adult SPC services for the period 2013 to 2019, based on 
the SPC MDS. It updates a previously published report1. 
Data show that while there was an upward trend in the 
number of new patients admitted to an in-patient SPC unit 
and receiving SPC community care for the first time, the 
number of new patients receiving SPC day care decreased 
from 2018. While nationally the number of SPC in-patient 
beds per 100,000 population increased to 4.7, this is still 
below the level recommended in 2001 by the National 
Advisory Committee on Palliative Care (NACPC)2, 
and there is wide variation regionally, with only one 
Community Healthcare Organisation (CHO) achieving the 
recommended level of beds. There was one CHO with no 
in-patient SPC beds in 2019. With respect to Community 
SPC, access also varied regionally.
The primary diagnosis of the vast majority of new patients 
admitted to in-patient SPC units and receiving Community 
SPC and specialist palliative day care is cancer. However, 
patients with life-limiting illness other than cancer make 
up a greater proportion of new patients using SPC services. 
This is in keeping with the principle underpinning the 
NACPC2 and the substantial work by IHF over many  
years through their Palliative Care for All programme,  
that palliative care should be available to all, irrespective  
of diagnosis. The desired level of activity for these  
patients is being achieved in Community SPC,  
but not in other SPC services.
In regard to place of death, the SPC MDS showed that 
two-thirds of new patients admitted to in-patient SPC 
units die there, with most of the remainder discharged 
home. The place of death for new patients receiving 
Community SPC is varied.
1.4 Hospital emergency admissions
Chapter 7 showed that people with a diagnosis of cancer, 
major organ failure or dementia make up approximately 
half of all adult emergency admissions to acute hospitals 
in Ireland. These admissions account disproportionately for 
both length of stay and discharges ending in death. Patterns 
of length of stay and discharge locations are broadly 
consistent across hospital groups and over time.
Death and dying are a core activity of acute public hospitals 
in Ireland. We estimate that among all adults in an acute 
public hospital in Ireland following emergency admission 
on a given day, one in five will die within the next 12 
months. It is clear that the volume of admissions with a 
serious illness far exceeds the capacity of SPC services in 
acute hospitals. Diffusing palliative care approaches across 
hospital staff is essential to meet this large and growing 
need. Moreover, better community services could potentially 
reduce emergency admission of patients with serious illness 
to acute hospitals in the first place.
2 Challenges, policy implications and next steps
2.1 Reliable indicators and outcome 
measures
In this report we have used available data to establish  
what is known in relation to important issues on death  
and dying in Ireland. In reviewing our findings, it is 
essential to remember what is not currently measured.  
This should inform interpretation of the data that we  
have and prompt consideration of improved data collection 
practices in future.
Dying at the preferred place is widely held to be a desirable 
outcome of palliative care. Accordingly, place of death is 
commonly used as an indicator of a ‘good death’ and as a 
proxy for quality of care. However, place of death on its own 
is not necessarily a good indicator or proxy for either. For 
example, where a person dies is determined by a complex 
interplay of factors, some of which are not easily modified. 
Therefore, while population-level indicators of home and 
hospital deaths may tell us something about how the overall 
system is performing, they tell us nothing about individual 
experiences, which will vary very widely. There is a need 
to broaden the focus beyond place of death, with place of 
death used as one indicator in a suite of indicators of quality 
of care at end of life.
Similarly, cause of death is a measure that must be carefully 
interpreted. We have highlighted, for example, that the 
proportion of deaths (8%) attributed to dementia is likely to 
be an undercount, signalling the need for improvements in 
dementia diagnosis as well as better reporting of dementia 
on death certificates. Moreover, as populations age and 
people live and die with multiple serious conditions and 
limitations, the concept of a single identifiable ‘cause of 
death’ is increasingly flawed. What is recorded on the 
death certificate as the primary cause is often a value 
judgement by the person filling the certificate in. Improved 
understanding of the total prevalence of conditions, and the 
co-occurrence of specific conditions, as people age and die is 
critical to planning and providing appropriate services.
The SPC MDS is a standardised dataset, with a focus on 
SPC services activity and utilisation. It does not tell us 
if there is an essential minimum core of professionally 
trained staff with recognised post-qualification specialist 
training and critical expertise in SPC services. Moreover, 
it does not include standardised outcome measures for use 
in evaluating and monitoring the quality of SPC services 
at a national level. Increasingly, person-centred outcome 
measures are seen as the gold standard for measuring 
quality of care. The Palliative Care Outcomes Collaboration 
(PCOC) in Australia (https://www.uow.edu.au/ahsri/
pcoc/), which provides a useful source of routine palliative 
care outcome data in Australia and is being implemented 
internationally, offers a useful model for consideration for 
Ireland. There may also be examples from other countries.
Furthermore, not all patients who could benefit from SPC 
services will receive SPC services. These patients will be 
excluded from the MDS. Some people will be receiving 
SPC services provided by voluntary sector organisations 
such as the Nurses for Night Care Programme operated 
by the Irish Hospice Foundation and Night Nursing by 
the Irish Cancer Society, neither of which is captured by 
the MDS. For this reason, access to a broad range of data 
is needed to understand end-of-life care of all people with 
life-limiting illnesses in Ireland.
With respect to in-patients in acute hospitals, the lack  
of a reliable indicator of SPC receipt is an important  
barrier to measuring access, and to evaluating the 
effectiveness and cost-effectiveness of in-patient care  
in acute hospital services.
2.2 Classification and coding 
practices
A methodological challenge associated with using 
secondary data relates to classification and coding 
practices. Although changes to classifications can affect 
comparability over time, we regard the new place of death 
classification introduced by the CSO in 2017 as a positive 
development. For example, ‘hospice’ is now included as a 
separate place of death category. We found that the new 
11-category classification introduced by the CSO allows 
for reasonably accurate data that will inform regional and 
national trends of place of death and impact future service 
planning. However, we found interpreting CSO data on 
place of death to be challenging as definitions are not 
provided for each category. Two categories in particular, i.e. 
‘community hospitals’ and ‘nursing homes’, are problematic, 
as, lacking clear definitions, they make interpretation of the 
findings more difficult. The provision of clear definitions 
by the CSO for ‘nursing homes’ and ‘community hospitals’ 
would be helpful for data interpretation. Moreover, we 
found that each of the datasets that we used classifies 
long-stay residential care facilities in a different way, 
and incompatibility across datasets is an issue that needs 
to be addressed. Classification changes occurred with 
respect to the MDS, specifically with respect to place of 
residence both before admission to and after discharge 
from an in-patient SPC unit, and to length of stay. These 
changes affected comparability over time. Expansion of age 
categories in the MDS is to be welcomed.
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2.3 Absence of a unique patient 
identifier
There is no unique patient identifier in Ireland, which 
presents challenges for secondary data analysis. For example, 
it means that investigators cannot track people before or 
following a given hospital admission, which profoundly 
limits our understanding of how they came to be admitted 
and how they fared after discharge. Indeed, in this report 
we could not quantify how many individuals were admitted 
to acute hospital or receiving SPC services, only the total 
numbers in receipt of these services. Palliative and end-of-
life care is complex care: people use a variety of different 
services in different settings, and optimally they do so 
from early in the diagnosis of a serious disease until death. 
Therefore, understanding how the trajectory of disease 
and need changes, how people use and access services, 
and how people die requires the linking of multiple data 
sources over time at the individual level. The Covid-19 
crisis has provided a further illustration of the limitations 
placed upon providers and patients by the lack of a unique 
identifier. Acting upon existing legislation to implement 
a unique identifier is a long-standing priority in the Irish 
health system and a pre-requisite if patients are to receive 
responsive, efficient, high-quality health care across multiple 
providers and settings as they approach end of life.
2.4 Data limitations and gaps
We have shown that there are wide regional variations with 
respect to use of SPC services, highlighting that access to 
services may be limited by where a person lives. Similarly, 
we have shown that there are age disparities with respect to 
place of death.
Concerns about equity often fuel debates regarding the 
extension of palliative care services. While the datasets we 
used allowed us to examine some variations between groups, 
for the purposes of demonstrating inequities, we would 
also need to show that such variations can be attributed to 
variations in need. This was not possible with the datasets 
available to us, highlighting the need for research to 
examine why the variations identified occur.
We do not have data to show place of death for people 
with dementia. Having evidence about where people with 
dementia die is important for knowing where the focus 
needs to be for end-of-life and palliative care services 
for people with dementia. A more general problem with 
the CSO data is that it does not provide a breakdown of 
place of death by sex, ethnicity or socio-economic status, 
thus limiting the usefulness of the data for understanding 
gendered, ethnic and socio-economic variations in place of 
death. A specific request could be made for a breakdown by 
gender and by occupational status. However, ethnicity is not 
currently recorded on the Death Notification Form.
It is possible to analyse data from the MDS by age, but 
not by sex, ethnicity or socio-economic group. This is in 
spite of the fact that the NACPC in 2001 stated that the 
SPC MDS ‘should include demographic (e.g. age, sex, 
ethnic) information on all patients of the SPC services’ (p. 
120)2. The NACPC in 2001 drew particular attention to 
ethnicity stating that: ‘ethnic and cultural diversity is now 
a demographic reality within most western societies and 
cannot be ignored by SPC services’ (p. 45)2. It must not be 
ignored in death registration data either. These data gaps 
need to be addressed.
2.5 Challenges accessing data
The research team faced challenges in gaining access to 
data for secondary analysis. The National Cancer Registry 
Ireland (NCRI) maintains a national cancer register with 
information on every case of cancer in Ireland. It was 
intended at the outset to use NCRI data, but access to the 
national dataset was not achieved due to NCRI capacity 
issues in processing the data. While access to data from 
other sources was achieved, capacity issues contributed to 
delays in accessing data from the MDS and HIPE data, 
and there were limits to the level of data that the CSO 
could produce for the research team. Getting access to or 
clarification on data was further hampered by the Covid-19 
pandemic and in 2021 the cybersecurity attack on the 
HSE. There is increasing recognition of the power of data 
to inform better care, but our experience is that accessing 
population data for secondary data analysis is problematic. 
Better systems need to be put in place to facilitate 
researchers to gain access to health and social care data, and 
capacity issues preventing access needs to be addressed.
2.6 Data on impact of Covid-19 
pandemic not yet available
Undoubtedly, the Covid-19 pandemic has had a significant 
impact on dying and death in Ireland. Data for 2020 is 
not yet available from any of the datasets examined and 
it remains to be seen how the Covid-19 pandemic has 
impacted this area, although it is highly likely that when 
it becomes available the data will show that the Covid-19 
pandemic had an impact on place of death, SPC activity 
and utilisation, and hospital emergency admissions. In the 
UK, for example, data show that the number of deaths 
from all causes in private homes for 2020 increased by 
approximately one-third when compared with previous 
years and the increase was sustained throughout 20203,4. 
Several reasons were identified for this increase4. However, 
in the UK, concerns have been raised that without adequate 
support and care in the community, dying at home may 
not have been a positive experience during the pandemic, 
and many gaps in knowledge were highlighted. In Ireland, 
even in the absence of data, Covid-19 provides us with an 
opportunity to generate debate on important issues relating 
to dying and death.
2.7 Suggested next steps in data 
infrastructure
The following steps have been identified by the research 
team for progressing work in the area of secondary data 
analysis on death and dying in the Republic of Ireland.
• Promote the use of person-centred outcome 
measures, including people’s preferences,  
to better evaluate and monitor end-of-life  
care at national level.
• Address data gaps relating to sex, ethnicity and 
socio-economic status.
• Address the lack of a unique identifier so that we  
can understand people’s experiences and health care 
use across the trajectory of serious illness.
• Increase compatibility between datasets, particularly 
in relation to data on long-stay residential care and 
how it is classified.
• Improve access to relevant datasets by researchers.
• Promote collaboration among data-holding bodies 
and researchers.
Such considerations should be taken alongside other 
relevant work in this area in recent times5.
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